Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
17-beta hydroxysteroid dehydrogenase 3 deficiency | HSD17B3* | Hsd17b3* | 1 model | Alliance of Genome Resources | |||
2-aminoadipic 2-oxoadipic aciduria | DHTKD1* | Dhtkd1* | 1 model | Alliance of Genome Resources | |||
3-methylglutaconic aciduria type 3 | OPA3* | Opa3* | 1 model | Alliance of Genome Resources | |||
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | SERAC1* | Serac1* | 1 model | Alliance of Genome Resources | |||
aceruloplasminemia | CP* | Cp* | 3 models | Alliance of Genome Resources | |||
acheiropody | LMBR1* | Lmbr1* | 1 model | Alliance of Genome Resources | |||
achondrogenesis type IA | TRIP11* | Trip11* | 3 models | Alliance of Genome Resources | |||
achondrogenesis type II | COL2A1* | Col2a1* | 1 model | Alliance of Genome Resources | |||
achromatopsia 2 | CNGA3* | Cnga3* | 3 models | Alliance of Genome Resources | |||
achromatopsia 3 | CNGB3* | Cngb3* | 2 models | Alliance of Genome Resources | |||
achromatopsia 7 | ATF6* | Atf6* | 1 model | Alliance of Genome Resources | |||
acromesomelic dysplasia, Grebe type | GDF5* | Gdf5* | 2 models | Alliance of Genome Resources | |||
acromesomelic dysplasia, Hunter-Thompson type | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
acromesomelic dysplasia, Maroteaux type | NPR2* | Npr2* | 2 models | Alliance of Genome Resources | |||
adenine phosphoribosyltransferase deficiency | APRT* | Aprt* | 3 models | Alliance of Genome Resources | |||
adult hypophosphatasia | ALPL* | Alpl* | 9 models | Alliance of Genome Resources | |||
adult-onset autosomal dominant demyelinating leukodystrophy | LMNB1* | Lmnb1* | 1 model | Alliance of Genome Resources | |||
advanced sleep phase syndrome 1 | PER2* | Per2* | 1 model | Alliance of Genome Resources | |||
agenesis of the corpus callosum with peripheral neuropathy | SLC12A6* | Slc12a6* | 3 models | Alliance of Genome Resources | |||
age related macular degeneration 12 | CX3CR1* | Cx3cr1* | 2 models | Alliance of Genome Resources | |||
age related macular degeneration 4 | CFH* | Cfh*, Cfhr4 | 1 model | Alliance of Genome Resources | |||
Aicardi-Goutieres syndrome | ADAR* | Adar* | 3 models | Alliance of Genome Resources | |||
Aicardi-Goutieres syndrome | TREX1* | Trex1* | 1 model | Alliance of Genome Resources | |||
alacrima, achalasia, and impaired intellectual development syndrome | GMPPA* | Gmppa* | 1 model | Alliance of Genome Resources | |||
Alexander disease | GFAP* | Gfap* | 4 models | Alliance of Genome Resources | |||
alopecia universalis | HR* | Hr* | 3 models | Alliance of Genome Resources | |||
alpha-2-plasmin inhibitor deficiency | SERPINF2* | Serpinf2* | 1 model | Alliance of Genome Resources | |||
alpha thalassemia-X-linked intellectual disability syndrome | ATRX* | Atrx* | 3 models | Alliance of Genome Resources | |||
Alstrom syndrome | ALMS1* | Alms1* | 6 models | Alliance of Genome Resources | |||
Alzheimer's disease 3 | PSEN1* | Psen1* | 6 models | Alliance of Genome Resources | |||
amelogenesis imperfecta hypomaturation type 2A2 | MMP20* | Mmp20* | 1 model | Alliance of Genome Resources | |||
amelogenesis imperfecta hypomaturation type 2A3 | WDR72* | Wdr72* | 1 model | Alliance of Genome Resources | |||
amelogenesis imperfecta type 1B | ENAM* | Enam* | 6 models | Alliance of Genome Resources | |||
amelogenesis imperfecta type 3C | RELT* | Relt* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD1* | Sod1* | 2 models | Alliance of Genome Resources | |||
ankyloblepharon-ectodermal defects-cleft lip/palate syndrome | TP63* | Trp63* | 1 model | Alliance of Genome Resources | |||
ankyrin-B-related cardiac arrhythmia | ANK2* | Ank2* | 1 model | Alliance of Genome Resources | |||
antithrombin III deficiency | SERPINC1* | Serpinc1* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 10 | DSG2* | Dsg2* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 12 | JUP* | Jup* | 4 models | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 8 | DSP* | Dsp* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 2 | IFT80* | Ift80* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 3 | DYNC2H1* | Dync2h1* | 1 model | Alliance of Genome Resources | |||
ataxia telangiectasia | ATM* | Atm* | 9 models | Alliance of Genome Resources | |||
Athabaskan brainstem dysgenesis syndrome | HOXA1* | Hoxa1* | 1 model | Alliance of Genome Resources | |||
atransferrinemia | TF* | Trf* | 2 models | Alliance of Genome Resources | |||
atrial heart septal defect 2 | GATA4* | Gata4* | 1 model | Alliance of Genome Resources | |||
atrial heart septal defect 7 | NKX2-5* | Nkx2-5* | 2 models | Alliance of Genome Resources | |||
atrichia with papular lesions | HR* | Hr* | 2 models | Alliance of Genome Resources | |||
autoimmune interstitial lung, joint, and kidney disease | COPA* | Copa* | 1 model | Alliance of Genome Resources | |||
autoimmune lymphoproliferative syndrome type 2B | CASP8* | Casp8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant auditory neuropathy 1 | DIAPH3* | Diaph3* | 2 models | Alliance of Genome Resources | |||
autosomal dominant congenital deafness with onychodystrophy | ATP6V1B2* | Atp6v1b2* | 2 models | Alliance of Genome Resources | |||
autosomal dominant distal hereditary motor neuronopathy 2 | HSPB8* | Hspb8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant hypocalcemia 1 | CASR* | Casr* | 2 models | Alliance of Genome Resources | |||
autosomal dominant hypocalcemia 2 | GNA11* | Gna11* | 2 models | Alliance of Genome Resources | |||
autosomal dominant hypophosphatemic rickets | FGF23* | Fgf23* | 2 models | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 26 | AUTS2* | Auts2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 38 | EEF1A2* | Eef1a2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 39 | MYT1L* | Myt1l* | 2 models | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 7 | DYRK1A* | Dyrk1a* | 1 model | Alliance of Genome Resources | |||
autosomal dominant keratitis-ichthyosis-deafness syndrome | GJB2* | Gjb2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 3 | CHRNB2* | Chrnb2* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 12 | TECTA* | Tecta* | 4 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 13 | COL11A2* | Col11a2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 22 | MYO6* | Myo6* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | SLC17A8* | Slc17a8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 36 | TMC1* | Tmc1* | 3 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 41 | P2RX2* | P2rx2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 67 | OSBPL2* | Osbpl2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 9 | COCH* | Coch* | 1 model | Alliance of Genome Resources | |||
autosomal dominant osteopetrosis 2 | CLCN7* | Clcn7* | 7 models | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | PKD2* | Pkd2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant pseudohypoaldosteronism type 1 | NR3C2* | Nr3c2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive Alport syndrome | COL4A3* | Col4a3* | 5 models | Alliance of Genome Resources | |||
autosomal recessive Alport syndrome | COL4A4* | Col4a4* | 5 models | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 1 | TGM1* | Tgm1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 10 | PNPLA1* | Pnpla1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 13 | SDR9C7* | Sdr9c7* | 1 model | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 4B | ABCA12* | Abca12* | 4 models | Alliance of Genome Resources | |||
autosomal recessive distal hereditary motor neuronopathy 1 | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive intellectual developmental disorder 41 | KPTN* | Kptn* | 1 model | Alliance of Genome Resources | |||
autosomal recessive isolated ectopia lentis 2 | ADAMTSL4* | Adamtsl4* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2A | CAPN3* | Capn3* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2B | DYSF* | Dysf* | 5 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2C | SGCG* | Sgcg* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2D | SGCA* | Sgca* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2E | SGCB* | Sgcb* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2F | SGCD* | Sgcd* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2G | TCAP* | Tcap* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2H | TRIM32* | Trim32* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2I | FKRP* | Fkrp* | 4 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2J | TTN* | Ttn* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2L | ANO5* | Ano5* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2P | DAG1* | Dag1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2U | CRPPA* | Crppa* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 12 | CDH23* | Cdh23* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 16 | STRC*, STRCP1 | Strc* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 18A | USH1C* | Ush1c* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 18B | OTOG* | Otog* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 1A | GJB2* | Gjb2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 1A | GJB6* | Gjb6* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 2 | MYO7A* | Myo7a* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 22 | OTOA* | Otoa* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 23 | PCDH15* | Pcdh15* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 28 | TRIOBP* | Triobp* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 29 | CLDN14* | Cldn14* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 3 | MYO15A* | Myo15a* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 30 | MYO3A* | Myo3a* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 31 | WHRN* | Whrn* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 32 | CDC14A* | Cdc14a* | 4 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 37 | MYO6* | Myo6* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 39 | HGF* | Hgf* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 42 | ILDR1* | Ildr1* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 48 | CIB2* | Cib2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 49 | MARVELD2* | Marveld2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 59 | PJVK* | Pjvk* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 63 | LRTOMT*, LRRC51, TOMT | Tomt*, Lrrc51 | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 68 | S1PR2* | S1pr2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 7 | TMC1* | Tmc1* | 6 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 74 | MSRB3* | Msrb3* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 79 | TPRN* | Tprn* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 88 | ELMOD3* | Elmod3* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 9 | OTOF* | Otof* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 93 | CABP2* | Cabp2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 1 | TCIRG1* | Tcirg1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 2 | TNFSF11* | Tnfsf11* | 3 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 3 | CA2* | Car2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 4 | CLCN7* | Clcn7* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 5 | OSTM1* | Ostm1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 6 | PLEKHM1* | Plekhm1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 8 | SNX10* | Snx10* | 2 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | PKHD1* | Pkhd1* | 6 models | Alliance of Genome Resources | |||
autosomal recessive Robinow syndrome | ROR2* | Ror2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 12 | WWOX* | Wwox* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 13 | GRM1* | Grm1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 16 | STUB1* | Stub1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 18 | GRID2* | Grid2* | 2 models | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | PITX2* | Pitx2* | 6 models | Alliance of Genome Resources | |||
Bannayan-Riley-Ruvalcaba syndrome | PTEN* | Pten* | 3 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 1 | BBS1* | Bbs1* | 3 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 10 | BBS10* | Bbs10* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 16 | SDCCAG8* | Sdccag8* | 2 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 17 | LZTFL1* | Lztfl1* | 2 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 18 | BBIP1* | Bbip1* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 2 | BBS2* | Bbs2* | 2 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 3 | ARL6* | Arl6* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 4 | BBS4* | Bbs4* | 5 models | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 5 | BBS5* | Bbs5* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 6 | MKKS* | Mkks* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome 8 | TTC8* | Ttc8* | 1 model | Alliance of Genome Resources | |||
Beare-Stevenson cutis gyrata syndrome | FGFR2* | Fgfr2* | 1 model | Alliance of Genome Resources | |||
Bernard-Soulier syndrome | GP1BA* | Gp1ba* | 1 model | Alliance of Genome Resources | |||
Bernard-Soulier syndrome | GP1BB* | Gp1bb* | 4 models | Alliance of Genome Resources | |||
beta thalassemia | HBB*, HBD | Hbb-b1*, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | 17 models | Alliance of Genome Resources | |||
BH4-deficient hyperphenylalaninemia A | PTS* | Pts* | 2 models | Alliance of Genome Resources | |||
BH4-deficient hyperphenylalaninemia B | GCH1* | Gch1* | 1 model | Alliance of Genome Resources | |||
biotinidase deficiency | BTD* | Btd* | 1 model | Alliance of Genome Resources | |||
Birt-Hogg-Dube syndrome | FLCN* | Flcn* | 2 models | Alliance of Genome Resources | |||
blepharophimosis, ptosis, and epicanthus inversus syndrome | FOXL2* | Foxl2* | 2 models | Alliance of Genome Resources | |||
Bloom syndrome | BLM* | Blm* | 7 models | Alliance of Genome Resources | |||
Bosch-Boonstra-Schaaf optic atrophy syndrome | NR2F1* | Nr2f1* | 1 model | Alliance of Genome Resources | |||
Bowen-Conradi syndrome | EMG1* | Emg1* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1 | IHH* | Ihh* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A2 | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachyolmia-amelogenesis imperfecta syndrome | LTBP3* | Ltbp3* | 1 model | Alliance of Genome Resources | |||
brain small vessel disease 1 | COL4A1* | Col4a1* | 1 model | Alliance of Genome Resources | |||
branched-chain keto acid dehydrogenase kinase deficiency | BCKDK* | Bckdk* | 1 model | Alliance of Genome Resources | |||
branchiootorenal syndrome | SIX1* | Six1* | 1 model | Alliance of Genome Resources | |||
branchiootorenal syndrome | EYA1* | Eya1* | 4 models | Alliance of Genome Resources | |||
brittle cornea syndrome 1 | ZNF469* | Zfp469* | 1 model | Alliance of Genome Resources | |||
Brugada syndrome 1 | SCN5A* | Scn5a* | 2 models | Alliance of Genome Resources | |||
Brugada syndrome 7 | SCN3B* | Scn3b* | 1 model | Alliance of Genome Resources | |||
bullous congenital ichthyosiform erythroderma | KRT2* | Krt2* | 2 models | Alliance of Genome Resources | |||
CADASIL 1 | NOTCH3* | Notch3* | 6 models | Alliance of Genome Resources | |||
campomelic dysplasia | SOX9* | Sox9* | 9 models | Alliance of Genome Resources | |||
Canavan disease | ASPA* | Aspa* | 5 models | Alliance of Genome Resources | |||
carbamoyl phosphate synthetase I deficiency disease | CPS1* | Cps1* | 1 model | Alliance of Genome Resources | |||
Carney complex | PRKAR1A* | Prkar1a* | 4 models | Alliance of Genome Resources | |||
cataract 10 multiple types | CRYBA1* | Cryba1* | 2 models | Alliance of Genome Resources | |||
cataract 14 multiple types | GJA3* | Gja3* | 2 models | Alliance of Genome Resources | |||
cataract 15 multiple types | MIP* | Mip* | 7 models | Alliance of Genome Resources | |||
cataract 16 multiple types | CRYAB* | Cryab* | 1 model | Alliance of Genome Resources | |||
cataract 19 multiple types | LIM2* | Lim2* | 4 models | Alliance of Genome Resources | |||
cataract 1 multiple types | GJA8* | Gja8* | 4 models | Alliance of Genome Resources | |||
cataract 20 multiple types | CRYGS* | Crygs* | 3 models | Alliance of Genome Resources | |||
cataract 21 multiple types | MAF* | Maf* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGC* | Crygc* | 2 models | Alliance of Genome Resources | |||
cataract 30 | VIM* | Vim* | 1 model | Alliance of Genome Resources | |||
cataract 39 multiple types | CRYGB* | Crygb* | 6 models | Alliance of Genome Resources | |||
cataract 3 multiple types | CRYBB2* | Crybb2* | 3 models | Alliance of Genome Resources | |||
cataract 4 multiple types | CRYGD* | Crygd*, Cryge, Crygf | 2 models | Alliance of Genome Resources | |||
cataract 5 multiple types | HSF4* | Hsf4* | 2 models | Alliance of Genome Resources | |||
cataract 6 multiple types | EPHA2* | Epha2* | 1 model | Alliance of Genome Resources | |||
cataract 9 multiple types | CRYAA* | Cryaa* | 9 models | Alliance of Genome Resources | |||
Cayman type cerebellar ataxia | ATCAY* | Atcay* | 3 models | Alliance of Genome Resources | |||
CEDNIK syndrome | SNAP29* | Snap29* | 2 models | Alliance of Genome Resources | |||
central precocious puberty 2 | MKRN3* | Mkrn3* | 1 model | Alliance of Genome Resources | |||
cerebellar ataxia type 42 | CACNA1G* | Cacna1g* | 2 models | Alliance of Genome Resources | |||
cerebrocostomandibular syndrome | SNRPB* | Snrpb* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2K | GDAP1* | Gdap1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2O | DYNC1H1* | Dync1h1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2P | LRSAM1* | Lrsam1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Q | DHTKD1* | Dhtkd1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2S | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Z | MORC2* | Morc2a*, Morc2b | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease dominant intermediate C | YARS1* | Yars1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease recessive intermediate D | COX6A1* | Cox6a1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1A | PMP22* | Pmp22* | 6 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1B | MPZ* | Mpz* | 10 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1C | LITAF* | Litaf* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1E | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A1 | KIF1B* | Kif1b* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A2A | MFN2* | Mfn2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B | RAB7A* | Rab7* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B1 | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2D | GARS1* | Gars1* | 4 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2E | NEFL* | Nefl* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | MPZ* | Mpz* | 3 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B1 | MTMR2* | Mtmr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B2 | SBF2* | Sbf2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B3 | SBF1* | Sbf1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4C | SH3TC2* | Sh3tc2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4D | NDRG1* | Ndrg1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4E | EGR2* | Egr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4H | FGD4* | Fgd4* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4J | FIG4* | Fig4* | 2 models | Alliance of Genome Resources | |||
Charlevoix-Saguenay spastic ataxia | SACS* | Sacs* | 2 models | Alliance of Genome Resources | |||
Chediak-Higashi syndrome | LYST* | Lyst* | 9 models | Alliance of Genome Resources | |||
cherubism | SH3BP2* | Sh3bp2* | 2 models | Alliance of Genome Resources | |||
childhood hypophosphatasia | ALPL* | Alpl* | 1 model | Alliance of Genome Resources | |||
chondrodysplasia with joint dislocations gPAPP type | BPNT2* | Bpnt2* | 1 model | Alliance of Genome Resources | |||
choreaacanthocytosis | VPS13A* | Vps13a* | 1 model | Alliance of Genome Resources | |||
CINCA Syndrome | NLRP3* | Nlrp3* | 1 model | Alliance of Genome Resources | |||
cleidocranial dysplasia | RUNX2* | Runx2* | 4 models | Alliance of Genome Resources | |||
Clouston syndrome | GJB6* | Gjb6* | 1 model | Alliance of Genome Resources | |||
Cockayne syndrome | ERCC6* | Ercc6* | 4 models | Alliance of Genome Resources | |||
Cockayne syndrome | ERCC8* | Ercc8* | 2 models | Alliance of Genome Resources | |||
Coffin-Siris syndrome 1 | ARID1B* | Arid1b* | 1 model | Alliance of Genome Resources | |||
Cohen syndrome | VPS13B* | Vps13b* | 1 model | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 4 | TUBG1* | Tubg1* | 1 model | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 7 | TUBB2B* | Tubb2b* | 1 model | Alliance of Genome Resources | |||
Compton-North congenital myopathy | CNTN1* | Cntn1* | 3 models | Alliance of Genome Resources | |||
congenital afibrinogenemia | FGG* | Fgg* | 1 model | Alliance of Genome Resources | |||
congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | PBX1* | Pbx1* | 1 model | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | PHOX2B* | Phox2b* | 2 models | Alliance of Genome Resources | |||
congenital diarrhea 5 with tufting enteropathy | EPCAM* | Epcam* | 1 model | Alliance of Genome Resources | |||
congenital disorder of glycosylation type IIa | MGAT2* | Mgat2* | 2 models | Alliance of Genome Resources | |||
congenital disorder of glycosylation type IIc | SLC35C1* | Slc35c1* | 1 model | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 1 | AGPAT2* | Agpat2* | 1 model | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 2 | BSCL2* | Bscl2* | 3 models | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 4 | CAVIN1* | Cavin1* | 1 model | Alliance of Genome Resources | |||
congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | CDK13* | Cdk13* | 1 model | Alliance of Genome Resources | |||
congenital hereditary endothelial dystrophy of cornea | SLC4A11* | Slc4a11* | 1 model | Alliance of Genome Resources | |||
congenital megabladder | MYOCD* | Myocd* | 2 models | Alliance of Genome Resources | |||
congenital merosin-deficient muscular dystrophy 1A | LAMA2* | Lama2* | 10 models | Alliance of Genome Resources | |||
congenital muscular dystrophy due to integrin alpha-7 deficiency | ITGA7* | Itga7* | 1 model | Alliance of Genome Resources | |||
congenital muscular dystrophy due to LMNA mutation | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 10 | DOK7* | Dok7* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 11 | RAPSN* | Rapsn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 12 | GFPT1* | Gfpt1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 19 | COL13A1* | Col13a1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 3A | CHRND* | Chrnd* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4A | CHRNE* | Chrne* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4C | CHRNE* | Chrne* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 5 | COLQ* | Colq* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 6 | CHAT* | Chat* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 8 | AGRN* | Agrn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 9 | MUSK* | Musk* | 3 models | Alliance of Genome Resources | |||
congenital myopathy 1A | RYR1* | Ryr1* | 3 models | Alliance of Genome Resources | |||
congenital nystagmus 1 | FRMD7* | Frmd7* | 2 models | Alliance of Genome Resources | |||
congenital secretory chloride diarrhea 1 | SLC26A3* | Slc26a3* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1B | GRM6* | Grm6* | 2 models | Alliance of Genome Resources | |||
congenital stationary night blindness 1C | TRPM1* | Trpm1* | 2 models | Alliance of Genome Resources | |||
congenital stationary night blindness 1D | SLC24A1* | Slc24a1* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1E | GPR179* | Gpr179* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1F | LRIT3* | Lrit3* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 1 | RHO* | Rho* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 2 | PDE6B* | Pde6b* | 14 models | Alliance of Genome Resources | |||
Cornelia de Lange syndrome 1 | NIPBL* | Nipbl* | 2 models | Alliance of Genome Resources | |||
Cornelia de Lange syndrome 3 | SMC3* | Smc3* | 1 model | Alliance of Genome Resources | |||
cortical dysplasia-focal epilepsy syndrome | CNTNAP2* | Cntnap2* | 1 model | Alliance of Genome Resources | |||
cortisone reductase deficiency 2 | HSD11B1* | Hsd11b1* | 1 model | Alliance of Genome Resources | |||
Costello syndrome | HRAS* | Hras* | 2 models | Alliance of Genome Resources | |||
craniotubular dysplasia Ikegawa type | TMEM53* | Tmem53* | 1 model | Alliance of Genome Resources | |||
cystathioninuria | CTH* | Cth* | 1 model | Alliance of Genome Resources | |||
cystic fibrosis | CFTR* | Cftr* | 19 models | Alliance of Genome Resources | |||
cystinosis | CTNS* | Ctns* | 1 model | Alliance of Genome Resources | |||
dentinogenesis imperfecta | DSPP* | Dspp* | 1 model | Alliance of Genome Resources | |||
Denys-Drash syndrome | WT1* | Wt1* | 6 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 14 | KCNT1* | Kcnt1* | 2 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 16 | TBC1D24* | Tbc1d24* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 17 | GNAO1* | Gnao1* | 3 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 39 | SLC25A12* | Slc25a12* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 54 | HNRNPU* | Hnrnpu* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 7 | KCNQ2* | Kcnq2* | 1 model | Alliance of Genome Resources | |||
Diamond-Blackfan anemia 6 | RPL5* | Rpl5* | 1 model | Alliance of Genome Resources | |||
Diamond-Blackfan anemia 7 | RPL11* | Rpl11* | 1 model | Alliance of Genome Resources | |||
diastrophic dysplasia | SLC26A2* | Slc26a2* | 1 model | Alliance of Genome Resources | |||
dicarboxylic aminoaciduria | SLC1A1* | Slc1a1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | TBX1* | Tbx1* | 23 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1A | LMNA* | Lmna* | 4 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1C | LDB3* | Ldb3* | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1CC | NEXN* | Nexn* | 4 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1D | TNNT2* | Tnnt2* | 3 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1DD | RBM20* | Rbm20* | 3 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1HH | BAG3* | Bag3* | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1R | ACTC1* | Actc1* | 1 model | Alliance of Genome Resources | |||
dilated cardiomyopathy 1Y | TPM1* | Tpm1* | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 2F | BAG5* | Bag5* | 1 model | Alliance of Genome Resources | |||
diphthamide deficiency syndrome 1 | DPH1* | Dph1* | 1 model | Alliance of Genome Resources | |||
DNA ligase IV deficiency | LIG4* | Lig4* | 2 models | Alliance of Genome Resources | |||
Donnai-Barrow syndrome | LRP2* | Lrp2* | 1 model | Alliance of Genome Resources | |||
Doyne honeycomb retinal dystrophy | EFEMP1* | Efemp1* | 4 models | Alliance of Genome Resources | |||
Dravet syndrome | SCN1A* | Scn1a* | 8 models | Alliance of Genome Resources | |||
Duane-radial ray syndrome | SALL4* | Sall4* | 4 models | Alliance of Genome Resources | |||
EAST syndrome | KCNJ10* | Kcnj10* | 2 models | Alliance of Genome Resources | |||
ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 | TP63* | Trp63* | 4 models | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A1* | Col5a1* | 3 models | Alliance of Genome Resources | |||
Ellis-Van Creveld syndrome | EVC2* | Evc2* | 1 model | Alliance of Genome Resources | |||
Ellis-Van Creveld syndrome | EVC* | Evc* | 1 model | Alliance of Genome Resources | |||
endocrine-cerebro-osteodysplasia syndrome | CILK1* | Cilk1* | 2 models | Alliance of Genome Resources | |||
enhanced S-cone syndrome | NR2E3* | Nr2e3* | 2 models | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Ogna type | PLEC* | Plec* | 4 models | Alliance of Genome Resources | |||
epidermolysis bullosa simplex with muscular dystrophy | PLEC* | Plec* | 2 models | Alliance of Genome Resources | |||
episodic kinesigenic dyskinesia 1 | PRRT2* | Prrt2* | 2 models | Alliance of Genome Resources | |||
factor XI deficiency | F11* | F11* | 1 model | Alliance of Genome Resources | |||
factor XII deficiency | F12* | F12* | 1 model | Alliance of Genome Resources | |||
factor XIII deficiency | F13A1* | F13a1* | 2 models | Alliance of Genome Resources | |||
familial cold autoinflammatory syndrome 1 | NLRP3* | Nlrp3* | 2 models | Alliance of Genome Resources | |||
familial cold autoinflammatory syndrome 4 | NLRC4* | Nlrc4* | 1 model | Alliance of Genome Resources | |||
familial encephalopathy with neuroserpin inclusion bodies | SERPINI1* | Serpini1* | 1 model | Alliance of Genome Resources | |||
familial episodic pain syndrome 3 | SCN11A* | Scn11a* | 1 model | Alliance of Genome Resources | |||
familial erythrocytosis 2 | VHL*, VHLL | Vhl* | 1 model | Alliance of Genome Resources | |||
familial hemophagocytic lymphohistiocytosis 2 | PRF1* | Prf1* | 1 model | Alliance of Genome Resources | |||
familial hemophagocytic lymphohistiocytosis 3 | UNC13D* | Unc13d* | 1 model | Alliance of Genome Resources | |||
familial hemophagocytic lymphohistiocytosis 4 | STX11* | Stx11* | 1 model | Alliance of Genome Resources | |||
familial hyperinsulinemic hypoglycemia 3 | GCK* | Gck* | 1 model | Alliance of Genome Resources | |||
familial hypocalciuric hypercalcemia 1 | CASR* | Casr* | 7 models | Alliance of Genome Resources | |||
familial lipoprotein lipase deficiency | LPL* | Lpl* | 4 models | Alliance of Genome Resources | |||
familial Mediterranean fever | MEFV* | Mefv* | 4 models | Alliance of Genome Resources | |||
familial temporal lobe epilepsy 1 | LGI1* | Lgi1* | 4 models | Alliance of Genome Resources | |||
Fanconi anemia complementation group A | FANCA* | Fanca* | 3 models | Alliance of Genome Resources | |||
Fanconi anemia complementation group C | FANCC* | Fancc* | 2 models | Alliance of Genome Resources | |||
Fanconi anemia complementation group D1 | BRCA2* | Brca2* | 1 model | Alliance of Genome Resources | |||
Fanconi anemia complementation group D2 | FANCD2* | Fancd2* | 6 models | Alliance of Genome Resources | |||
fetal encasement syndrome | CHUK* | Chuk* | 3 models | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | ACVR1* | Acvr1* | 5 models | Alliance of Genome Resources | |||
fibular hypoplasia and complex brachydactyly | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
focal segmental glomerulosclerosis 1 | ACTN4* | Actn4* | 1 model | Alliance of Genome Resources | |||
focal segmental glomerulosclerosis 2 | TRPC6* | Trpc6* | 3 models | Alliance of Genome Resources | |||
focal segmental glomerulosclerosis 3 | CD2AP* | Cd2ap* | 1 model | Alliance of Genome Resources | |||
foveal hypoplasia 2 | SLC38A8* | Slc38a8* | 1 model | Alliance of Genome Resources | |||
Friedreich ataxia | FXN* | Fxn* | 8 models | Alliance of Genome Resources | |||
frontonasal dysplasia 3 | ALX1* | Alx1* | 1 model | Alliance of Genome Resources | |||
Fuhrmann syndrome | WNT7A* | Wnt7a* | 2 models | Alliance of Genome Resources | |||
Fukuyama congenital muscular dystrophy | FKTN* | Fktn* | 6 models | Alliance of Genome Resources | |||
GAND syndrome | GATAD2B* | Gatad2b* | 1 model | Alliance of Genome Resources | |||
geleophysic dysplasia 1 | ADAMTSL2* | Adamtsl2* | 1 model | Alliance of Genome Resources | |||
giant axonal neuropathy 1 | GAN* | Gan* | 2 models | Alliance of Genome Resources | |||
Gitelman syndrome | SLC12A3* | Slc12a3* | 2 models | Alliance of Genome Resources | |||
glucose transporter type 1 deficiency syndrome 1 | SLC2A1* | Slc2a1* | 1 model | Alliance of Genome Resources | |||
glutaric acidemia I | GCDH* | Gcdh* | 2 models | Alliance of Genome Resources | |||
glutaric acidemia type 3 | SUGCT* | Sugct* | 1 model | Alliance of Genome Resources | |||
glycine encephalopathy | GLDC* | Gldc* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease Ia | G6PC1* | G6pc1* | 5 models | Alliance of Genome Resources | |||
glycogen storage disease II | GAA* | Gaa* | 5 models | Alliance of Genome Resources | |||
glycogen storage disease III | AGL* | Agl* | 2 models | Alliance of Genome Resources | |||
glycogen storage disease IV | GBE1* | Gbe1* | 4 models | Alliance of Genome Resources | |||
glycogen storage disease V | PYGM* | Pygm* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease VI | PYGL* | Pygl* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease VII | PFKM* | Pfkm* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease XV | GYG1* | Gyg1* | 1 model | Alliance of Genome Resources | |||
GM1 gangliosidosis | GLB1* | Glb1* | 3 models | Alliance of Genome Resources | |||
GM2 gangliosidosis, AB variant | GM2A* | Gm2a* | 1 model | Alliance of Genome Resources | |||
gnathodiaphyseal dysplasia | ANO5* | Ano5* | 2 models | Alliance of Genome Resources | |||
Goldberg-Shprintzen syndrome | KIFBP* | Kifbp* | 2 models | Alliance of Genome Resources | |||
GRACILE syndrome | BCS1L* | Bcs1l* | 1 model | Alliance of Genome Resources | |||
gray platelet syndrome | NBEAL2* | Nbeal2* | 3 models | Alliance of Genome Resources | |||
Greig cephalopolysyndactyly syndrome | GLI3* | Gli3* | 1 model | Alliance of Genome Resources | |||
Griscelli syndrome type 1 | MYO5A* | Myo5a* | 2 models | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | GRN* | Grn* | 3 models | Alliance of Genome Resources | |||
Hajdu-Cheney syndrome | NOTCH2* | Notch2* | 4 models | Alliance of Genome Resources | |||
hand-foot-genital syndrome | HOXA13* | Hoxa13* | 5 models | Alliance of Genome Resources | |||
hereditary hemorrhagic telangiectasia | ACVRL1* | Acvrl1* | 5 models | Alliance of Genome Resources | |||
hereditary hemorrhagic telangiectasia | ENG* | Eng* | 6 models | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT1* | Ext1* | 5 models | Alliance of Genome Resources | |||
hereditary neuropathy with liability to pressure palsies | PMP22* | Pmp22* | 3 models | Alliance of Genome Resources | |||
hereditary neutrophilia | CSF3R* | Csf3r* | 1 model | Alliance of Genome Resources | |||
hereditary sensory and autonomic neuropathy type 6 | DST* | Dst* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 11 | SPG11* | Spg11* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 13 | HSPD1* | Hspd1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 15 | ZFYVE26* | Zfyve26* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 30 | KIF1A* | Kif1a* | 2 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 31 | REEP1* | Reep1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 35 | FA2H* | Fa2h* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 4 | SPAST* | Spast* | 3 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 48 | AP5Z1* | Ap5z1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 54 | DDHD2* | Ddhd2* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 7 | SPG7* | Spg7* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 80 | UBAP1* | Ubap1* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | ANK1* | Ank1* | 4 models | Alliance of Genome Resources | |||
hereditary spherocytosis type 3 | SPTA1* | Spta1* | 5 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | BLOC1S5* | Bloc1s5* | 2 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 1 | HPS1* | Hps1* | 4 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 2 | AP3B1* | Ap3b1* | 4 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 3 | HPS3* | Hps3* | 3 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 4 | HPS4* | Hps4* | 2 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 5 | HPS5* | Hps5* | 3 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 6 | HPS6* | Hps6* | 2 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 7 | DTNBP1* | Dtnbp1* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 8 | BLOC1S3* | Bloc1s3* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 9 | BLOC1S6* | Bloc1s6* | 1 model | Alliance of Genome Resources | |||
high myopia-sensorineural deafness syndrome | SLITRK6* | Slitrk6* | 1 model | Alliance of Genome Resources | |||
HMG-CoA synthase 2 deficiency | HMGCS2* | Hmgcs2* | 2 models | Alliance of Genome Resources | |||
holoprosencephaly 11 | CDON* | Cdon* | 8 models | Alliance of Genome Resources | |||
holoprosencephaly 2 | SIX3* | Six3* | 4 models | Alliance of Genome Resources | |||
holoprosencephaly 3 | SHH* | Shh* | 3 models | Alliance of Genome Resources | |||
holoprosencephaly 5 | ZIC2* | Zic2* | 3 models | Alliance of Genome Resources | |||
Holt-Oram syndrome | TBX5* | Tbx5* | 3 models | Alliance of Genome Resources | |||
hyperekplexia 1 | GLRA1* | Glra1* | 4 models | Alliance of Genome Resources | |||
hyperekplexia 2 | GLRB* | Glrb* | 1 model | Alliance of Genome Resources | |||
hyperekplexia 3 | SLC6A5* | Slc6a5* | 2 models | Alliance of Genome Resources | |||
hyper IgE recurrent infection syndrome 1 | STAT3* | Stat3* | 1 model | Alliance of Genome Resources | |||
hypochondroplasia | FGFR3* | Fgfr3* | 1 model | Alliance of Genome Resources | |||
hypogonadotropic hypogonadism 11 with or without anosmia | TACR3* | Tacr3* | 1 model | Alliance of Genome Resources | |||
hypogonadotropic hypogonadism 12 with or without anosmia | GNRH1* | Gnrh1* | 1 model | Alliance of Genome Resources | |||
hypogonadotropic hypogonadism 13 with or without anosmia | KISS1* | Kiss1* | 2 models | Alliance of Genome Resources | |||
hypogonadotropic hypogonadism 7 with or without anosmia | GNRHR* | Gnrhr* | 1 model | Alliance of Genome Resources | |||
hypogonadotropic hypogonadism 8 with or without anosmia | KISS1R* | Kiss1r* | 4 models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 2 | GJC2* | Gjc2* | 3 models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 6 | TUBB4A* | Tubb4a* | 3 models | Alliance of Genome Resources | |||
hypotrichosis 13 | KRT71* | Krt71* | 1 model | Alliance of Genome Resources | |||
hypotrichosis 6 | DSG4* | Dsg4* | 3 models | Alliance of Genome Resources | |||
immunodeficiency 15A | IKBKB* | Ikbkb* | 2 models | Alliance of Genome Resources | |||
immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia | RAC2* | Rac2* | 1 model | Alliance of Genome Resources | |||
immunodeficiency-centromeric instability-facial anomalies syndrome 1 | DNMT3B* | Dnmt3b* | 7 models | Alliance of Genome Resources | |||
immunodeficiency with hyper-IgM type 2 | AICDA* | Aicda* | 1 model | Alliance of Genome Resources | |||
infantile hypophosphatasia | ALPL* | Alpl* | 3 models | Alliance of Genome Resources | |||
isolated microphthalmia 6 | PRSS56* | Prss56* | 3 models | Alliance of Genome Resources | |||
isolated mitochondrial myopathy | CHCHD10* | Chchd10* | 1 model | Alliance of Genome Resources | |||
Johanson-Blizzard syndrome | UBR1* | Ubr1* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa with pyloric atresia | ITGB4* | Itgb4* | 1 model | Alliance of Genome Resources | |||
juvenile polyposis syndrome | SMAD4* | Smad4* | 1 model | Alliance of Genome Resources | |||
juvenile polyposis syndrome | BMPR1A* | Bmpr1a* | 1 model | Alliance of Genome Resources | |||
karyomegalic interstitial nephritis | FAN1* | Fan1* | 3 models | Alliance of Genome Resources | |||
Kaufman oculocerebrofacial syndrome | UBE3B* | Ube3b* | 1 model | Alliance of Genome Resources | |||
KINSSHIP syndrome | AFF3* | Aff3* | 1 model | Alliance of Genome Resources | |||
Kleefstra syndrome 1 | EHMT1* | Ehmt1* | 2 models | Alliance of Genome Resources | |||
Kohlschutter-Tonz syndrome | ROGDI* | Rogdi* | 1 model | Alliance of Genome Resources | |||
Koolen de Vries syndrome | KANSL1* | Kansl1* | 1 model | Alliance of Genome Resources | |||
Kufor-Rakeb syndrome | ATP13A2* | Atp13a2* | 1 model | Alliance of Genome Resources | |||
Laron syndrome | GHR* | Ghr* | 2 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 1 | GUCY2D* | Gucy2e* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 12 | RD3* | Rd3* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 14 | LRAT* | Lrat* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 2 | RPE65* | Rpe65* | 4 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 4 | AIPL1* | Aipl1* | 5 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 5 | LCA5* | Lca5* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 6 | RPGRIP1* | Rpgrip1* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 8 | CRB1* | Crb1* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 9 | NMNAT1* | Nmnat1* | 2 models | Alliance of Genome Resources | |||
leukocyte adhesion deficiency 1 | ITGB2* | Itgb2*, Itgb2l | 3 models | Alliance of Genome Resources | |||
leukocyte adhesion deficiency 3 | FERMT3* | Fermt3* | 1 model | Alliance of Genome Resources | |||
leukoencephalopathy with vanishing white matter | EIF2B5* | Eif2b5* | 7 models | Alliance of Genome Resources | |||
Li-Fraumeni syndrome | TP53* | Trp53* | 8 models | Alliance of Genome Resources | |||
long QT syndrome 1 | KCNQ1* | Kcnq1* | 1 model | Alliance of Genome Resources | |||
long QT syndrome 3 | SCN5A* | Scn5a* | 4 models | Alliance of Genome Resources | |||
Lynch syndrome | MLH1* | Mlh1* | 2 models | Alliance of Genome Resources | |||
Lynch syndrome | MSH2* | Msh2* | 5 models | Alliance of Genome Resources | |||
macrocephaly-autism syndrome | PTEN* | Pten* | 2 models | Alliance of Genome Resources | |||
Mahvash Disease | GCGR* | Gcgr* | 1 model | Alliance of Genome Resources | |||
mal de Meleda | SLURP1* | Slurp1* | 2 models | Alliance of Genome Resources | |||
malignant hyperthermia | RYR1* | Ryr1* | 5 models | Alliance of Genome Resources | |||
Marsili syndrome | ZFHX2* | Zfhx2* | 2 models | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 1 | HNF4A* | Hnf4a* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 2 | GCK* | Gck* | 29 models | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 3 | HNF1A* | Hnf1a* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 4 | PDX1* | Pdx1* | 1 model | Alliance of Genome Resources | |||
megaconial type congenital muscular dystrophy | CHKB* | Chkb* | 1 model | Alliance of Genome Resources | |||
mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations | MAST1* | Mast1* | 1 model | Alliance of Genome Resources | |||
megalencephalic leukoencephalopathy with subcortical cysts 1 | MLC1* | Mlc1* | 1 model | Alliance of Genome Resources | |||
microcephalic osteodysplastic primordial dwarfism type II | PCNT* | Pcnt* | 1 model | Alliance of Genome Resources | |||
microphthalmia with limb anomalies | SMOC1* | Smoc1* | 2 models | Alliance of Genome Resources | |||
microvillus inclusion disease | MYO5B* | Myo5b* | 2 models | Alliance of Genome Resources | |||
mitochondrial DNA depletion syndrome 2 | TK2* | Tk2* | 1 model | Alliance of Genome Resources | |||
mitochondrial DNA depletion syndrome 5 | SUCLA2* | Sucla2* | 1 model | Alliance of Genome Resources | |||
mosaic variegated aneuploidy syndrome 1 | BUB1B* | Bub1b* | 2 models | Alliance of Genome Resources | |||
Mowat-Wilson syndrome | ZEB2* | Zeb2* | 1 model | Alliance of Genome Resources | |||
mucosulfatidosis | SUMF1* | Sumf1* | 1 model | Alliance of Genome Resources | |||
Muenke Syndrome | FGFR3* | Fgfr3* | 6 models | Alliance of Genome Resources | |||
mulibrey nanism | TRIM37* | Trim37* | 1 model | Alliance of Genome Resources | |||
multicentric carpotarsal osteolysis syndrome | MAFB* | Mafb* | 1 model | Alliance of Genome Resources | |||
multiple endocrine neoplasia type 1 | MEN1* | Men1* | 7 models | Alliance of Genome Resources | |||
multiple endocrine neoplasia type 2B | RET* | Ret* | 2 models | Alliance of Genome Resources | |||
multiple epiphyseal dysplasia 5 | MATN3* | Matn3* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMT1* | Pomt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B5 | FKRP* | Fkrp* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B6 | LARGE1* | Large1* | 1 model | Alliance of Genome Resources | |||
myoclonic dystonia 11 | SGCE* | Sgce* | 2 models | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | DES* | Des* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 2 | CRYAB* | Cryab* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 5 | FLNC* | Flnc* | 1 model | Alliance of Genome Resources | |||
nail-patella syndrome | LMX1B* | Lmx1b* | 4 models | Alliance of Genome Resources | |||
Nasu-Hakola disease | TYROBP* | Tyrobp* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 10 | LMOD3* | Lmod3* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 11 | MYPN* | Mypn* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 2 | NEB* | Neb* | 4 models | Alliance of Genome Resources | |||
nemaline myopathy 3 | ACTA1* | Acta1* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 5A | TNNT1* | Tnnt1* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 6 | KBTBD13* | Kbtbd13* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 8 | KLHL40* | Klhl40* | 1 model | Alliance of Genome Resources | |||
neonatal diabetes mellitus with congenital hypothyroidism | GLIS3* | Glis3* | 2 models | Alliance of Genome Resources | |||
nephronophthisis 1 | NPHP1* | Nphp1* | 1 model | Alliance of Genome Resources | |||
nephronophthisis 2 | INVS* | Invs* | 1 model | Alliance of Genome Resources | |||
nephronophthisis 3 | NPHP3* | Nphp3* | 2 models | Alliance of Genome Resources | |||
nephronophthisis 4 | NPHP4* | Nphp4* | 1 model | Alliance of Genome Resources | |||
nephronophthisis 7 | GLIS2* | Glis2* | 1 model | Alliance of Genome Resources | |||
Netherton syndrome | SPINK5* | Spink5* | 5 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 2a | PLA2G6* | Pla2g6* | 4 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 6 | COASY* | Coasy* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | BPTF* | Bptf* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with involuntary movements | GNAO1* | Gnao1* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with midbrain and hindbrain malformations | ARHGEF2* | Arhgef2* | 1 model | Alliance of Genome Resources | |||
neurofibromatosis 1 | NF1* | Nf1* | 17 models | Alliance of Genome Resources | |||
neurohypophyseal diabetes insipidus | AVP* | Avp* | 2 models | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 1 | PPT1* | Ppt1* | 3 models | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 10 | CTSD* | Ctsd* | 4 models | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 2 | TPP1* | Tpp1* | 4 models | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 3 | CLN3* | Cln3* | 7 models | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 5 | CLN5* | Cln5* | 1 model | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 6A | CLN6* | Cln6* | 1 model | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 7 | MFSD8* | Mfsd8* | 1 model | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 8 | CLN8* | Cln8* | 4 models | Alliance of Genome Resources | |||
Nijmegen breakage syndrome | NBN* | Nbn* | 7 models | Alliance of Genome Resources | |||
Noonan syndrome 1 | PTPN11* | Ptpn11* | 3 models | Alliance of Genome Resources | |||
Noonan syndrome 10 | LZTR1* | Lztr1* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome 3 | KRAS* | Kras* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome 4 | SOS1* | Sos1* | 2 models | Alliance of Genome Resources | |||
Noonan syndrome 5 | RAF1* | Raf1* | 2 models | Alliance of Genome Resources | |||
Noonan syndrome 8 | RIT1* | Rit1* | 1 model | Alliance of Genome Resources | |||
nuclear type mitochondrial complex I deficiency 20 | ACAD9* | Acad9* | 2 models | Alliance of Genome Resources | |||
oculocutaneous albinism | TYR* | Tyr* | 2 models | Alliance of Genome Resources | |||
Oguchi disease-2 | GRK1* | Grk1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 1 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 10 | SERPINH1* | Serpinh1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | COL1A1* | Col1a1* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A2* | Col1a2* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 4 | COL1A1* | Col1a1* | 3 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | IFITM5* | Ifitm5* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 7 | CRTAP* | Crtap* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 8 | P3H1* | P3h1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 9 | PPIB* | Ppib* | 2 models | Alliance of Genome Resources | |||
osteoporosis-pseudoglioma syndrome | LRP5*, LRP5L | Lrp5* | 3 models | Alliance of Genome Resources | |||
otospondylomegaepiphyseal dysplasia, autosomal recessive | COL11A2* | Col11a2* | 1 model | Alliance of Genome Resources | |||
pachyonychia congenita | KRT16* | Krt16* | 1 model | Alliance of Genome Resources | |||
Pallister-Hall syndrome | GLI3* | Gli3* | 1 model | Alliance of Genome Resources | |||
palmoplantar keratoderma-esophageal carcinoma syndrome | RHBDF2* | Rhbdf2* | 3 models | Alliance of Genome Resources | |||
Parkinson's disease 1 | SNCA* | Snca* | 6 models | Alliance of Genome Resources | |||
Parkinson's disease 14 | PLA2G6* | Pla2g6* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 17 | VPS35* | Vps35* | 2 models | Alliance of Genome Resources | |||
Parkinson's disease 2 | PRKN* | Prkn* | 9 models | Alliance of Genome Resources | |||
Parkinson's disease 4 | SNCA* | Snca* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 6 | PINK1* | Pink1* | 4 models | Alliance of Genome Resources | |||
Parkinson's disease 7 | PARK7* | Park7* | 4 models | Alliance of Genome Resources | |||
Parkinson's disease 8 | LRRK2* | Lrrk2* | 1 model | Alliance of Genome Resources | |||
paroxysmal nonkinesigenic dyskinesia 1 | PNKD* | Pnkd* | 2 models | Alliance of Genome Resources | |||
PCWH syndrome | SOX10* | Sox10* | 1 model | Alliance of Genome Resources | |||
Pelger-Huet anomaly | LBR* | Lbr* | 1 model | Alliance of Genome Resources | |||
Pendred Syndrome | SLC26A4* | Slc26a4* | 4 models | Alliance of Genome Resources | |||
permanent neonatal diabetes mellitus | KCNJ11* | Kcnj11* | 3 models | Alliance of Genome Resources | |||
permanent neonatal diabetes mellitus | INS* | Ins2*, Ins1 | 1 model | Alliance of Genome Resources | |||
peroxisomal acyl-CoA oxidase deficiency | ACOX1* | Acox1* | 1 model | Alliance of Genome Resources | |||
Perrault syndrome | CLPP* | Clpp* | 2 models | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR1* | Fgfr1* | 2 models | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR2* | Fgfr2* | 1 model | Alliance of Genome Resources | |||
PHARC syndrome | ABHD12* | Abhd12* | 1 model | Alliance of Genome Resources | |||
piebaldism | KIT* | Kit* | 1 model | Alliance of Genome Resources | |||
Pierpont syndrome | TBL1XR1* | Tbl1xr1* | 1 model | Alliance of Genome Resources | |||
Pierson syndrome | LAMB2* | Lamb2* | 2 models | Alliance of Genome Resources | |||
Pitt-Hopkins syndrome | TCF4* | Tcf4* | 6 models | Alliance of Genome Resources | |||
platelet-type bleeding disorder 10 | CD36* | Cd36* | 1 model | Alliance of Genome Resources | |||
platelet-type bleeding disorder 16 | ITGA2B* | Itga2b* | 1 model | Alliance of Genome Resources | |||
platelet-type bleeding disorder 16 | ITGB3* | Itgb3* | 1 model | Alliance of Genome Resources | |||
platelet-type bleeding disorder 8 | P2RY12* | P2ry12* | 2 models | Alliance of Genome Resources | |||
polycystic kidney disease 1 | PKD1* | Pkd1* | 27 models | Alliance of Genome Resources | |||
polycystic kidney disease 2 | PKD2* | Pkd2* | 7 models | Alliance of Genome Resources | |||
polycystic kidney disease 4 | PKHD1* | Pkhd1* | 2 models | Alliance of Genome Resources | |||
pontocerebellar hypoplasia type 14 | PPIL1* | Ppil1* | 2 models | Alliance of Genome Resources | |||
poor metabolism of thiopurines | TPMT* | Tpmt* | 1 model | Alliance of Genome Resources | |||
popliteal pterygium syndrome | IRF6* | Irf6* | 2 models | Alliance of Genome Resources | |||
primary autosomal recessive microcephaly 2 with or without cortical malformations | WDR62* | Wdr62* | 1 model | Alliance of Genome Resources | |||
primary ovarian insufficiency 12 | SYCE1* | Syce1* | 1 model | Alliance of Genome Resources | |||
primary ovarian insufficiency 13 | MSH5* | Msh5* | 1 model | Alliance of Genome Resources | |||
primary ovarian insufficiency 19 | HSF2BP* | Hsf2bp* | 1 model | Alliance of Genome Resources | |||
progeria | LMNA* | Lmna* | 14 models | Alliance of Genome Resources | |||
progressive familial heart block type IA | SCN5A* | Scn5a* | 2 models | Alliance of Genome Resources | |||
progressive myoclonus epilepsy 1B | PRICKLE1* | Prickle1* | 1 model | Alliance of Genome Resources | |||
progressive pseudorheumatoid arthropathy of childhood | CCN6* | Ccn6* | 3 models | Alliance of Genome Resources | |||
proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome | FLVCR2* | Flvcr2* | 1 model | Alliance of Genome Resources | |||
pseudoachondroplasia | COMP* | Comp* | 2 models | Alliance of Genome Resources | |||
pseudoxanthoma elasticum | ABCC6* | Abcc6* | 2 models | Alliance of Genome Resources | |||
purine nucleoside phosphorylase deficiency | PNP* | Pnp*, Pnp2 | 5 models | Alliance of Genome Resources | |||
pyruvate kinase deficiency of red cells | PKLR* | Pklr* | 2 models | Alliance of Genome Resources | |||
renal coloboma syndrome | PAX2* | Pax2* | 6 models | Alliance of Genome Resources | |||
retinitis pigmentosa 1 | RP1* | Rp1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 11 | PRPF31* | Prpf31* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 12 | CRB1* | Crb1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 13 | PRPF8* | Prpf8* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 14 | TULP1* | Tulp1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 18 | PRPF3* | Prpf3* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 19 | ABCA4* | Abca4* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 20 | RPE65* | Rpe65* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 26 | CERKL* | Cerkl* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 28 | FAM161A* | Fam161a* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 4 | RHO* | Rho* | 13 models | Alliance of Genome Resources | |||
retinitis pigmentosa 40 | PDE6B* | Pde6b* | 9 models | Alliance of Genome Resources | |||
retinitis pigmentosa 41 | PROM1* | Prom1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 56 | IMPG2* | Impg2* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 59 | DHDDS* | Dhdds* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 7 | PRPH2* | Prph2* | 3 models | Alliance of Genome Resources | |||
retinitis pigmentosa 77 | REEP6* | Reep6* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa with or without situs inversus | ARL2BP* | Arl2bp* | 1 model | Alliance of Genome Resources | |||
rhizomelic chondrodysplasia punctata type 1 | PEX7* | Pex7* | 2 models | Alliance of Genome Resources | |||
rhizomelic chondrodysplasia punctata type 2 | GNPAT* | Gnpat* | 1 model | Alliance of Genome Resources | |||
rhizomelic chondrodysplasia punctata type 3 | AGPS* | Agps* | 1 model | Alliance of Genome Resources | |||
RIDDLE syndrome | RNF168* | Rnf168* | 2 models | Alliance of Genome Resources | |||
rigid spine muscular dystrophy 1 | SELENON* | Selenon* | 1 model | Alliance of Genome Resources | |||
rippling muscle disease 2 | CAV3* | Cav3* | 3 models | Alliance of Genome Resources | |||
Rubinstein-Taybi syndrome | CREBBP* | Crebbp* | 4 models | Alliance of Genome Resources | |||
Saethre-Chotzen syndrome | TWIST1* | Twist1* | 8 models | Alliance of Genome Resources | |||
Sandhoff disease | HEXB* | Hexb* | 9 models | Alliance of Genome Resources | |||
scalp-ear-nipple syndrome | KCTD1* | Kctd1* | 2 models | Alliance of Genome Resources | |||
Schimke immuno-osseous dysplasia | SMARCAL1* | Smarcal1* | 1 model | Alliance of Genome Resources | |||
Schnyder corneal dystrophy | UBIAD1* | Ubiad1* | 2 models | Alliance of Genome Resources | |||
Schwartz-Jampel syndrome 1 | HSPG2* | Hspg2* | 6 models | Alliance of Genome Resources | |||
sclerosteosis 1 | SOST* | Sost* | 1 model | Alliance of Genome Resources | |||
sclerosteosis 2 | LRP4* | Lrp4* | 2 models | Alliance of Genome Resources | |||
septooptic dysplasia | HESX1* | Hesx1* | 3 models | Alliance of Genome Resources | |||
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive | RAG2* | Rag2* | 1 model | Alliance of Genome Resources | |||
severe combined immunodeficiency with sensitivity to ionizing radiation | DCLRE1C* | Dclre1c* | 2 models | Alliance of Genome Resources | |||
short-rib thoracic dysplasia 7 with or without polydactyly | WDR35* | Wdr35* | 1 model | Alliance of Genome Resources | |||
short-rib thoracic dysplasia 9 with or without polydactyly | IFT140* | Ift140* | 1 model | Alliance of Genome Resources | |||
SHORT syndrome | PIK3R1* | Pik3r1* | 1 model | Alliance of Genome Resources | |||
Silverman-Handmaker type dyssegmental dysplasia | HSPG2* | Hspg2* | 2 models | Alliance of Genome Resources | |||
sitosterolemia 1 | ABCG8* | Abcg8* | 1 model | Alliance of Genome Resources | |||
Smith-McCort dysplasia 2 | RAB33B* | Rab33b* | 2 models | Alliance of Genome Resources | |||
Sorsby's fundus dystrophy | TIMP3* | Timp3* | 2 models | Alliance of Genome Resources | |||
Sotos syndrome 2 | NFIX* | Nfix* | 1 model | Alliance of Genome Resources | |||
spastic tetraplegia, thin corpus callosum, and progressive microcephaly | SLC1A4* | Slc1a4* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 19 | CFAP43* | Cfap43* | 2 models | Alliance of Genome Resources | |||
spermatogenic failure 20 | CFAP44* | Cfap44* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 24 | CFAP69* | Cfap69* | 2 models | Alliance of Genome Resources | |||
spermatogenic failure 31 | PMFBP1* | Pmfbp1* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 39 | DNAH17* | Dnah17* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 40 | CFAP65* | Cfap65* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 46 | DNAH8* | Dnah8* | 1 model | Alliance of Genome Resources | |||
spermatogenic failure 47 | DZIP1* | Dzip1* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 1 | ATXN1* | Atxn1* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 14 | PRKCG* | Prkcg* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 17 | TBP* | Tbp* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 2 | ATXN2* | Atxn2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 28 | AFG3L2* | Afg3l2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 5 | SPTBN2* | Sptbn2* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 6 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 7 | ATXN7* | Atxn7* | 5 models | Alliance of Genome Resources | |||
spinocerebellar ataxia with axonal neuropathy 1 | TDP1* | Tdp1* | 1 model | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX5* | Dlx5* | 2 models | Alliance of Genome Resources | |||
spondylocarpotarsal synostosis syndrome | FLNB* | Flnb* | 2 models | Alliance of Genome Resources | |||
spondyloepimetaphyseal dysplasia, Pakistani type | PAPSS2* | Papss2* | 1 model | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | COL2A1* | Col2a1* | 7 models | Alliance of Genome Resources | |||
STING-associated vasculopathy with onset in infancy | STING1* | Sting1* | 1 model | Alliance of Genome Resources | |||
Stormorken syndrome | STIM1* | Stim1* | 1 model | Alliance of Genome Resources | |||
Tay-Sachs disease | HEXA* | Hexa* | 3 models | Alliance of Genome Resources | |||
T-cell immunodeficiency, congenital alopecia, and nail dystrophy | FOXN1* | Foxn1* | 4 models | Alliance of Genome Resources | |||
Teebi hypertelorism syndrome 1 | SPECC1L* | Specc1l* | 2 models | Alliance of Genome Resources | |||
thiamine-responsive megaloblastic anemia syndrome | SLC19A2* | Slc19a2* | 2 models | Alliance of Genome Resources | |||
tibial muscular dystrophy | TTN* | Ttn* | 1 model | Alliance of Genome Resources | |||
Tietz syndrome | MITF* | Mitf* | 14 models | Alliance of Genome Resources | |||
Timothy syndrome | CACNA1C* | Cacna1c* | 1 model | Alliance of Genome Resources | |||
TNF receptor associated periodic syndrome | TNFRSF1A* | Tnfrsf1a* | 3 models | Alliance of Genome Resources | |||
torsion dystonia 1 | TOR1A* | Tor1a* | 4 models | Alliance of Genome Resources | |||
torsion dystonia 6 | THAP1* | Thap1* | 2 models | Alliance of Genome Resources | |||
Townes-Brocks syndrome | SALL1* | Sall1* | 3 models | Alliance of Genome Resources | |||
transthyretin amyloidosis | TTR* | Ttr* | 4 models | Alliance of Genome Resources | |||
Treacher Collins syndrome | TCOF1* | Tcof1* | 2 models | Alliance of Genome Resources | |||
trichorhinophalangeal syndrome type I | TRPS1* | Trps1* | 1 model | Alliance of Genome Resources | |||
Troyer syndrome | SPART* | Spart* | 1 model | Alliance of Genome Resources | |||
tuberous sclerosis | TSC1* | Tsc1* | 10 models | Alliance of Genome Resources | |||
tuberous sclerosis | TSC2* | Tsc2* | 9 models | Alliance of Genome Resources | |||
tubular aggregate myopathy 1 | STIM1* | Stim1* | 2 models | Alliance of Genome Resources | |||
ulnar-mammary syndrome | TBX3* | Tbx3* | 1 model | Alliance of Genome Resources | |||
urofacial syndrome | HPSE2* | Hpse2* | 1 model | Alliance of Genome Resources | |||
Usher syndrome type 1 | MYO7A* | Myo7a* | 13 models | Alliance of Genome Resources | |||
Usher syndrome type 1C | USH1C* | Ush1c* | 6 models | Alliance of Genome Resources | |||
Usher syndrome type 1D | CDH23* | Cdh23* | 11 models | Alliance of Genome Resources | |||
Usher syndrome type 1F | PCDH15* | Pcdh15* | 3 models | Alliance of Genome Resources | |||
Usher syndrome type 1G | USH1G* | Ush1g* | 3 models | Alliance of Genome Resources | |||
Usher syndrome type 2A | USH2A* | Ush2a* | 1 model | Alliance of Genome Resources | |||
Usher syndrome type 2C | ADGRV1* | Adgrv1* | 3 models | Alliance of Genome Resources | |||
Usher syndrome type 2D | WHRN* | Whrn* | 2 models | Alliance of Genome Resources | |||
Usher syndrome type 3A | CLRN1* | Clrn1* | 3 models | Alliance of Genome Resources | |||
vascular type Ehlers-Danlos syndrome | COL3A1* | Col3a1* | 2 models | Alliance of Genome Resources | |||
vestibular schwannomatosis | NF2* | Nf2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome type 1 | PAX3* | Pax3* | 6 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 2A | MITF* | Mitf* | 14 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4A | EDNRB* | Ednrb* | 2 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4B | EDN3* | Edn3* | 3 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4C | SOX10* | Sox10* | 1 model | Alliance of Genome Resources | |||
Walker-Warburg syndrome | POMGNT1* | Pomgnt1* | 2 models | Alliance of Genome Resources | |||
Warburg micro syndrome 3 | RAB18* | Rab18* | 2 models | Alliance of Genome Resources | |||
Warburg micro syndrome 4 | TBC1D20* | Tbc1d20* | 2 models | Alliance of Genome Resources | |||
Weaver syndrome | EZH2* | Ezh2* | 3 models | Alliance of Genome Resources | |||
Weill-Marchesani syndrome | ADAMTS17* | Adamts17* | 1 model | Alliance of Genome Resources | |||
Weill-Marchesani syndrome | FBN1* | Fbn1* | 2 models | Alliance of Genome Resources | |||
Weill-Marchesani syndrome | ADAMTS10* | Adamts10* | 2 models | Alliance of Genome Resources | |||
Werner syndrome | WRN* | Wrn* | 2 models | Alliance of Genome Resources | |||
WHIM syndrome 1 | CXCR4* | Cxcr4* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | EIF4H* | Eif4h* | 3 models | Alliance of Genome Resources | |||
Wolcott-Rallison syndrome | EIF2AK3* | Eif2ak3* | 2 models | Alliance of Genome Resources | |||
Wolfram syndrome 1 | WFS1* | Wfs1* | 6 models | Alliance of Genome Resources | |||
Wolman disease | LIPA* | Lipa* | 1 model | Alliance of Genome Resources | |||
xanthinuria type II | MOCOS* | Mocos* | 1 model | Alliance of Genome Resources | |||
xeroderma pigmentosum group A | XPA* | Xpa* | 2 models | Alliance of Genome Resources | |||
xeroderma pigmentosum group B | ERCC3* | Ercc3* | 1 model | Alliance of Genome Resources | |||
xeroderma pigmentosum group C | XPC* | Xpc* | 1 model | Alliance of Genome Resources | |||
xeroderma pigmentosum group D | ERCC2* | Ercc2* | 1 model | Alliance of Genome Resources | |||
xeroderma pigmentosum group E | DDB2* | Ddb2* | 4 models | Alliance of Genome Resources | |||
xeroderma pigmentosum group F | ERCC4* | Ercc4* | 1 model | Alliance of Genome Resources | |||
xeroderma pigmentosum group G | ERCC5* | Ercc5* | 4 models | Alliance of Genome Resources | |||
xeroderma pigmentosum variant type | POLH* | Polh* | 3 models | Alliance of Genome Resources | |||
Xia-Gibbs Syndrome | AHDC1* | Ahdc1* | 1 model | Alliance of Genome Resources | |||
Yunis-Varon syndrome | FIG4* | Fig4* | 1 model | Alliance of Genome Resources | |||
Zaki syndrome | WLS* | Wls* | 2 models | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | SLC2A9 | Slc2a9* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | LEP | Lep* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | SIRT3 | Sirt3* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | PRKCI | Prkci* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | PPARG | Pparg* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | NEIL1 | Neil1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | CTF1 | Ctf1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | GUCY2C | Gucy2c* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome 1 | TP53INP1 | Trp53inp1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome 1 | LEP | Lep* | 3 models | Alliance of Genome Resources | |||
age related macular degeneration | CCL2, CCL13 | Ccl2*, Ccl12 | 3 models | Alliance of Genome Resources | |||
age related macular degeneration | CCR2 | Ccr2* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | CD46 | Cd46* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | PPARGC1A | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | VLDLR | Vldlr* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | CRYBA1 | Cryba1* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SNCG | Sncg* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VEGFA | Vegfa* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
ARC syndrome | VPS33B | Vps33b* | 1 model | Alliance of Genome Resources | |||
ARC syndrome | VIPAS39 | Vipas39* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 5 | RPSA | Rpsa* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 1 | IFT140 | Ift140* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 3 | IFT80 | Ift80* | 1 model | Alliance of Genome Resources | |||
atrichia with papular lesions | ODC1 | Odc1* | 1 model | Alliance of Genome Resources | |||
autosomal dominant disease | FGFR3 | Fgfr3* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | ZBTB18 | Zbtb18* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | MBD5 | Mbd5* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | AUTS2 | Auts2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | TRPV4 | Trpv4* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 4A | CEACAM16 | Ceacam16* | 1 model | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | MYC | Myc*, Bmyc | 1 model | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | BICC1 | Bicc1* | 1 model | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | NPHP3 | Nphp3* | 3 models | Alliance of Genome Resources | |||
autosomal recessive Alport syndrome | MPV17 | Mpv17* | 1 model | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 4B | CST6 | Cst6* | 1 model | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 4B | PIGA | Piga* | 2 models | Alliance of Genome Resources | |||
autosomal recessive congenital ichthyosis 4B | PRSS8 | Prss8* | 1 model | Alliance of Genome Resources | |||
autosomal recessive disease | PPP1R13L | Ppp1r13l* | 1 model | Alliance of Genome Resources | |||
autosomal recessive hypophosphatemic rickets | DMP1 | Dmp1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive intellectual developmental disorder | CRBN | Crbn* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness | ATP6V1B1 | Atp6v1b1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 1 | CCDC154 | Ccdc154* | 1 model | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | TSC1 | Tsc1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | SCLT1 | Sclt1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | PKD1 | Pkd1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | NEK8 | Nek8* | 1 model | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | NEK1 | Nek1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | DZIP1L | Dzip1l* | 2 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | CYS1 | Cys1* | 5 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | BICC1 | Bicc1* | 6 models | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | ARL3 | Arl3* | 1 model | Alliance of Genome Resources | |||
autosomal recessive polycystic kidney disease | IFT88 | Ift88* | 4 models | Alliance of Genome Resources | |||
autosomal recessive pseudohypoaldosteronism type 1 | SCNN1B | Scnn1b* | 1 model | Alliance of Genome Resources | |||
autosomal recessive pseudohypoaldosteronism type 1 | SCNN1G | Scnn1g* | 1 model | Alliance of Genome Resources | |||
autosomal recessive Robinow syndrome | PRICKLE1 | Prickle1* | 2 models | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | HMGN2 | Hmgn2*, Hmgn2-ps | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 3 | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
Bardet-Biedl syndrome | TBC1D32 | Tbc1d32* | 1 model | Alliance of Genome Resources | |||
beta thalassemia | KLF1 | Klf1* | 1 model | Alliance of Genome Resources | |||
blepharophimosis, ptosis, and epicanthus inversus syndrome | E330023G01Rik* | 1 model | |||||
Bloom syndrome | NSMCE2 | Nsmce2* | 1 model | Alliance of Genome Resources | |||
Canavan disease | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
Caroli syndrome | PKHD1 | Pkhd1* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGD | Crygd*, Cryge, Crygf | 1 model | Alliance of Genome Resources | |||
central conducting lymphatic anomaly | MDFIC | Mdfic* | 1 model | Alliance of Genome Resources | |||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome | CA8 | Car8* | 1 model | Alliance of Genome Resources | |||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome | ATP8A2 | Atp8a2* | 4 models | Alliance of Genome Resources | |||
Charlevoix-Saguenay spastic ataxia | ANKFY1 | Ankfy1* | 1 model | Alliance of Genome Resources | |||
chromosome 1q41-q42 deletion syndrome | TP53BP2 | Trp53bp2* | 3 models | Alliance of Genome Resources | |||
cleidocranial dysplasia | Ccd* | 2 models | |||||
Coffin-Siris syndrome | ARID1A | Arid1a* | 2 models | Alliance of Genome Resources | |||
common variable immunodeficiency | NFKB2 | Nfkb2* | 3 models | Alliance of Genome Resources | |||
common variable immunodeficiency | ICOS | Icos* | 2 models | Alliance of Genome Resources | |||
congenital amegakaryocytic thrombocytopenia | MPL | Mpl* | 1 model | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | TLX3 | Tlx3* | 1 model | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 2 | PPARG | Pparg* | 2 models | Alliance of Genome Resources | |||
cystic fibrosis | SCNN1B | Scnn1b* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | DOCK1 | Dock1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | CHRD | Chrd* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | CRKL | Crkl* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | ZNF366 | Zfp366* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | VEGFA | Vegfa* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | pta* | 1 model | |||||
DiGeorge syndrome | PLXND1 | Plxnd1* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | NDST1 | Ndst1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | DICER1 | Dicer1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | KAT6A | Kat6a* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | HOXA3 | Hoxa3* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | FOXN1 | Foxn1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | FGF8 | Fgf8* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | ALDH1A2 | Aldh1a2* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | b2b954Clo* | 1 model | |||||
DiGeorge syndrome | b2b1941Clo* | 1 model | |||||
DiGeorge syndrome | b2b2696Clo* | 1 model | |||||
dilated cardiomyopathy 1A | DOT1L | Dot1l* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A2 | Col5a2* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | LUM | Lum* | 2 models | Alliance of Genome Resources | |||
enhanced S-cone syndrome | NRL | Nrl* | 1 model | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Dowling-Meara type | KRT5 | Krt5* | 1 model | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Dowling-Meara type | KRT14 | Krt14* | 3 models | Alliance of Genome Resources | |||
familial adenomatous polyposis | APC | Apc* | 10 models | Alliance of Genome Resources | |||
familial medullary thyroid carcinoma | PRLR | Prlr* | 1 model | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
Fraser syndrome | FREM2 | Frem2* | 6 models | Alliance of Genome Resources | |||
Fraser syndrome | FRAS1 | Fras1* | 6 models | Alliance of Genome Resources | |||
Fraser syndrome | GRIP1 | Grip1* | 2 models | Alliance of Genome Resources | |||
Fraser syndrome | FREM1 | Frem1* | 4 models | Alliance of Genome Resources | |||
Gitelman syndrome | STK39 | Stk39* | 3 models | Alliance of Genome Resources | |||
Gitelman syndrome | WNK4 | Wnk4* | 1 model | Alliance of Genome Resources | |||
glycine encephalopathy | SLC6A9 | Slc6a9* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease Ia | SLC37A4 | Slc37a4* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease V | HIF1A | Hif1a* | 1 model | Alliance of Genome Resources | |||
glycogen storage disease VII | HIF1A | Hif1a* | 1 model | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | TARDBP | Tardbp* | 1 model | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT2 | Ext2* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | SPTA1 | Spta1* | 3 models | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | EPB42 | Epb42* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | ADD2 | Add2* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 4 | SLC4A1 | Slc4a1* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | BLOC1S4 | Bloc1s4* | 2 models | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | VPS33A | Vps33a* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | SLC7A11 | Slc7a11* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | KXD1 | Kxd1* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome | RABGGTA | Rabggta* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 1 | RAB27A | Rab27a* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 1 | AP3D1 | Ap3d1* | 1 model | Alliance of Genome Resources | |||
Hermansky-Pudlak syndrome 2 | AP3D1 | Ap3d1* | 1 model | Alliance of Genome Resources | |||
Holt-Oram syndrome | vsd* | 2 models | |||||
hydrolethalus syndrome | KIF7 | Kif7* | 1 model | Alliance of Genome Resources | |||
hyperphosphatemic familial tumoral calcinosis | GALNT3 | Galnt3* | 2 models | Alliance of Genome Resources | |||
hyperphosphatemic familial tumoral calcinosis | KL | Kl* | 2 models | Alliance of Genome Resources | |||
hypotrichosis 4 | HR | Hr* | 1 model | Alliance of Genome Resources | |||
ichthyosis vulgaris | LBR | Lbr* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | TNF | Tnf* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | FOSL2 | Fosl2* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa Herlitz type | ITGA6 | Itga6* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa Herlitz type | LAMC2 | Lamc2* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa Herlitz type | LAMB3 | Lamb3* | 2 models | Alliance of Genome Resources | |||
junctional epidermolysis bullosa non-Herlitz type | LAMA3 | Lama3* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa non-Herlitz type | COL17A1 | Col17a1* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa non-Herlitz type | LAMC2 | Lamc2* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa non-Herlitz type | LAMB3 | Lamb3* | 1 model | Alliance of Genome Resources | |||
junctional epidermolysis bullosa non-Herlitz type | ITGB4 | Itgb4* | 1 model | Alliance of Genome Resources | |||
juvenile glaucoma | PAX6 | Pax6* | 1 model | Alliance of Genome Resources | |||
lacrimoauriculodentodigital syndrome 1 | FGF10 | Fgf10* | 1 model | Alliance of Genome Resources | |||
Lafora disease | EPM2A | Epm2a* | 1 model | Alliance of Genome Resources | |||
Lafora disease | NHLRC1 | Nhlrc1* | 3 models | Alliance of Genome Resources | |||
leukocyte adhesion deficiency 3 | RASGRP2 | Rasgrp2* | 1 model | Alliance of Genome Resources | |||
leukoencephalopathy with vanishing white matter | EIF2B4 | Eif2b4* | 4 models | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFBR1 | Tgfbr1* | 1 model | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFB2 | Tgfb2* | 2 models | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
lysosomal acid lipase deficiency | LIPA | Lipa* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | TGM2 | Tgm2* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | PDX1 | Pdx1* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | MAFA | Mafa* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | INS | Ins2*, Ins1 | 3 models | Alliance of Genome Resources | |||
microvillus inclusion disease | CDC42 | Cdc42* | 1 model | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | MNT | Mnt* | 1 model | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | HIC1 | Hic1* | 1 model | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | DPH1 | Dph1* | 3 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | YWHAE | Ywhae* | 2 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | PAFAH1B1 | Pafah1b1* | 5 models | Alliance of Genome Resources | |||
mitochondrial DNA depletion syndrome 3 | MPV17 | Mpv17* | 1 model | Alliance of Genome Resources | |||
Muir-Torre syndrome | FHIT | Fhit* | 1 model | Alliance of Genome Resources | |||
multiple synostoses syndrome | FGF9 | Fgf9* | 2 models | Alliance of Genome Resources | |||
multiple synostoses syndrome | GDF5 | Gdf5* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | B4GAT1 | B4gat1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMGNT1 | Pomgnt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | LARGE1 | Large1* | 3 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKTN | Fktn* | 3 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKRP | Fkrp* | 2 models | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | LDB3 | Ldb3* | 1 model | Alliance of Genome Resources | |||
nail-patella syndrome | LDB1 | Ldb1* | 1 model | Alliance of Genome Resources | |||
nephronophthisis | WWTR1 | Wwtr1* | 1 model | Alliance of Genome Resources | |||
nephronophthisis | SDCCAG8 | Sdccag8* | 1 model | Alliance of Genome Resources | |||
nephronophthisis | CNTRL | Cntrl* | 1 model | Alliance of Genome Resources | |||
nephronophthisis | AHI1 | Ahi1* | 2 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 2a | gnd* | 1 model | |||||
neurodegeneration with brain iron accumulation 2a | inad* | 1 model | |||||
neurodegeneration with brain iron accumulation 2a | nad* | 1 model | |||||
neurogenic-type arthrogryposis multiplex congenita-2 | pma* | 1 model | |||||
neuronal ceroid lipofuscinosis 3 | PPT1 | Ppt1* | 1 model | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 3 | CLCN6 | Clcn6* | 1 model | Alliance of Genome Resources | |||
neuronal ceroid lipofuscinosis 3 | CLCN3 | Clcn3* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome with multiple lentigines | PTPN11 | Ptpn11* | 3 models | Alliance of Genome Resources | |||
ocular albinism with sensorineural deafness | MITF | Mitf* | 14 models | Alliance of Genome Resources | |||
oculocutaneous albinism | OCA2 | Oca2* | 1 model | Alliance of Genome Resources | |||
oculocutaneous albinism | SLC45A2 | Slc45a2* | 7 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | SUCO | Suco* | 1 model | Alliance of Genome Resources | |||
PCWH syndrome | MPZ | Mpz* | 1 model | Alliance of Genome Resources | |||
Pendred Syndrome | FOXI1 | Foxi1* | 1 model | Alliance of Genome Resources | |||
Pierson syndrome | TNS2 | Tns2* | 1 model | Alliance of Genome Resources | |||
polycystic liver disease | PRKCSH | Prkcsh* | 1 model | Alliance of Genome Resources | |||
polycystic liver disease | UCP2 | Ucp2* | 1 model | Alliance of Genome Resources | |||
popliteal pterygium syndrome | RIPK4 | Ripk4* | 1 model | Alliance of Genome Resources | |||
progeria | ZMPSTE24 | Zmpste24* | 3 models | Alliance of Genome Resources | |||
progeria | VCPIP1 | Vcpip1* | 1 model | Alliance of Genome Resources | |||
progeria | SIRT6 | Sirt6* | 1 model | Alliance of Genome Resources | |||
pyridoxine-dependent epilepsy | ALDH7A1 | Aldh7a1* | 1 model | Alliance of Genome Resources | |||
recessive dystrophic epidermolysis bullosa | GRIP1 | Grip1* | 1 model | Alliance of Genome Resources | |||
recessive dystrophic epidermolysis bullosa | COL7A1 | Col7a1* | 5 models | Alliance of Genome Resources | |||
right atrial isomerism | ACVR2B | Acvr2b* | 1 model | Alliance of Genome Resources | |||
right atrial isomerism | CFC1, CFC1B | Cfc1* | 2 models | Alliance of Genome Resources | |||
Robinow syndrome | b2b3077Clo* | 1 model | |||||
Robinow syndrome | DNAAF4 | Dnaaf4* | 1 model | Alliance of Genome Resources | |||
Robinow syndrome | WNT5A | Wnt5a* | 1 model | Alliance of Genome Resources | |||
sarcosinemia | sar* | 1 model | |||||
Seckel syndrome | ATR | Atr* | 1 model | Alliance of Genome Resources | |||
Seckel syndrome | CPAP | Cpap* | 1 model | Alliance of Genome Resources | |||
Seckel syndrome | CEP63 | Cep63* | 1 model | Alliance of Genome Resources | |||
Seckel syndrome | ATRIP | Atrip* | 1 model | Alliance of Genome Resources | |||
Senior-Loken syndrome | TMEM218 | Tmem218* | 1 model | Alliance of Genome Resources | |||
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive | PRKDC | Prkdc* | 1 model | Alliance of Genome Resources | |||
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, Nk cell-positive | JAK3 | Jak3* | 2 models | Alliance of Genome Resources | |||
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, Nk cell-positive | CORO1A | Coro1a* | 4 models | Alliance of Genome Resources | |||
sickle cell anemia | SPTA1 | Spta1* | 1 model | Alliance of Genome Resources | |||
Smith-McCort dysplasia | DYM | Dym* | 1 model | Alliance of Genome Resources | |||
SOST-related sclerosing bone dysplasia | SOST | Sost* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 27 | FGF14 | Fgf14* | 1 model | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX6 | Dlx6* | 2 models | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | HAPLN1 | Hapln1* | 1 model | Alliance of Genome Resources | |||
Stargardt disease | ABCA4 | Abca4* | 5 models | Alliance of Genome Resources | |||
Stargardt disease | ELOVL4 | Elovl4* | 2 models | Alliance of Genome Resources | |||
thalassemia | PPP1R15A | Ppp1r15a* | 1 model | Alliance of Genome Resources | |||
type 1 diabetes mellitus 2 | IGF2 | Igf2* | 3 models | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A1 | Col6a1* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
Usher syndrome type 2C | SLC4A7 | Slc4a7* | 1 model | Alliance of Genome Resources | |||
Usher syndrome type 3 | CLRN1 | Clrn1* | 2 models | Alliance of Genome Resources | |||
Waardenburg syndrome | SNAI2 | Snai2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome | AEBP2 | Aebp2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome type 1 | MITF | Mitf* | 1 model | Alliance of Genome Resources | |||
Walker-Warburg syndrome | COL4A1 | Col4a1* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | SRC | Src* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | LOX | Lox* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | LIMK1 | Limk1* | 3 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | GTF2IRD1 | Gtf2ird1* | 6 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | GTF2I | Gtf2i* | 4 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FZD9 | Fzd9* | 4 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | DLG4 | Dlg4* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | CLIP2 | Clip2* | 3 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | BAZ1B | Baz1b* | 6 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | b2b370Clo* | 1 model | |||||
xeroderma pigmentosum | TERF2 | Terf2* | 2 models | Alliance of Genome Resources | |||
XFE progeroid syndrome | ERCC1 | Ercc1* | 1 model | Alliance of Genome Resources | |||
Zellweger syndrome | PEX11B | Pex11b* | 3 models | Alliance of Genome Resources | |||
Zellweger syndrome | PEX1 | Pex1* | 2 models | Alliance of Genome Resources | |||
3-hydroxy-3-methylglutaryl-CoA lyase deficiency | HMGCL* | Hmgcl | Alliance of Genome Resources | ||||
3-hydroxyisobutryl-CoA hydrolase deficiency | HIBCH* | Hibch | Alliance of Genome Resources | ||||
3MC syndrome 1 | MASP1* | Masp1 | Alliance of Genome Resources | ||||
3MC syndrome 2 | COLEC11* | Colec11 | Alliance of Genome Resources | ||||
3MC syndrome 3 | COLEC10* | Colec10 | Alliance of Genome Resources | ||||
3-methylcrotonyl-CoA carboxylase 1 deficiency | MCCC1* | Mccc1 | Alliance of Genome Resources | ||||
3-methylcrotonyl-CoA carboxylase 2 deficiency | MCCC2* | Mccc2 | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 1 | AUH* | Auh | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 5 | DNAJC19* | Dnajc19, Dnajc19-ps | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 7a | CLPB* | Clpb | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 7b | CLPB* | Clpb | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 8 | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
3-methylglutaconic aciduria type 9 | TIMM50* | Timm50 | Alliance of Genome Resources | ||||
3-M syndrome | CCDC8* | Ccdc8 | Alliance of Genome Resources | ||||
3-M syndrome | CUL7* | Cul7 | Alliance of Genome Resources | ||||
3-M syndrome | OBSL1* | Obsl1 | Alliance of Genome Resources | ||||
46,XX sex reversal 4 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
46,XX sex reversal 5 | NR2F2* | Nr2f2 | Alliance of Genome Resources | ||||
46,XY sex reversal 3 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
46,XY sex reversal 5 | CBX2* | Cbx2 | Alliance of Genome Resources | ||||
46,XY sex reversal 6 | MAP3K1* | Map3k1 | Alliance of Genome Resources | ||||
46,XY sex reversal 7 | DHH* | Dhh | Alliance of Genome Resources | ||||
46,XY sex reversal 8 | AKR1C2*, AKR1C4*, AKR1C1, AKR1C3 | Akr1c6, Akr1c12, Akr1c13, Akr1c14, Akr1c18, Akr1c19, Akr1c20, Akr1c21, Akr1cl | Alliance of Genome Resources | ||||
46,XY sex reversal 9 | ZFPM2* | Zfpm2 | Alliance of Genome Resources | ||||
ABCD syndrome | EDNRB* | Ednrb | Alliance of Genome Resources | ||||
abdominal obesity-metabolic syndrome 3 | DYRK1B* | Dyrk1b | Alliance of Genome Resources | ||||
abdominal obesity-metabolic syndrome 4 | CELA2A*, CELA2B | Cela2a | Alliance of Genome Resources | ||||
abetalipoproteinemia | MTTP* | Mttp | Alliance of Genome Resources | ||||
ablepharon macrostomia syndrome | TWIST2* | Twist2 | Alliance of Genome Resources | ||||
achondrogenesis type IB | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
acrocapitofemoral dysplasia | IHH* | Ihh | Alliance of Genome Resources | ||||
acrofacial dysostosis Cincinnati type | POLR1A* | Polr1a | Alliance of Genome Resources | ||||
acrokeratosis verruciformis | ATP2A2* | Atp2a2 | Alliance of Genome Resources | ||||
acromelic frontonasal dysostosis | ZSWIM6* | Zswim6 | Alliance of Genome Resources | ||||
acromesomelic dysplasia-4 | PRKG2* | Prkg2 | Alliance of Genome Resources | ||||
adermatoglyphia | SMARCAD1* | Smarcad1 | Alliance of Genome Resources | ||||
adult-onset leukoencephalopathy with axonal spheroids and pigmented glia | CSF1R* | Csf1r | Alliance of Genome Resources | ||||
adult spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
ADULT syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | AANAT* | Aanat | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | TIMELESS* | Timeless | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | PER3* | Per3 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | PER2* | Per2 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome 2 | CSNK1D* | Csnk1d | Alliance of Genome Resources | ||||
advanced sleep phase syndrome 3 | PER3* | Per3 | Alliance of Genome Resources | ||||
agammaglobulinemia 1 | IGHM* | Ighm | Alliance of Genome Resources | ||||
agammaglobulinemia 10 | SPI1* | Spi1 | Alliance of Genome Resources | ||||
agammaglobulinemia 2 | IGLL1*, IGLL5 | Igll1 | Alliance of Genome Resources | ||||
agammaglobulinemia 3 | CD79A* | Cd79a | Alliance of Genome Resources | ||||
agammaglobulinemia 4 | BLNK* | Blnk | Alliance of Genome Resources | ||||
agammaglobulinemia 5 | LRRC8A* | Lrrc8a | Alliance of Genome Resources | ||||
agammaglobulinemia 6 | CD79B* | Cd79b | Alliance of Genome Resources | ||||
agammaglobulinemia 7 | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
agammaglobulinemia 8A | TCF3* | Tcf3 | Alliance of Genome Resources | ||||
agammaglobulinemia 8B | TCF3* | Tcf3 | Alliance of Genome Resources | ||||
agammaglobulinemia 9 | SLC39A7* | Slc39a7 | Alliance of Genome Resources | ||||
AGAT deficiency | GATM* | Gatm | Alliance of Genome Resources | ||||
age related macular degeneration | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
age related macular degeneration | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | APOE* | Apoe | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | CFHR1*, CFHR2 | Cfhr1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | CFHR3* | Cfhr2 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | HMCN1* | Hmcn1 | Alliance of Genome Resources | ||||
age related macular degeneration 11 | CST3* | Cst3 | Alliance of Genome Resources | ||||
age related macular degeneration 13 | CFI* | Cfi | Alliance of Genome Resources | ||||
age related macular degeneration 14 | C2* | C2 | Alliance of Genome Resources | ||||
age related macular degeneration 14 | CFB* | Cfb | Alliance of Genome Resources | ||||
age related macular degeneration 15 | C9* | C9 | Alliance of Genome Resources | ||||
age related macular degeneration 2 | ABCA4* | Abca4 | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 5 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
age related macular degeneration 6 | RAX2* | ||||||
age related macular degeneration 7 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration 7 | C3* | C3 | Alliance of Genome Resources | ||||
age related macular degeneration 8 | ARMS2* | ||||||
age related macular degeneration 9 | C3* | C3 | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | RNASEH2C* | Rnaseh2c | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | SAMHD1* | Samhd1 | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | RNU7-1* | ||||||
Aicardi-Goutieres syndrome | RNASEH2B* | Rnaseh2b | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | RNASEH2A* | Rnaseh2a | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | LSM11* | Lsm11 | Alliance of Genome Resources | ||||
Aicardi-Goutieres syndrome | IFIH1* | Ifih1 | Alliance of Genome Resources | ||||
Alkuraya-Kucinskas syndrome | BLTP1* | Bltp1 | Alliance of Genome Resources | ||||
alopecia-mental retardation syndrome 1 | AHSG* | Ahsg | Alliance of Genome Resources | ||||
alopecia-mental retardation syndrome 4 | LSS* | Lss | Alliance of Genome Resources | ||||
alopecia, neurologic defects, and endocrinopathy syndrome | RBM28* | Rbm28 | Alliance of Genome Resources | ||||
Alpers-Huttenlocher syndrome | POLG* | Polg | Alliance of Genome Resources | ||||
alpha thalassemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
alpha thalassemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
alpha thalassemia | HBA1*, HBA2* | Hba-a1, Hba-a2 | 7 models | Alliance of Genome Resources | |||
Alzheimer's disease 1 | APP* | App | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | MPO* | Mpo | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | PLAU* | Plau | Alliance of Genome Resources | ||||
Alzheimer's disease 2 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 3 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 4 | PSEN2* | Psen2 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease 9 | ABCA7* | Abca7 | Alliance of Genome Resources | ||||
AMED syndrome | ADH5* | Adh5 | Alliance of Genome Resources | ||||
amelogenesis imperfecta hypomaturation type 2A4 | ODAPH* | Odaph | Alliance of Genome Resources | ||||
amelogenesis imperfecta hypomaturation type 2A5 | SLC24A4* | Slc24a4 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1A | LAMB3* | Lamb3 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1C | ENAM* | Enam | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1F | AMBN* | Ambn | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1G | FAM20A* | Fam20a | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1H | ITGB6* | Itgb6 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1J | ACP4* | Acp4 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 2A1 | KLK4* | Klk4 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 2A6 | GPR68* | Gpr68 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 3A | FAM83H* | Fam83h | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 3B | AMTN* | Amtn | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 4 | DLX3* | Dlx3 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | NEFH* | Nefh | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | PRPH* | Prph | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 24 | NEK1* | Nek1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 25 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 26 | TIA1* | Tia1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 28 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
anauxetic dysplasia 1 | RMRP* | Rmrp | Alliance of Genome Resources | ||||
anauxetic dysplasia 2 | POP1* | Pop1 | Alliance of Genome Resources | ||||
anauxetic dysplasia 3 | NEPRO* | Nepro | Alliance of Genome Resources | ||||
Andersen-Tawil syndrome | KCNJ2* | Kcnj2 | Alliance of Genome Resources | ||||
aniridia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 1 | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 2 | FOXE3* | Foxe3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 4 | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 7 | PXDN* | Pxdn | Alliance of Genome Resources | ||||
anterior segment dysgenesis 8 | CPAMD8* | ||||||
Antley-Bixler syndrome with disordered steroidogenesis | POR* | Por | Alliance of Genome Resources | ||||
Antley-Bixler syndrome without disordered steroidogenesis | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
aortic valve disease 1 | NOTCH1* | Notch1 | Alliance of Genome Resources | ||||
aortic valve disease 2 | SMAD6* | Smad6 | Alliance of Genome Resources | ||||
aortic valve disease 2 | FTO* | Fto | Alliance of Genome Resources | ||||
aortic valve disease 2 | NKX2-5* | Nkx2-5 | Alliance of Genome Resources | ||||
aortic valve disease 3 | ROBO4* | Robo4 | Alliance of Genome Resources | ||||
aplasia of lacrimal and salivary glands | FGF10* | Fgf10 | Alliance of Genome Resources | ||||
apolipoprotein C-III deficiency | APOC3* | Apoc3 | Alliance of Genome Resources | ||||
APP-related cerebral amyloid angiopathy | APP* | App | Alliance of Genome Resources | ||||
Arboleda-Tham syndrome | KAT6A* | Kat6a | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 1 | TGFB3* | Tgfb3 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 13 | CTNNA3* | Ctnna3 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 14 | CDH2* | Cdh2 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 5 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 9 | PKP2* | Pkp2 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | MYH8* | Myh8 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | TNNI2* | Tnni2 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | VPS33B* | Vps33b | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-1 | LGI4* | Lgi4 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-3 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-4 | SCYL2* | Scyl2 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-5 | TOR1A* | Tor1a | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-6 | NEB* | Neb | Alliance of Genome Resources | ||||
arthrogryposis, renal dysfunction, and cholestasis 1 | VPS33B* | Vps33b | Alliance of Genome Resources | ||||
arthrogryposis, renal dysfunction, and cholestasis 2 | VIPAS39* | Vipas39 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy 4 | TTC21B* | Ttc21b | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy 5 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
ataxia-oculomotor apraxia type 4 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
ataxia telangiectasia | IL2* | Il2 | Alliance of Genome Resources | ||||
ataxia telangiectasia | HDAC4* | Hdac4 | Alliance of Genome Resources | ||||
ataxia telangiectasia | BAX* | Bax | Alliance of Genome Resources | ||||
ataxia telangiectasia | IFNG* | Ifng | Alliance of Genome Resources | ||||
ataxia telangiectasia | BIK* | Bik | Alliance of Genome Resources | ||||
ataxia telangiectasia | BAK1* | Bak1 | Alliance of Genome Resources | ||||
ataxia-telangiectasia-like disorder-1 | MRE11* | Mre11a | Alliance of Genome Resources | ||||
ataxia-telangiectasia-like disorder-2 | PCNA* | Pcna | Alliance of Genome Resources | ||||
ataxia with oculomotor apraxia type 1 | APTX* | Aptx | Alliance of Genome Resources | ||||
ataxia with oculomotor apraxia type 3 | PIK3R5* | Pik3r5 | Alliance of Genome Resources | ||||
atrial heart septal defect 5 | ACTC1* | Actc1 | Alliance of Genome Resources | ||||
atrial heart septal defect 6 | TLL1* | Tll1 | Alliance of Genome Resources | ||||
atrial heart septal defect 8 | CITED2* | Cited2 | Alliance of Genome Resources | ||||
atrial heart septal defect 9 | GATA6* | Gata6 | Alliance of Genome Resources | ||||
atrial standstill 1 | GJA5* | Gja5 | Alliance of Genome Resources | ||||
atrial standstill 2 | NPPA* | Nppa | Alliance of Genome Resources | ||||
autoimmune lymphoproliferative syndrome type 2A | CASP10* | ||||||
autoimmune lymphoproliferative syndrome type 3 | PRKCD* | Prkcd | Alliance of Genome Resources | ||||
autoimmune lymphoproliferative syndrome type 4 | KRAS* | Kras | Alliance of Genome Resources | ||||
autoimmune lymphoproliferative syndrome type 4 | NRAS* | Nras | Alliance of Genome Resources | ||||
autosomal dominant Alport syndrome | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
autosomal dominant Alport syndrome | MYH9* | Myh9 | Alliance of Genome Resources | ||||
autosomal dominant auditory neuropathy 3 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant beta thalassemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | NPTX1* | Nptx1 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | SAMD9L* | Samd9l | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | FGF14* | Fgf14 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia, deafness and narcolepsy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
autosomal dominant craniodiaphyseal dysplasia | SOST* | Sost | Alliance of Genome Resources | ||||
autosomal dominant craniometaphyseal dysplasia | ANKH* | Ank | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 1 | ELN* | Eln | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 2 | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 3 | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 10 | EMILIN1* | Emilin1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 11 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 12 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 13 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 14 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 3 | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 4 | HSPB3* | Hspb3 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 5 | GARS1* | Gars1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 6 | FBXO38* | Fbxo38 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 7 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 8 | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 9 | WARS1* | Wars1 | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 1 | TERC* | ||||||
autosomal dominant dyskeratosis congenita 2 | TERT* | Tert | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 3 | TINF2* | Tinf2 | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 6 | ACD* | Acd | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | SYNE2* | Syne2 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 7 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant hyaline body myopathy | MYH7* | Myh7 | Alliance of Genome Resources | ||||
autosomal dominant hypocalcemia | CASR* | Casr | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SET*, SETSIP | Set | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | AP2M1* | Ap2m1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | ATP2B1* | Atp2b1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | CAMK2G* | Camk2g | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | DIP2B* | Dip2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | DLG4* | Dlg4 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | GRIA1* | Gria1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | HNRNPC* | Hnrnpc | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | KDM4B* | Kdm4b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | LMAN2L* | Lman2l | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | MED13* | Med13 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | RFX7* | Rfx7 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SETD2* | Setd2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SRRM2* | Srrm2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TAF4* | Taf4 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TLK2* | Tlk2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TRIO* | Trio | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | ZNF292* | Zfp292 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 1 | MBD5* | Mbd5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 10 | CACNG2* | Cacng2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 11 | EPB41L1* | Epb41l1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 13 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 19 | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 21 | CTCF* | Ctcf | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 22 | ZBTB18* | Zbtb18 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 23 | SETD5* | Setd5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 29 | SETBP1* | Setbp1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 3 | CDH15* | Cdh15 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 30 | ZMYND11* | Zmynd11 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 31 | PURA* | Pura | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 33 | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 34 | CERT1* | Cert1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 35 | PPP2R5D* | Ppp2r5d | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 36 | PPP2R1A* | Ppp2r1a | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 40 | CHAMP1* | Champ1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 41 | TBL1XR1* | Tbl1xr1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 42 | GNB1* | Gnb1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 43 | HIVEP2* | Hivep2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 44 | TRIO* | Trio | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 45 | CIC* | Cic | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 46 | KCNQ5* | Kcnq5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 47 | STAG1* | Stag1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 48 | RAC1* | Rac1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 5 | SYNGAP1* | Syngap1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 50 | NAA15* | Naa15 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 51 | KMT5B* | Kmt5b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 52 | ASH1L* | Ash1l | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 53 | CAMK2A* | Camk2a | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 54 | CAMK2B* | Camk2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 55 | NUS1* | Nus1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 56 | CLTC* | Cltc | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 6 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 8 | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
autosomal dominant isolated ectopia lentis 1 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
autosomal dominant isolated macrothrombocytopenia 1 | TUBB1* | Tubb1 | Alliance of Genome Resources | ||||
autosomal dominant keratitis | PAX6* | Pax6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 1 | DNAJB6* | Dnajb6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 2 | TNPO3* | Tnpo3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 3 | HNRNPDL* | Hnrnpdl | Alliance of Genome Resources | ||||
autosomal dominant mutilating palmoplantar keratoderma with periorificial keratotic plaques | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy | CHRNB2* | Chrnb2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 1 | CHRNA4* | Chrna4 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 4 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 5 | KCNT1* | Kcnt1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MYO3A* | Myo3a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MAP1B* | Map1b | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | GREB1L* | Greb1l | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | EPHA10* | Epha10 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ELMOD3* | Elmod3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATOH1* | Atoh1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP2B2* | Atp2b2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | USP48* | Usp48 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | THOC1* | Thoc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | PI4KB* | Pi4kb | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 1 | DIAPH1* | Diaph1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 10 | EYA4* | Eya4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 11 | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 15 | POU4F3* | Pou4f3 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 17 | MYH9* | Myh9 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 20 | ACTG1* | Actg1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 21 | RIPOR2* | Ripor2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 23 | SIX1* | Six1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 27 | REST* | Rest | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 28 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2A | KCNQ4* | Kcnq4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2B | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 34 | NLRP3* | Nlrp3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3A | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3B | GJB6* | Gjb6 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 40 | CRYM* | Crym | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 44 | CCDC50* | Ccdc50 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4A | MYH14* | Myh14 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4B | CEACAM16* | Ceacam16 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 5 | GSDME* | Gsdme | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 50 | MIR96* | Mir96 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 56 | TNC* | Tnc | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 6 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 64 | DIABLO* | Diablo | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 65 | TBC1D24* | Tbc1d24 | 2 "NOT" models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 66 | CD164* | Cd164 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 68 | HOMER2* | Homer2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 69 | KITLG* | Kitl | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 7 | LMX1A* | Lmx1a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 70 | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 71 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 72 | SLC44A4* | Slc44a4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 73 | PTPRQ* | Ptprq | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 74 | PDE1C* | Pde1c | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 75 | TRRAP* | Trrap | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 76 | PLS1* | Pls1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 77 | ABCC1* | Abcc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 78 | SLC12A2* | Slc12a2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 79 | SCD5* | ||||||
autosomal dominant osteopetrosis 1 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | MTOR* | Mtor | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia 1 | POLG* | Polg | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | TWNK* | Twnk | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | POLG2* | Polg2 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | RRM2B* | Rrm2b | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 6 | DNA2* | Dna2 | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 1 | WNT5A* | Wnt5a | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 2 | DVL1*, DVL1P1 | Dvl1 | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 3 | DVL3* | Dvl3 | Alliance of Genome Resources | ||||
autosomal dominant sensory ataxia 1 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
autosomal dominant sideroblastic anemia 4 | HSPA9* | Hspa9 | Alliance of Genome Resources | ||||
autosomal dominant thrombophilia due to protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
autosomal dominant thrombophilia due to protein S deficiency | PROS1* | Pros1 | Alliance of Genome Resources | ||||
autosomal dominant vitreoretinochoroidopathy | BEST1* | Best1 | Alliance of Genome Resources | ||||
autosomal dominant Wolfram syndrome | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
autosomal dominant woolly hair | KRT74* | Krt74 | Alliance of Genome Resources | ||||
autosomal hemophilia A | IFNL4* | ||||||
autosomal recessive chronic granulomatous disease 1 | NCF1*, NCF1B, NCF1C | Ncf1 | Alliance of Genome Resources | ||||
autosomal recessive chronic granulomatous disease 2 | NCF2* | Ncf2 | Alliance of Genome Resources | ||||
autosomal recessive chronic granulomatous disease 3 | NCF4* | Ncf4 | Alliance of Genome Resources | ||||
autosomal recessive chronic granulomatous disease 4 | CYBA* | Cyba | Alliance of Genome Resources | ||||
autosomal recessive chronic granulomatous disease 5 | CYBC1* | Cybc1 | Alliance of Genome Resources | ||||
autosomal recessive congenital bilateral absence of vas deferens | CFTR* | Cftr | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis | CASP14* | Casp14 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 1 | ABHD5* | Abhd5 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 1 | ALOXE3* | Aloxe3 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 1 | ABCA12* | Abca12 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 11 | ST14* | St14 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 14 | SULT2B1* | Sult2b1 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 2 | ALOX12B* | Alox12b | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 3 | ALOXE3* | Aloxe3 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 4A | ABCA12* | Abca12 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 5 | CYP4F22* | Cyp4f39 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 6 | NIPAL4* | Nipal4 | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 8 | LIPN* | Lipn | Alliance of Genome Resources | ||||
autosomal recessive congenital ichthyosis 9 | CERS3* | Cers3 | Alliance of Genome Resources | ||||
autosomal recessive congenital nystagmus | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
autosomal recessive craniometaphyseal dysplasia | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IA | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IB | EFEMP2* | Efemp2 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IC | LTBP4* | Ltbp4 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IIA | ATP6V0A2* | Atp6v0a2 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IIB | PYCR1* | Pycr1 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IIC | ATP6V1E1* | Atp6v1e1 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IID | ATP6V1A* | Atp6v1a | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type III | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IIIA | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
autosomal recessive cutis laxa type IIIB | PYCR1* | Pycr1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 10 | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 2 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 4 | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 5 | DNAJB2* | Dnajb2 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 6 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 7 | VWA1* | Vwa1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 8 | SORD* | Sord | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 9 | COQ7* | Coq7 | Alliance of Genome Resources | ||||
autosomal recessive dyskeratosis congenita 1 | NOP10* | Nop10 | Alliance of Genome Resources | ||||
autosomal recessive dyskeratosis congenita 2 | NHP2* | Nhp2 | Alliance of Genome Resources | ||||
autosomal recessive dyskeratosis congenita 3 | WRAP53* | Wrap53 | Alliance of Genome Resources | ||||
autosomal recessive dyskeratosis congenita 5 | RTEL1* | Rtel1 | Alliance of Genome Resources | ||||
autosomal recessive dyskeratosis congenita 6 | PARN* | Parn | Alliance of Genome Resources | ||||
autosomal recessive Emery-Dreifuss muscular dystrophy 3 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal recessive hyaline body myopathy | MYH7* | Myh7 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder | ASCC3* | Ascc3 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder | CASP2* | Casp2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder | TPR* | Tpr | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder | WDR11* | Wdr11 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 1 | PRSS12* | Prss12 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 12 | ST3GAL3* | St3gal3 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 13 | TRAPPC9* | Trappc9 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 14 | TECR* | Tecr | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 18 | MED23* | Med23 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 2 | CRBN* | Crbn | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 27 | LINS1* | Lins1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 3 | CC2D1A* | Cc2d1a | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 34 | CRADD* | Cradd | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 37 | ANK3* | Ank3 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 38 | HERC2* | Herc2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 39 | TTI2* | Tti2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 40 | TAF2* | Taf2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 43 | WASHC4* | Washc4 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 44 | METTL23* | Mettl23 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 45 | FBXO31* | Fbxo31 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 46 | NDST1* | Ndst1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 47 | FMN2* | Fmn2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 48 | SLC6A17* | Slc6a17 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 5 | NSUN2* | Nsun2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 50 | EDC3* | Edc3 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 51 | HNMT* | Hnmt | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 52 | LMAN2L* | Lman2l | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 54 | TNIK* | Tnik | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 56 | ZC3H14* | Zc3h14 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 57 | MBOAT7* | Mboat7 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 58 | ELP2* | Elp2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 59 | IMPA1* | Impa1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 6 | GRIK2* | Grik2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 60 | TAF13* | Taf13 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 61 | RUSC2* | Rusc2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 63 | CAMK2A* | Camk2a | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 64 | LINGO1* | Lingo1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 65 | KDM5B* | Kdm5b | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 66 | FERRY3* | D6Wsu163e | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 67 | EIF3F* | Eif3f | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 68 | TRMT1* | Trmt1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 69 | ZBTB11* | Zbtb11 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 7 | TUSC3* | Tusc3 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 70 | RSRC1* | Rsrc1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 71 | ALKBH8* | Alkbh8 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 72 | METTL5* | Mettl5 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 73 | NAA20* | Naa20 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 74 | APC2* | Apc2 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 75 | PIDD1* | Pidd1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 76 | GRIA1* | Gria1 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 77 | CEP104* | Cep104 | Alliance of Genome Resources | ||||
autosomal recessive intellectual developmental disorder 82 | NSUN6* | Nsun6 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | JAG2* | Jag2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POPDC3* | Popdc3 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2D | DAG1* | Dag1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2K | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2L | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2M | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2N | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2O | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Q | PLEC* | Plec | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2S | TRAPPC11* | Trappc11 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2T | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2W | LIMS2* | Lims2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2X | POPDC1* | Popdc1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Y | TOR1AIP1* | Tor1aip1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Z | POGLUT1* | Poglut1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | CDH23* | Cdh23 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | AFG2B* | Afg2b | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | CLRN2* | Clrn2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | GPR156* | Gpr156 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | MINAR2* | Minar2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | PKHD1L1* | Pkhd1l1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | STX4* | Stx4a | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | TMTC4* | Tmtc4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 100 | PPIP5K2* | Ppip5k2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 101 | GRXCR2* | Grxcr2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 102 | EPS8* | Eps8 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 103 | CLIC5* | Clic5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 104 | RIPOR2* | Ripor2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 106 | EPS8L2* | Eps8l2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 107 | WBP2* | Wbp2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 108 | ROR1* | Ror1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 109 | ESRP1* | Esrp1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 110 | COCH* | Coch | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 111 | MPZL2* | Mpzl2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 112 | BDP1* | Bdp1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 113 | CEACAM16* | Ceacam16 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 114 | GRAP*, GRAPL | Grap | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 115 | SPNS2* | Spns2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 116 | CLDN9* | Cldn9 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 12 | ATP2B2* | Atp2b2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 15 | GIPC3* | Gipc3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 1A | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 1B | GJB6* | Gjb6 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 21 | TECTA* | Tecta | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 24 | RDX* | Rdx | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 25 | GRXCR1* | Grxcr1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 26 | GAB1* | Gab1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 35 | ESRRB* | Esrrb | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 36 | ESPN* | Espn | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | SLC26A4* | Slc26a4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | FOXI1* | Foxi1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | KCNJ10* | Kcnj10 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 44 | ADCY1* | Adcy1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 53 | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 57 | PDZD7* | Pdzd7 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 6 | TMIE* | Tmie | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 61 | SLC26A5* | Slc26a5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 66 | DCDC2* | Dcdc2a | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 67 | LHFPL5* | Lhfpl5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 70 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 76 | SYNE4* | Syne4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 77 | LOXHD1* | Loxhd1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 8 | TMPRSS3* | Tmprss3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 84A | PTPRQ* | Ptprq | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 84B | OTOGL* | Otogl | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 86 | TBC1D24* | Tbc1d24 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 89 | KARS1* | Kars1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 91 | SERPINB6* | Serpinb6a, Serpinb6b, Serpinb6c, Serpinb6d, Serpinb6e | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 94 | NARS2* | Nars2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 97 | MET* | Met | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 98 | TSPEAR* | Tspear | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 99 | TMEM132E* | Tmem132e | Alliance of Genome Resources | ||||
autosomal recessive osteopetrosis 7 | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia 1 | POLG* | Polg | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | RNASEH1* | Rnaseh1 | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | TK2* | Tk2 | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | DGUOK* | Dguok | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | TOP3A* | Top3a | Alliance of Genome Resources | ||||
autosomal recessive pyridoxine-refractory sideroblastic anemia 2 | SLC25A38* | Slc25a38 | Alliance of Genome Resources | ||||
autosomal recessive pyridoxine-refractory sideroblastic anemia 3 | GLRX5* | Glrx5 | Alliance of Genome Resources | ||||
autosomal recessive Robinow syndrome 2 | NXN* | Nxn | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 10 | ANO10* | Ano10 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 11 | SYT14* | Syt14 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 14 | SPTBN2* | Sptbn2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 15 | RUBCN* | Rubcn | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 17 | CWF19L1* | Cwf19l1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 19 | SLC9A1* | Slc9a1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 2 | PMPCA* | Pmpca | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 20 | SNX14* | Snx14 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 21 | SCYL1* | Scyl1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 22 | VWA3B* | Vwa3b | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 23 | TDP2* | Tdp2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 24 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 25 | ATG5* | Atg5 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 26 | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 27 | GDAP2* | Gdap2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 28 | THG1L* | Thg1l | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 29 | VPS41* | Vps41 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 30 | PITRM1* | Pitrm1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 31 | ATG7* | Atg7 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 32 | PRDX3* | Prdx3 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 33 | RNU12* | ||||||
autosomal recessive spinocerebellar ataxia 4 | VPS13D* | Vps13d | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 7 | TPP1* | Tpp1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 8 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
autosomal recessive thrombophilia due to protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
autosomal recessive thrombophilia due to protein S deficiency | PROS1* | Pros1 | Alliance of Genome Resources | ||||
autosomal recessive woolly hair 3 | KRT25* | Krt25 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome type 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
axial spondylometaphyseal dysplasia | CFAP410* | Cfap410 | Alliance of Genome Resources | ||||
Ayme-Gripp syndrome | MAF* | Maf | Alliance of Genome Resources | ||||
Bainbridge-Ropers syndrome | ASXL3* | Asxl3 | Alliance of Genome Resources | ||||
Baraitser-Winter syndrome 1 | ACTB* | Actb | Alliance of Genome Resources | ||||
Baraitser-Winter syndrome 2 | ACTG1* | Actg1 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | TTC8* | Ttc8 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | TRIM32* | Trim32 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | MKS1* | Mks1 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | MKKS* | Mkks | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | CCDC28B* | Ccdc28b | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS10* | Bbs10 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS7* | Bbs7 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS5* | Bbs5 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS2* | Bbs2 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | BBS1* | Bbs1 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome | ARL6* | Arl6 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 1 | ARL6* | Arl6 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 1 | CCDC28B* | Ccdc28b | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 11 | TRIM32* | Trim32 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 12 | BBS12* | Bbs12 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 13 | MKS1* | Mks1 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 14 | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 14 | CEP290* | Cep290 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 15 | WDPCP* | Wdpcp | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 19 | IFT27* | Ift27 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 20 | IFT172* | Ift172 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 21 | CFAP418* | Cfap418 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 22 | IFT74* | Ift74 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 7 | BBS7* | Bbs7 | Alliance of Genome Resources | ||||
Bardet-Biedl syndrome 9 | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
Bart-Pumphrey syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
Becker disease | CLCN1* | Clcn1 | Alliance of Genome Resources | ||||
Behr syndrome | OPA1* | Opa1 | Alliance of Genome Resources | ||||
benign familial hematuria | COL4A4* | Col4a4 | Alliance of Genome Resources | ||||
benign familial hematuria | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
benign familial infantile seizures 2 | PRRT2* | Prrt2 | Alliance of Genome Resources | ||||
benign familial infantile seizures 3 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
benign familial infantile seizures 5 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
benign familial infantile seizures 6 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
benign recurrent intrahepatic cholestasis 1 | ATP8B1* | Atp8b1 | Alliance of Genome Resources | ||||
benign recurrent intrahepatic cholestasis 2 | ABCB11* | Abcb11 | Alliance of Genome Resources | ||||
Bernard-Soulier syndrome | GP9* | Gp9 | Alliance of Genome Resources | ||||
Bernard-Soulier syndrome | VWF* | Vwf | Alliance of Genome Resources | ||||
Bernard-Soulier syndrome type A2 | GP1BA* | Gp1ba | Alliance of Genome Resources | ||||
beta-ketothiolase deficiency | ACAT1* | Acat1 | Alliance of Genome Resources | ||||
beta thalassemia | HBS1L* | Hbs1l | Alliance of Genome Resources | ||||
beta thalassemia | TNF* | Tnf | Alliance of Genome Resources | ||||
beta thalassemia | HFE* | Hfe | Alliance of Genome Resources | ||||
beta thalassemia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
beta thalassemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
beta thalassemia | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
beta thalassemia | GATA1* | Gata1 | Alliance of Genome Resources | ||||
beta thalassemia | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
beta thalassemia | BCL11A* | Bcl11a | Alliance of Genome Resources | ||||
Beukes hip dysplasia | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
BH4-deficient hyperphenylalaninemia C | QDPR* | Qdpr | Alliance of Genome Resources | ||||
BH4-deficient hyperphenylalaninemia D | PCBD1* | Pcbd1 | Alliance of Genome Resources | ||||
bilateral frontoparietal polymicrogyria | ADGRG1* | Adgrg1 | Alliance of Genome Resources | ||||
bilateral optic nerve hypoplasia | PAX6* | Pax6 | Alliance of Genome Resources | ||||
bilateral parasagittal parieto-occipital polymicrogyria | FIG4* | Fig4 | Alliance of Genome Resources | ||||
Birk-Barel syndrome | KCNK9* | Kcnk9 | Alliance of Genome Resources | ||||
Birt-Hogg-Dube syndrome | PRDM10* | Prdm10 | Alliance of Genome Resources | ||||
Bjornstad syndrome | BCS1L* | Bcs1l | Alliance of Genome Resources | ||||
Blau syndrome | NOD2* | Nod2 | Alliance of Genome Resources | ||||
blepharocheilodontic syndrome 1 | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
blepharocheilodontic syndrome 2 | CTNND1* | Ctnnd1 | Alliance of Genome Resources | ||||
blepharophimosis-impaired intellectual development syndrome | SMARCA2* | Smarca2 | Alliance of Genome Resources | ||||
blue color blindness | OPN1SW* | Opn1sw | Alliance of Genome Resources | ||||
Bothnian type palmoplantar keratoderma | AQP5* | Aqp5 | Alliance of Genome Resources | ||||
Boucher-Neuhauser syndrome | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
brachycephaly, trichomegaly, and developmental delay | RPS23* | Rps23 | Alliance of Genome Resources | ||||
brachydactyly-syndactyly syndrome | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly type A1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
brachydactyly type A1D | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type D | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
bradyopsia 1 | RGS9* | Rgs9 | Alliance of Genome Resources | ||||
bradyopsia 2 | RGS9BP* | Rgs9bp | Alliance of Genome Resources | ||||
brain small vessel disease 2 | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
brain small vessel disease 3 | COLGALT1* | Colgalt1 | Alliance of Genome Resources | ||||
branchiooculofacial syndrome | TFAP2A* | Tfap2a | Alliance of Genome Resources | ||||
branchiootorenal syndrome | PAX1* | Pax1 | Alliance of Genome Resources | ||||
branchiootorenal syndrome 1 | EYA1* | Eya1 | Alliance of Genome Resources | ||||
branchiootorenal syndrome 2 | SIX5* | Six5 | Alliance of Genome Resources | ||||
brittle cornea syndrome 2 | PRDM5* | Prdm5 | Alliance of Genome Resources | ||||
bronchiectasis 1 | CFTR* | Cftr | Alliance of Genome Resources | ||||
bronchiectasis 1 | SCNN1B* | Scnn1b | Alliance of Genome Resources | ||||
bronchiectasis 2 | SCNN1A* | Scnn1a | Alliance of Genome Resources | ||||
bronchiectasis 3 | SCNN1G* | Scnn1g | Alliance of Genome Resources | ||||
Brooke-Spiegler syndrome | CYLD* | Cyld | Alliance of Genome Resources | ||||
Brown-Vialetto-Van Laere syndrome 1 | SLC52A3* | Slc52a3 | Alliance of Genome Resources | ||||
Brown-Vialetto-Van Laere syndrome 2 | SLC52A2*, SLC52A1 | Slc52a2 | Alliance of Genome Resources | ||||
Brugada syndrome 9 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
Buschke-Ollendorff syndrome | LEMD3* | Lemd3 | Alliance of Genome Resources | ||||
CADASIL 2 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
camptodactyly-arthropathy-coxa vara-pericarditis syndrome | PRG4* | Prg4 | Alliance of Genome Resources | ||||
camptodactyly-tall stature-scoliosis-hearing loss syndrome | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
carboxypeptidase N deficiency | CPN1* | Cpn1 | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 1 | BRAF* | Braf | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 2 | KRAS* | Kras | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 3 | MAP2K1* | Map2k1 | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 4 | MAP2K2* | Map2k2 | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHC* | Sdhc | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHD* | Sdhd | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHB* | Sdhb | Alliance of Genome Resources | ||||
carnitine-acylcarnitine translocase deficiency | SLC25A20* | Slc25a20 | Alliance of Genome Resources | ||||
carpal tunnel syndrome 1 | TTR* | Ttr | Alliance of Genome Resources | ||||
carpal tunnel syndrome 2 | COMP* | Comp | Alliance of Genome Resources | ||||
cartilage-hair hypoplasia | RMRP* | Rmrp | Alliance of Genome Resources | ||||
cataract 11 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
cataract 12 multiple types | BFSP2* | Bfsp2 | Alliance of Genome Resources | ||||
cataract 13 with adult i phenotype | GCNT2* | Gcnt2 | Alliance of Genome Resources | ||||
cataract 17 multiple types | CRYBB1* | Crybb1 | Alliance of Genome Resources | ||||
cataract 18 | FYCO1* | Fyco1 | Alliance of Genome Resources | ||||
cataract 22 multiple types | CRYBB3* | Crybb3 | Alliance of Genome Resources | ||||
cataract 31 multiple types | CHMP4B* | Chmp4b | Alliance of Genome Resources | ||||
cataract 33 | BFSP1* | Bfsp1 | Alliance of Genome Resources | ||||
cataract 36 | TDRD7* | Tdrd7 | Alliance of Genome Resources | ||||
cataract 38 | AGK* | Agk | Alliance of Genome Resources | ||||
cataract 41 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
cataract 42 | CRYBA2* | Cryba2 | Alliance of Genome Resources | ||||
cataract 43 | UNC45B* | Unc45b | Alliance of Genome Resources | ||||
cataract 44 | LSS* | Lss | Alliance of Genome Resources | ||||
cataract 45 | SIPA1L3* | Sipa1l3 | Alliance of Genome Resources | ||||
cataract 46 juvenile-onset | LEMD2* | Lemd2 | Alliance of Genome Resources | ||||
cataract 47 | SLC16A12* | Slc16a12 | Alliance of Genome Resources | ||||
cataract 48 | DNMBP* | Dnmbp | Alliance of Genome Resources | ||||
cataract 7 | CRYGD* | Crygd, Cryge, Crygf | Alliance of Genome Resources | ||||
cataract 9 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
central conducting lymphatic anomaly | EPHB4* | Ephb4 | Alliance of Genome Resources | ||||
central precocious puberty 1 | KISS1R* | Kiss1r | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | MTMR14* | Mtmr14 | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
centronuclear myopathy 2 | BIN1* | Bin1 | Alliance of Genome Resources | ||||
centronuclear myopathy 4 | CCDC78* | Ccdc78 | Alliance of Genome Resources | ||||
centronuclear myopathy 5 | SPEG* | Speg | Alliance of Genome Resources | ||||
centronuclear myopathy 6 with fiber-type disproportion | MAP3K20* | Map3k20 | Alliance of Genome Resources | ||||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1 | VLDLR* | Vldlr | Alliance of Genome Resources | ||||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 2 | WDR81* | Wdr81 | Alliance of Genome Resources | ||||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 3 | CA8* | Car8 | Alliance of Genome Resources | ||||
cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4 | ATP8A2* | Atp8a2 | Alliance of Genome Resources | ||||
cerebellar ataxia type 41 | TRPC3* | Trpc3 | Alliance of Genome Resources | ||||
cerebellar ataxia type 43 | MME* | Mme | Alliance of Genome Resources | ||||
cerebellar ataxia type 47 | PUM1* | Pum1 | Alliance of Genome Resources | ||||
cerebellar ataxia type 48 | STUB1* | Stub1 | Alliance of Genome Resources | ||||
cerebellar atrophy, visual impairment, and psychomotor retardation | EMC1* | Emc1 | Alliance of Genome Resources | ||||
cerebellofaciodental syndrome | BRF1* | Brf1 | Alliance of Genome Resources | ||||
cerebral folate receptor alpha deficiency | FOLR1* | Folr1 | Alliance of Genome Resources | ||||
cerebrooculofacioskeletal syndrome 1 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
cerebrooculofacioskeletal syndrome 2 | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
cerebrooculofacioskeletal syndrome 3 | ERCC5* | Ercc5 | Alliance of Genome Resources | ||||
cerebrooculofacioskeletal syndrome 4 | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2CC | NEFH* | Nefh | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2F | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2K | JPH1* | Jph1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2L | HSPB8* | Hspb8 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2N | AARS1* | Aars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2T | MME* | Mme | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2U | MARS1* | Mars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2V | NAGLU* | Naglu | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease, axonal type 2W | HARS1* | Hars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2X | SPG11* | Spg11 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate A | GBF1* | Gbf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate B | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate D | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate E | INF2* | Inf2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate F | GNB4* | Gnb4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate G | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate B | KARS1* | Kars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate C | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1D | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1F | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1G | PMP2* | Pmp2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2A2B | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2B2 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2DD | ATP1A1* | Atp1a1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2EE | MPV17* | Mpv17 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2I | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2J | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2R | TRIM2* | Trim2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2Y | VCP* | Vcp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4F | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4G | HK1* | Hk1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4K | SURF1* | Surf1 | Alliance of Genome Resources | ||||
childhood-onset dystonia with optic atrophy and basal ganglia abnormalities | MECR* | Mecr | Alliance of Genome Resources | ||||
childhood-onset neurodegeneration with brain atrophy | UBTF* | Ubtf | Alliance of Genome Resources | ||||
CHIME syndrome | PIGL* | Pigl | Alliance of Genome Resources | ||||
cholesterol ester storage disease | LIPA* | Lipa | Alliance of Genome Resources | ||||
chromosome 15q24 deletion syndrome | SIN3A* | Sin3a | Alliance of Genome Resources | ||||
Clark-Baraitser syndrome | TRIP12* | Trip12 | Alliance of Genome Resources | ||||
classic dopamine transporter deficiency syndrome | SLC6A3* | Slc6a3 | Alliance of Genome Resources | ||||
classic galactosemia | GALT* | Galt | Alliance of Genome Resources | ||||
cleft lip-palate-ectodermal dysplasia syndrome | NECTIN1* | Nectin1 | 3 "NOT" models | Alliance of Genome Resources | |||
cleft palate, cardiac defects, and intellectual disabillity | MEIS2* | Meis2 | Alliance of Genome Resources | ||||
COACH syndrome | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
Cockayne syndrome A | ERCC8* | Ercc8 | Alliance of Genome Resources | ||||
Cockayne syndrome B | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
CODAS syndrome | LONP1* | Lonp1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome | ARID1B* | Arid1b | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 10 | SOX4* | Sox4 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 11 | SMARCD1* | Smarcd1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 12 | BICRA* | Bicra | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 2 | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 3 | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 4 | SMARCA4* | Smarca4 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 5 | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 6 | ARID2* | Arid2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 7 | DPF2* | Dpf2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 8 | SMARCC2* | Smarcc2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 9 | SOX11* | Sox11 | Alliance of Genome Resources | ||||
cold-induced sweating syndrome 1 | CRLF1* | Crlf1 | Alliance of Genome Resources | ||||
cold-induced sweating syndrome 2 | CLCF1* | Clcf1 | Alliance of Genome Resources | ||||
cold-induced sweating syndrome 3 | KLHL7* | Klhl7 | Alliance of Genome Resources | ||||
combined cellular and humoral immune defects with granulomas | RAG1* | Rag1 | Alliance of Genome Resources | ||||
combined cellular and humoral immune defects with granulomas | RAG2* | Rag2 | Alliance of Genome Resources | ||||
combined D-2- and L-2-hydroxyglutaric aciduria | SLC25A1* | Slc25a1 | Alliance of Genome Resources | ||||
combined deficiency of vitamin K-dependent clotting factors 1 | GGCX* | Ggcx | Alliance of Genome Resources | ||||
combined deficiency of vitamin K-dependent clotting factors 2 | VKORC1* | Vkorc1 | Alliance of Genome Resources | ||||
combined malonic and methylmalonic acidemia | ACSF3* | Acsf3 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 1 | GFM1* | Gfm1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 10 | MTO1* | Mto1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 11 | RMND1* | Rmnd1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 12 | EARS2* | Ears2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 13 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 14 | FARS2* | Fars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 15 | MTFMT* | Mtfmt | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 16 | MRPL44* | Mrpl44 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 17 | ELAC2* | Elac2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 18 | SFXN4* | Sfxn4 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 19 | LYRM4* | Lyrm4 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 2 | MRPS16* | Mrps16 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 20 | VARS2* | Vars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 21 | TARS2* | Tars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 22 | ATP5F1A* | Atp5f1a | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 23 | GTPBP3* | Gtpbp3 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 24 | NARS2* | Nars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 25 | MARS2* | Mars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 26 | TRMT5* | Trmt5 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 27 | CARS2* | Cars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 28 | SLC25A26* | Slc25a26 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 29 | TXN2* | Txn2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 3 | TSFM* | Tsfm | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 30 | TRMT10C* | Trmt10c | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 31 | MIPEP* | Mipep | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 32 | MRPS34* | Mrps34 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 33 | C1QBP* | C1qbp | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 34 | MRPS7* | Mrps7 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 35 | TRIT1* | Trit1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 36 | MRPS2* | Mrps2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 37 | MICOS13* | Micos13 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 38 | MRPS14* | Mrps14 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 39 | GFM2* | Gfm2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 4 | TUFM* | Tufm | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 40 | QRSL1* | Qrsl1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 41 | GATB* | Gatb | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 42 | GATC* | Gatc | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 43 | TIMM22* | Timm22 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 44 | FASTKD2* | Fastkd2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 45 | MRPL12* | Mrpl12 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 46 | MRPS23* | Mrps23 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 47 | MRPS28* | Mrps28 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 48 | NSUN3* | Nsun3 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 49 | MIEF2* | Mief2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 5 | MRPS22* | Mrps22 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 50 | MRPS25* | Mrps25 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 51 | PTCD3* | Ptcd3 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 52 | NFS1* | Nfs1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 53 | C2orf69* | 1700066M21Rik | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 54 | PRORP* | Prorp | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 55 | POLRMT* | Polrmt | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 56 | TAMM41* | Tamm41 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 57 | CRLS1* | Crls1 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 7 | MTRFR* | Mtrfr | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 8 | AARS2* | Aars2 | Alliance of Genome Resources | ||||
combined oxidative phosphorylation deficiency 9 | MRPL3* | Mrpl3 | Alliance of Genome Resources | ||||
common variable immunodeficiency | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
common variable immunodeficiency | SEC61A1* | Sec61a1 | Alliance of Genome Resources | ||||
common variable immunodeficiency | DCLRE1C* | Dclre1c | Alliance of Genome Resources | ||||
common variable immunodeficiency | IL21R* | Il21r | Alliance of Genome Resources | ||||
common variable immunodeficiency | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
common variable immunodeficiency 1 | ICOS* | Icos | Alliance of Genome Resources | ||||
common variable immunodeficiency 10 | NFKB2* | Nfkb2 | Alliance of Genome Resources | ||||
common variable immunodeficiency 11 | IL21* | Il21 | Alliance of Genome Resources | ||||
common variable immunodeficiency 12 | NFKB1* | Nfkb1 | Alliance of Genome Resources | ||||
common variable immunodeficiency 13 | IKZF1* | Ikzf1 | Alliance of Genome Resources | ||||
common variable immunodeficiency 14 | IRF2BP2* | Irf2bp2 | Alliance of Genome Resources | ||||
common variable immunodeficiency 2 | TNFRSF13B* | Tnfrsf13b | Alliance of Genome Resources | ||||
common variable immunodeficiency 3 | CD19* | Cd19 | Alliance of Genome Resources | ||||
common variable immunodeficiency 4 | TNFRSF13C* | Tnfrsf13c | Alliance of Genome Resources | ||||
common variable immunodeficiency 5 | MS4A1* | Ms4a1 | Alliance of Genome Resources | ||||
common variable immunodeficiency 6 | CD81* | Cd81 | Alliance of Genome Resources | ||||
common variable immunodeficiency 7 | CR2* | Cr2 | Alliance of Genome Resources | ||||
common variable immunodeficiency 8 | LRBA* | Lrba | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CAMSAP1* | Camsap1 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | APC2* | Apc2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | KIF26A* | Kif26a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CTNNA2* | Ctnna2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 1 | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 2 | KIF5C* | Kif5c | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 3 | KIF2A* | Kif2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 5 | TUBB2A* | Tubb2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 6 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
cone-rod dystrophy 21 | DRAM2* | Dram2 | Alliance of Genome Resources | ||||
cone-rod dystrophy 22 | TLCD3B* | Tlcd3b | Alliance of Genome Resources | ||||
cone-rod dystrophy 24 | UNC119* | Unc119 | Alliance of Genome Resources | ||||
congenital adrenal insufficiency | CYP11A1* | Cyp11a1 | Alliance of Genome Resources | ||||
congenital afibrinogenemia | FGA* | Fga | Alliance of Genome Resources | ||||
congenital afibrinogenemia | FGB* | Fgb | Alliance of Genome Resources | ||||
congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | SON* | Son | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | LBX1* | Lbx1 | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | MYO1H* | Myo1h | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | BDNF* | Bdnf | Alliance of Genome Resources | ||||
congenital contractural arachnodactyly | FBN2* | Fbn2 | Alliance of Genome Resources | ||||
congenital diarrhea 6 | GUCY2C* | Gucy2c | Alliance of Genome Resources | ||||
congenital diarrhea 7 with exudative enteropathy | DGAT1* | Dgat1 | Alliance of Genome Resources | ||||
congenital disorder of deglycosylation 1 | NGLY1* | Ngly1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ia | PMM2* | Pmm2 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Iaa | NUS1* | Nus1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ib | MPI* | Mpi | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ic | ALG6* | Alg6 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Id | ALG3* | Alg3 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ie | DPM1* | Dpm1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation If | MPDU1* | Mpdu1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ig | ALG12* | Alg12 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ih | ALG8* | Alg8 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ii | ALG2* | Alg2 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ij | DPAGT1* | Dpagt1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ik | ALG1*, ALG1L1P, ALG1L2 | Alg1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Il | ALG9* | Alg9 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Im | DOLK* | Dolk | Alliance of Genome Resources | ||||
congenital disorder of glycosylation In | RFT1* | Rft1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ip | ALG11* | Alg11 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Iq | SRD5A3* | Srd5a3 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ir | DDOST* | Ddost | Alliance of Genome Resources | ||||
congenital disorder of glycosylation It | PGM1* | Pgm1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Iu | DPM2* | Dpm2 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Iw | STT3A* | Stt3a | Alliance of Genome Resources | ||||
congenital disorder of glycosylation Ix | STT3B* | Stt3b | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIb | MOGS* | Mogs | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IId | B4GALT1* | B4galt1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIe | COG7* | Cog7 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIf | SLC35A1* | Slc35a1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIg | COG1* | Cog1 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIh | COG8* | Cog8 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIi | COG5* | Cog5 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIj | COG4* | Cog4 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIk | TMEM165* | Tmem165 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIl | COG6* | Cog6 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIn | SLC39A8* | Slc39a8 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIo | CCDC115* | Ccdc115 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIp | TMEM199* | Tmem199 | Alliance of Genome Resources | ||||
congenital disorder of glycosylation type IIq | COG2* | Cog2 | Alliance of Genome Resources | ||||
congenital dyserythropoietic anemia type Ia | CDAN1* | Cdan1 | Alliance of Genome Resources | ||||
congenital dyserythropoietic anemia type Ib | CDIN1* | Cdin1 | Alliance of Genome Resources | ||||
congenital dyserythropoietic anemia type II | SEC23B* | Sec23b | Alliance of Genome Resources | ||||
congenital dyserythropoietic anemia type IV | KLF1* | Klf1 | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 1 | KIF21A* | Kif21a | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 2 | PHOX2A* | Phox2a | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 3A | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 5 | COL25A1* | Col25a1 | Alliance of Genome Resources | ||||
congenital generalized lipodystrophy | PCYT1A* | Pcyt1a | Alliance of Genome Resources | ||||
congenital generalized lipodystrophy type 3 | CAV1* | Cav1 | Alliance of Genome Resources | ||||
congenital glutamine deficiency | GLUL* | Glul | Alliance of Genome Resources | ||||
congenital heart defects, hamartomas of tongue, and polysyndactyly | WDPCP* | Wdpcp | Alliance of Genome Resources | ||||
congenital hypotrichosis with juvenile macular dystrophy | CDH3* | Cdh3 | Alliance of Genome Resources | ||||
congenital lactase deficiency | LCT* | Lct | Alliance of Genome Resources | ||||
congenital leptin deficiency | LEP* | Lep | Alliance of Genome Resources | ||||
congenital limbs-face contractures-hypotonia-developmental delay syndrome | NALCN* | Nalcn | Alliance of Genome Resources | ||||
congenital malabsorptive diarrhea 4 | NEUROG3* | Neurog3 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A7 | CRPPA* | Crppa | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A1 | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A10 | RXYLT1* | Rxylt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A11 | B3GALNT2* | B3galnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A12 | POMK* | Pomk | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A13 | B4GAT1* | B4gat1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A5 | FKRP* | Fkrp | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A6 | LARGE1* | Large1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A9 | DAG1* | Dag1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy with cataracts and intellectual disability | INPP5K* | Inpp5k | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 13 | DPAGT1* | Dpagt1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 14 | ALG2* | Alg2 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 15 | ALG14* | Alg14 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 16 | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 17 | LRP4* | Lrp4 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 18 | SNAP25* | Snap25 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CAST* | Cast | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1B | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 20 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 21 | SLC18A3* | Slc18a3 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 22 | PREPL* | Prepl | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2A | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2C | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3B | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3C | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 4B | CHRNE* | Chrne | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 7 | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital myopathy 10B | MEGF10* | Megf10 | Alliance of Genome Resources | ||||
congenital myopathy 14 | MYL1* | Myl1 | Alliance of Genome Resources | ||||
congenital myopathy 15 | TNNC2* | Tnnc2 | Alliance of Genome Resources | ||||
congenital myopathy 16 | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
congenital myopathy 17 | MYOD1* | Myod1 | Alliance of Genome Resources | ||||
congenital myopathy 18 | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
congenital myopathy 19 | PAX7* | Pax7 | Alliance of Genome Resources | ||||
congenital myopathy 20 | RYR3* | Ryr3 | Alliance of Genome Resources | ||||
congenital myopathy 21 | DNAJB4* | Dnajb4 | Alliance of Genome Resources | ||||
congenital myopathy 22A | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myopathy 22B | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myopathy 2B | ACTA1* | Acta1 | Alliance of Genome Resources | ||||
congenital myopathy 2C | ACTA1* | Acta1 | Alliance of Genome Resources | ||||
congenital myopathy 4A | TPM3* | Tpm3 | Alliance of Genome Resources | ||||
congenital myopathy 5 | TTN* | Ttn | Alliance of Genome Resources | ||||
congenital myopathy 6 | MYH2* | Myh2 | Alliance of Genome Resources | ||||
congenital myopathy 8 | ACTN2* | Actn2 | Alliance of Genome Resources | ||||
congenital myopathy 9A | FXR1* | Fxr1 | Alliance of Genome Resources | ||||
congenital myopathy 9B | FXR1* | Fxr1 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 2 | PAX8* | Pax8 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 4 | TSHB* | Tshb | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 5 | NKX2-5* | Nkx2-5 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 6 | THRA* | Thra | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 7 | TRHR* | Trhr | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 8 | TBL1X*, TBL1Y | Tbl1x | Alliance of Genome Resources | ||||
congenital secretory sodium diarrhea 3 | SPINT2* | Spint2 | 1 model | Alliance of Genome Resources | |||
congenital secretory sodium diarrhea 8 | SLC9A3* | Slc9a3 | Alliance of Genome Resources | ||||
congenital stationary night blindness 1G | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
congenital stationary night blindness 1H | GNB3* | Gnb3 | Alliance of Genome Resources | ||||
congenital stationary night blindness autosomal dominant 3 | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
congenital sucrase-isomaltase deficiency | SI* | Sis | Alliance of Genome Resources | ||||
congenital symmetric circumferential skin creases 1 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
congenital symmetric circumferential skin creases 2 | MAPRE2* | Mapre2 | Alliance of Genome Resources | ||||
congenital vertical talus | HOXD10* | Hoxd10 | Alliance of Genome Resources | ||||
contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A | MYH3* | Myh3 | Alliance of Genome Resources | ||||
contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B | MYH3* | Myh3 | Alliance of Genome Resources | ||||
corneal dystrophy-perceptive deafness syndrome | SLC4A11* | Slc4a11 | Alliance of Genome Resources | ||||
Cornelia de Lange syndrome 4 | RAD21* | Rad21 | Alliance of Genome Resources | ||||
Cornelia de Lange syndrome 6 | BRD4* | Brd4 | Alliance of Genome Resources | ||||
corticosterone methyloxidase deficiency 1 | CYP11B2*, CYP11B1 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
cortisone reductase deficiency 1 | H6PD* | H6pd | Alliance of Genome Resources | ||||
cranioectodermal dysplasia 1 | IFT122* | Ift122 | Alliance of Genome Resources | ||||
cranioectodermal dysplasia 2 | WDR35* | Wdr35 | Alliance of Genome Resources | ||||
cranioectodermal dysplasia 3 | IFT43* | Ift43 | Alliance of Genome Resources | ||||
cranioectodermal dysplasia 4 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
craniofacial-deafness-hand syndrome | PAX3* | Pax3 | Alliance of Genome Resources | ||||
craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 1 | TMCO1* | Tmco1 | Alliance of Genome Resources | ||||
craniolenticulosutural dysplasia | SEC23A* | Sec23a | Alliance of Genome Resources | ||||
Crouzon syndrome-acanthosis nigricans syndrome | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
CST3-related cerebral amyloid angiopathy | CST3* | Cst3 | Alliance of Genome Resources | ||||
C syndrome | CD96* | Cd96 | Alliance of Genome Resources | ||||
Culler-Jones syndrome | GLI2* | Gli2 | Alliance of Genome Resources | ||||
Currarino syndrome | MNX1* | Mnx1 | Alliance of Genome Resources | ||||
cystic fibrosis | MPO* | Mpo | Alliance of Genome Resources | ||||
cystic fibrosis | MIF* | Mif | Alliance of Genome Resources | ||||
cystic fibrosis | TLR5* | Tlr5 | Alliance of Genome Resources | ||||
cystic fibrosis | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
cystic fibrosis | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
cystic fibrosis | SERPINA3* | Serpina3a, Serpina3b, Serpina3c, Serpina3f, Serpina3g, Serpina3i, Serpina3j, Serpina3k, Serpina3m, Serpina3n | Alliance of Genome Resources | ||||
cystic fibrosis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
cystic fibrosis | PTX3* | Ptx3 | Alliance of Genome Resources | ||||
cystic fibrosis | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
cystic fibrosis | LTA* | Lta | Alliance of Genome Resources | ||||
cystic fibrosis | IL1B* | Il1b | Alliance of Genome Resources | ||||
cystic fibrosis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
cystic fibrosis | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
cystic fibrosis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
cystic fibrosis | NOS1* | Nos1 | Alliance of Genome Resources | ||||
cystic fibrosis | FAS* | Fas | Alliance of Genome Resources | ||||
cystic fibrosis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
cystic fibrosis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
cystic fibrosis | GCLC* | Gclc | Alliance of Genome Resources | ||||
cystic fibrosis | NOS3* | Nos3 | Alliance of Genome Resources | ||||
cystic fibrosis | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
cystic fibrosis | AGER* | Ager | Alliance of Genome Resources | ||||
cystic fibrosis | CD14* | Cd14 | Alliance of Genome Resources | ||||
cystic fibrosis | HFE* | Hfe | Alliance of Genome Resources | ||||
cystic fibrosis | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
cystic fibrosis | TNF* | Tnf | Alliance of Genome Resources | ||||
cytochrome P450 oxidoreductase deficiency | POR* | Por | Alliance of Genome Resources | ||||
D-2-hydroxyglutaric aciduria 1 | D2HGDH* | D2hgdh | Alliance of Genome Resources | ||||
D-2-hydroxyglutaric aciduria 2 | IDH2* | Idh2 | Alliance of Genome Resources | ||||
dehydrated hereditary stomatocytosis 1 | PIEZO1* | Piezo1 | Alliance of Genome Resources | ||||
dehydrated hereditary stomatocytosis 2 | KCNN4* | Kcnn4 | Alliance of Genome Resources | ||||
delta beta-thalassemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
delta beta-thalassemia | HBG1*, HBG2*, HBE1 | Hbb-bh0, Hbb-bh1, Hbb-y | Alliance of Genome Resources | ||||
dentatorubral-pallidoluysian atrophy | ATN1* | Atn1 | Alliance of Genome Resources | ||||
dentinogenesis imperfecta | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
dermatopathia pigmentosa reticularis | KRT14* | Krt14 | Alliance of Genome Resources | ||||
De Sanctis-Cacchione syndrome | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
DeSanto-Shinawi syndrome | WAC* | Wac | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 100 | FBXO28* | Fbxo28 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 101 | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 102 | SLC38A3* | Slc38a3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 103 | KCNC2* | Kcnc2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 104 | ATP6V0A1* | Atp6v0a1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 105 | HID1* | Hid1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 106 | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 107 | NAPB* | Napb | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 108 | MAST3* | Mast3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 109 | FZR1* | Fzr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 11 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 110 | CACNA2D1* | Cacna2d1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 116 | GLUL* | Glul | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 12 | PLCB1* | Plcb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 13 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 15 | ST3GAL3* | St3gal3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 18 | SZT2* | Szt2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 19 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 21 | NECAP1* | Necap1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 23 | DOCK7* | Dock7 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 24 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 25 | SLC13A5* | Slc13a5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 26 | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 27 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 28 | WWOX* | Wwox | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 29 | AARS1* | Aars1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 3 | SLC25A22* | Slc25a22 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 30 | SIK1* | Sik1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 31A | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 31B | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 32 | KCNA2* | Kcna2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 33 | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 34 | SLC12A5* | Slc12a5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 35 | ITPA* | Itpa | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 37 | FRRS1L* | Frrs1l | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 38 | ARV1* | Arv1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 4 | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 40 | GUF1* | Guf1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 41 | SLC1A2* | Slc1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 42 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 43 | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 44 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 45 | GABRB1* | Gabrb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 46 | GRIN2D* | Grin2d | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 47 | FGF12* | Fgf12 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 48 | AP3B2* | Ap3b2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 49 | DENND5A* | Dennd5a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 5 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 50 | CAD* | Cad | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 51 | MDH2* | Mdh2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 52 | SCN1B* | Scn1b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 53 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 55 | PIGP* | Pigp | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 56 | YWHAG* | Ywhag | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 57 | KCNT2* | Kcnt2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 58 | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 59 | GABBR2* | Gabbr2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 60 | CNPY3* | Cnpy3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 61 | ADAM22* | Adam22 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 62 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 63 | CPLX1* | Cplx1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 64 | RHOBTB2* | Rhobtb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 65 | CYFIP2* | Cyfip2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 66 | PACS2* | Pacs2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 67 | CUX2* | Cux2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 68 | TRAK1* | Trak1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 69 | CACNA1E* | Cacna1e | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 6B | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 70 | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 71 | GLS* | Gls | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 72 | NEUROD2* | Neurod2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 73 | RNF13* | Rnf13 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 74 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 75 | PARS2* | Pars2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 76 | ACTL6B* | Actl6b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 78 | GABRA2* | Gabra2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 79 | GABRA5* | Gabra5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 80 | PIGB* | Pigb | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 81 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 82 | GOT2* | Got2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 83 | UGP2* | Ugp2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 84 | UGDH* | Ugdh | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 86 | DALRD3* | Dalrd3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 87 | CDK19* | Cdk19 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 88 | MDH1* | Mdh1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 89 | GAD1* | Gad1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 91 | PPP3CA* | Ppp3ca | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 92 | GABRB2* | Gabrb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 93 | ATP6V1A* | Atp6v1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 95 | PIGS* | Pigs | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 96 | NSF* | Nsf | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 97 | CELF2* | Celf2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 98 | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 99 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
developmental delay, dysmorphic facies, and brain anomalies | U2AF2* | U2af2 | Alliance of Genome Resources | ||||
developmental delay, hypotonia, and impaired language | FBXW7* | Fbxw7 | Alliance of Genome Resources | ||||
developmental dysplasia of the hip 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
D-glyceric aciduria | GLYCTK* | Glyctk | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 1 | RPS19* | Rps19 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 10 | RPS26* | Rps26 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 11 | RPL26* | Rpl26 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 12 | RPL15* | Rpl15 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 13 | RPS29* | Rps29 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 15 with mandibulofacial dysostosis | RPS28* | Rps28 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 16 | RPL27* | Rpl27 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 17 | RPS27* | Rps27, Rps27rt | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 18 | RPL18* | Rpl18 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 19 | RPL35* | Rpl35, Rpl35rt | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 20 | RPS15A* | Rps15a | Alliance of Genome Resources | ||||
Diamond-blackfan anemia 3 | RPS24* | Rps24 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 4 | RPS17* | Rps17 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 5 | RPL35A* | Rpl35a | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 8 | RPS7* | Rps7 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 9 | RPS10* | Rps10 | Alliance of Genome Resources | ||||
diaphyseal medullary stenosis with malignant fibrous histiocytoma | MTAP* | Mtap | Alliance of Genome Resources | ||||
DICER1 syndrome | DICER1* | Dicer1 | Alliance of Genome Resources | ||||
diffuse cystic renal dysplasia | BICC1* | Bicc1 | Alliance of Genome Resources | ||||
DiGeorge syndrome | UFD1* | Ufd1 | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | DVL1*, DVL1P1* | Dvl1 | Alliance of Genome Resources | ||||
DiGeorge syndrome | ARVCF* | Arvcf | 2 models | Alliance of Genome Resources | |||
dihydropyrimidinase deficiency | DPYS* | Dpys | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1AA | ACTN2* | Actn2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1B | FKTN* | Fktn | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1E | SCN5A* | Scn5a | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1II | CRYAB* | Cryab | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1JJ | LAMA4* | Lama4 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1KK | MYPN* | Mypn | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1LL | PRDM16* | Prdm16 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1MM | MYBPC3* | Mybpc3 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1NN | RAF1* | Raf1 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1S | MYH7* | Myh7 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1U | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1V | PSEN2* | Psen2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1X | FKTN* | Fktn | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2A | TNNI3* | Tnni3 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2B | GATAD1* | Gatad1 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2C | PPCS* | Ppcs | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2D | RPL3L* | Rpl3l | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2E | JPH2* | Jph2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 2G | LMOD2* | Lmod2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome | LMNA* | Lmna | Alliance of Genome Resources | ||||
dimethylglycine dehydrogenase deficiency | DMGDH* | Dmgdh | Alliance of Genome Resources | ||||
diphthamide deficiency syndrome 2 | DPH2* | Dph2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1A | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1B | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1C | MYL11* | Mylpf | Alliance of Genome Resources | ||||
distal arthrogryposis type 2A | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B1 | TNNI2* | Tnni2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B2 | TNNT3* | Tnnt3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B3 | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 3 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 5 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 5D | ECEL1* | Ecel1 | Alliance of Genome Resources | ||||
distal arthrogryposis type 7 | MYH8* | Myh8 | Alliance of Genome Resources | ||||
distal myopathy 1 | MYH7* | Myh7 | Alliance of Genome Resources | ||||
distal myopathy 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
distal myopathy Tateyama type | CAV3* | Cav3 | Alliance of Genome Resources | ||||
distal myopathy with anterior tibial onset | DYSF* | Dysf | Alliance of Genome Resources | ||||
distal myopathy with rimmed vacuoles | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
dominant optic atrophy plus syndrome | OPA1* | Opa1 | Alliance of Genome Resources | ||||
Donohue syndrome | INSR* | Insr | 2 "NOT" models | Alliance of Genome Resources | |||
DOORS syndrome | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
dopa-responsive dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
Dyggve-Melchior-Clausen disease | DYM* | Dym | Alliance of Genome Resources | ||||
dysplastic nevus syndrome | CDKN2A* | Cdkn2a | 1 "NOT" model | Alliance of Genome Resources | |||
dystonia 12 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
dystonia 12 | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
dystonia 16 | PRKRA* | Prkra | Alliance of Genome Resources | ||||
dystonia 22, adult-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
dystonia 22, juvenile-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
dystonia 24 | ANO3* | Ano3 | Alliance of Genome Resources | ||||
dystonia 25 | GNAL* | Gnal | Alliance of Genome Resources | ||||
dystonia 27 | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
dystonia 28, childhood-onset | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
dystonia 30 | VPS16* | Vps16 | Alliance of Genome Resources | ||||
dystonia 31 | AOPEP* | Aopep | Alliance of Genome Resources | ||||
dystonia 32 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
dystonia 33 | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
dystonia 35, childhood-onset | SHQ1* | Shq1 | Alliance of Genome Resources | ||||
dystonia 37, early-onset with striatal lesions | NUP54* | Nup54 | Alliance of Genome Resources | ||||
dystonia 9 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
dystransthyretinemic hyperthyroxinemia | TTR* | Ttr | Alliance of Genome Resources | ||||
early-onset dystonia and/or spastic paraplegia | ATP5MC3* | Atp5mc3 | Alliance of Genome Resources | ||||
early-onset epilepsy 2 | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
early-onset epilepsy 3 | ATP6V0C* | Atp6v0c | Alliance of Genome Resources | ||||
early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome | MEGF10* | Megf10 | Alliance of Genome Resources | ||||
early onset progressive encephalopathy with brain atrophy and thin corpus callosum | TBCD* | Tbcd | Alliance of Genome Resources | ||||
early-onset vitamin B6-dependent epilepsy 1 | PLPBP* | Plpbp | Alliance of Genome Resources | ||||
early-onset vitamin B6-dependent epilepsy 4 | ALDH7A1* | Aldh7a1 | Alliance of Genome Resources | ||||
ectodermal dysplasia 10A | EDAR* | Edar | Alliance of Genome Resources | ||||
ectodermal dysplasia 10B | EDAR* | Edar | Alliance of Genome Resources | ||||
ectodermal dysplasia 11A | EDARADD* | Edaradd | Alliance of Genome Resources | ||||
ectodermal dysplasia 11B | EDARADD* | Edaradd | Alliance of Genome Resources | ||||
ectodermal dysplasia 12 | KDF1* | Kdf1 | Alliance of Genome Resources | ||||
ectodermal dysplasia 13 | KREMEN1* | Kremen1 | Alliance of Genome Resources | ||||
ectodermal dysplasia 14 | TSPEAR* | Tspear | Alliance of Genome Resources | ||||
ectodermal dysplasia 15 | CST6* | Cst6 | Alliance of Genome Resources | ||||
ectodermal dysplasia 4 | KRT85* | Krt85 | Alliance of Genome Resources | ||||
ectodermal dysplasia 7 | KRT74* | Krt74 | Alliance of Genome Resources | ||||
ectodermal dysplasia 9 | HOXC13* | Hoxc13 | Alliance of Genome Resources | ||||
ectodermal dysplasia and immunodeficiency 2 | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome | CDH3* | Cdh3 | Alliance of Genome Resources | ||||
ectopia lentis with ectopia of pupil | ADAMTSL4* | Adamtsl4 | Alliance of Genome Resources | ||||
EEC syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 1 | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome cardiac valvular type | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome classic-like 2 | AEBP1* | Aebp1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome classic type 2 | COL5A2* | Col5a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome dermatosparaxis type | ADAMTS2* | Adamts2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome kyphoscoliotic type 1 | PLOD1* | Plod1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome kyphoscoliotic type 2 | FKBP14* | Fkbp14 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome musculocontractural type 1 | CHST14* | Chst14 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome musculocontractural type 2 | DSE* | Dse | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 1 | C1R* | C1ra, C1rb | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 2 | C1S* | C1s1, C1s2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome spondylodysplastic type 1 | B4GALT7* | B4galt7 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome spondylodysplastic type 2 | B3GALT6* | B3galt6 | Alliance of Genome Resources | ||||
Eiken syndrome | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
Ellis-Van Creveld syndrome | WDR35* | Wdr35 | Alliance of Genome Resources | ||||
enterokinase deficiency | TMPRSS15* | Tmprss15 | Alliance of Genome Resources | ||||
epidermodysplasia verruciformis | IL7* | Il7 | Alliance of Genome Resources | ||||
epidermodysplasia verruciformis | TMC6* | Tmc6 | Alliance of Genome Resources | ||||
epidermodysplasia verruciformis | RHOH* | Rhoh | Alliance of Genome Resources | ||||
epidermodysplasia verruciformis | CIB1* | Cib1 | Alliance of Genome Resources | ||||
epidermodysplasia verruciformis | TMC8* | Tmc8 | Alliance of Genome Resources | ||||
epidermolysis bullosa simplex with mottled pigmentation | KRT5* | Krt5 | Alliance of Genome Resources | ||||
epidermolysis bullosa with congenital localized absence of skin and deformity of nails | COL7A1* | Col7a1 | Alliance of Genome Resources | ||||
epidermolytic hyperkeratosis 1 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
epidermolytic palmoplantar keratoderma 1 | KRT9* | Krt9 | Alliance of Genome Resources | ||||
epidermolytic palmoplantar keratoderma 2 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
episodic ataxia type 9 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
episodic kinesigenic dyskinesia 3 | TMEM151A* | Tmem151a | Alliance of Genome Resources | ||||
epithelial basement membrane dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
epithelial recurrent erosion dystrophy | COL17A1* | Col17a1 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 1 | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 2 | GJB4* | Gjb4 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 3 | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 4 | KDSR* | Kdsr | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 5 | KRT83*, KRT81, KRT86, KRT87P | Krt81, Krt83, Krt86, Krt87 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 6 | TRPM4* | Trpm4 | Alliance of Genome Resources | ||||
essential fructosuria | KHK* | Khk | Alliance of Genome Resources | ||||
essential tremor 1 | DRD3* | Drd3 | Alliance of Genome Resources | ||||
essential tremor 4 | FUS* | Fus | Alliance of Genome Resources | ||||
essential tremor 5 | TENM4* | Tenm4 | Alliance of Genome Resources | ||||
essential tremor 6 | NOTCH2NLC* | ||||||
exudative vitreoretinopathy 1 | FZD4* | Fzd4 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 4 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 5 | TSPAN12* | Tspan12 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 6 | ZNF408* | Zfp408 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 7 | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
factor V deficiency | F5* | F5 | Alliance of Genome Resources | ||||
factor V deficiency | LMAN1* | Lman1 | Alliance of Genome Resources | ||||
factor VII deficiency | F7* | F7 | Alliance of Genome Resources | ||||
factor X deficiency | F10* | F10 | Alliance of Genome Resources | ||||
factor XIII deficiency | LMAN1* | Lman1 | Alliance of Genome Resources | ||||
familial adenomatous polyposis | MUTYH* | Mutyh | Alliance of Genome Resources | ||||
familial adenomatous polyposis 1 | APC* | Apc | Alliance of Genome Resources | ||||
familial adenomatous polyposis 2 | MUTYH* | Mutyh | Alliance of Genome Resources | ||||
familial adenomatous polyposis 3 | NTHL1* | Nthl1 | Alliance of Genome Resources | ||||
familial adenomatous polyposis 4 | MSH3* | Msh3 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 1 | SAMD12* | Samd12 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 2 | STARD7* | Stard7 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 3 | MARCHF6* | Marchf6 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 4 | YEATS2* | Yeats2 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 5 | CNTN2* | Cntn2 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 6 | TNRC6A* | Tnrc6a | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 7 | RAPGEF2* | Rapgef2 | Alliance of Genome Resources | ||||
familial apolipoprotein A5 deficiency | APOA5* | Apoa5 | Alliance of Genome Resources | ||||
familial apolipoprotein C-II deficiency | APOC2* | Apoc2, Apoc2l | Alliance of Genome Resources | ||||
familial Behcet-like autoinflammatory syndrome | TNFAIP3* | Tnfaip3 | Alliance of Genome Resources | ||||
familial benign fleck retina | PLA2G5* | Pla2g5 | Alliance of Genome Resources | ||||
familial cold autoinflammatory syndrome 2 | NLRP12* | Nlrp12 | Alliance of Genome Resources | ||||
familial cold autoinflammatory syndrome 3 | PLCG2* | Plcg2 | Alliance of Genome Resources | ||||
familial encephalopathy with neuroserpin inclusion bodies | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 1 | TRPA1* | Trpa1 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 2 | SCN10A* | Scn10a | Alliance of Genome Resources | ||||
familial erythrocytosis 1 | EPOR* | Epor | 2 models | Alliance of Genome Resources | |||
familial erythrocytosis 1 | SH2B3* | Sh2b3 | Alliance of Genome Resources | ||||
familial erythrocytosis 1 | JAK2* | Jak2 | Alliance of Genome Resources | ||||
familial erythrocytosis 3 | EGLN1* | Egln1 | Alliance of Genome Resources | ||||
familial erythrocytosis 5 | EPO* | Epo | Alliance of Genome Resources | ||||
familial expansile osteolysis | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 1 | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 2 | NPRL2* | Nprl2 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 3 | NPRL3* | Nprl3 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 4 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
familial gestational hyperthyroidism | TSHR* | Tshr | Alliance of Genome Resources | ||||
familial GPIHBP1 deficiency | GPIHBP1* | Gpihbp1 | Alliance of Genome Resources | ||||
familial hepatic adenoma | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 1 | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 2 | KCNJ11* | Kcnj11 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 4 | HADH* | Hadh | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 5 | INSR* | Insr | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 6 | GLUD1*, GLUD2 | Glud1 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 7 | SLC16A1* | Slc16a1 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 8 | SLC25A36* | Slc25a36 | Alliance of Genome Resources | ||||
familial hypertryptophanemia | TDO2* | Tdo2 | Alliance of Genome Resources | ||||
familial hypocalciuric hypercalcemia 2 | GNA11* | Gna11 | Alliance of Genome Resources | ||||
familial hypocalciuric hypercalcemia 3 | AP2S1* | Ap2s1 | Alliance of Genome Resources | ||||
familial isolated trichomegaly | FGF5* | Fgf5 | Alliance of Genome Resources | ||||
familial lipase maturation factor 1 deficiency | LMF1* | Lmf1 | Alliance of Genome Resources | ||||
familial male-limited precocious puberty | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
familial Mediterranean fever | ACE* | Ace | Alliance of Genome Resources | ||||
familial Mediterranean fever | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
familial Mediterranean fever | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
familial Mediterranean fever | POMC* | Pomc | Alliance of Genome Resources | ||||
familial Mediterranean fever | NOD2* | Nod2 | Alliance of Genome Resources | ||||
familial Mediterranean fever | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
familial Mediterranean fever | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
familial Mediterranean fever | CYP3A4*, CYP3A5, CYP3A7, CYP3A7-CYP3A51P, CYP3A43 | Cyp3a11, Cyp3a13, Cyp3a16, Cyp3a25, Cyp3a41a, Cyp3a41b, Cyp3a44, Cyp3a57, Cyp3a59 | Alliance of Genome Resources | ||||
familial medullary thyroid carcinoma | RET* | Ret | 2 "NOT" models | Alliance of Genome Resources | |||
familial partial lipodystrophy type 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 3 | PPARG* | Pparg | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 4 | PLIN1* | Plin1 | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 5 | CIDEC* | Cidec | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 6 | LIPE* | Lipe | Alliance of Genome Resources | ||||
familial progressive hyperpigmentation with or without hypopigmentation | KITLG* | Kitl | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 5 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 7 | RELN* | Reln | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 8 | GAL* | Gal | Alliance of Genome Resources | ||||
familial visceral amyloidosis | FGA* | Fga | Alliance of Genome Resources | ||||
Fanconi anemia complementation group E | FANCE* | Fance | Alliance of Genome Resources | ||||
Fanconi anemia complementation group I | FANCI* | Fanci | Alliance of Genome Resources | ||||
Fanconi anemia complementation group L | FANCL* | Fancl | Alliance of Genome Resources | ||||
Fanconi anemia complementation group O | RAD51C* | Rad51c | Alliance of Genome Resources | ||||
Fanconi anemia complementation group P | SLX4* | Slx4 | 1 "NOT" model | Alliance of Genome Resources | |||
Fanconi anemia complementation group Q | ERCC4* | Ercc4 | Alliance of Genome Resources | ||||
Fanconi anemia complementation group R | RAD51* | Rad51 | Alliance of Genome Resources | ||||
Fanconi anemia complementation group S | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
Fanconi anemia complementation group T | UBE2T* | Ube2t | Alliance of Genome Resources | ||||
Fanconi anemia complementation group U | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
Fanconi anemia complementation group V | MAD2L2* | Mad2l2 | Alliance of Genome Resources | ||||
Fanconi anemia complementation group W | RFWD3* | Rfwd3 | Alliance of Genome Resources | ||||
Fanconi-Bickel syndrome | SLC2A2* | Slc2a2 | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 1 | GATM* | Gatm | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 2 | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 3 | EHHADH* | Ehhadh | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 4 | HNF4A* | Hnf4a | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 5 | NDUFAF6* | Ndufaf6 | Alliance of Genome Resources | ||||
fatal infantile hypertonic myofibrillar myopathy | CRYAB* | Cryab | Alliance of Genome Resources | ||||
Fazio-Londe disease | SLC52A3* | Slc52a3 | Alliance of Genome Resources | ||||
Feingold syndrome | MYCN* | Mycn, Mycs | Alliance of Genome Resources | ||||
fetal akinesia deformation sequence syndrome 1 | MUSK* | Musk | Alliance of Genome Resources | ||||
fetal akinesia deformation sequence syndrome 2 | RAPSN* | Rapsn | Alliance of Genome Resources | ||||
fetal akinesia deformation sequence syndrome 3 | DOK7* | Dok7 | Alliance of Genome Resources | ||||
fetal akinesia deformation sequence syndrome 4 | NUP88* | Nup88 | Alliance of Genome Resources | ||||
fibrochondrogenesis 1 | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
fibrochondrogenesis 2 | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
Filippi syndrome | CKAP2L* | Ckap2l | Alliance of Genome Resources | ||||
Finnish type amyloidosis | GSN* | Gsn | Alliance of Genome Resources | ||||
Floating-Harbor syndrome | SRCAP* | Srcap | Alliance of Genome Resources | ||||
focal nonepidermolytic palmoplantar keratoderma 1 | KRT16* | Krt16 | Alliance of Genome Resources | ||||
focal nonepidermolytic palmoplantar keratoderma 2 | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
focal or diffuse nonepidermolytic palmoplantar keratoderma | KRT6C*, KRT6A, KRT6B | Gm5414, Gm5478, Krt6a, Krt6b | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 5 | INF2* | Inf2 | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 6 | MYO1E* | Myo1e | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 7 | PAX2* | Pax2 | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 8 | ANLN* | Anln | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 9 | CRB2* | Crb2 | Alliance of Genome Resources | ||||
foveal hypoplasia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
Frank-Ter Haar syndrome | SH3PXD2B* | Sh3pxd2b | Alliance of Genome Resources | ||||
Fraser syndrome 1 | FRAS1* | Fras1 | Alliance of Genome Resources | ||||
Fraser syndrome 2 | FREM2* | Frem2 | Alliance of Genome Resources | ||||
Fraser syndrome 3 | GRIP1* | Grip1 | Alliance of Genome Resources | ||||
Frasier syndrome | WT1* | Wt1 | Alliance of Genome Resources | ||||
Friedreich ataxia | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
Friedreich ataxia | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
Friedreich ataxia 1 | FXN* | Fxn | Alliance of Genome Resources | ||||
frontometaphyseal dysplasia 2 | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
frontonasal dysplasia 1 | ALX3* | Alx3 | Alliance of Genome Resources | ||||
frontonasal dysplasia 2 | ALX4* | Alx4 | Alliance of Genome Resources | ||||
fumarase deficiency | FH* | Fh1 | Alliance of Genome Resources | ||||
galactose epimerase deficiency | GALE* | Gale | Alliance of Genome Resources | ||||
Galloway-Mowat syndrome 1 | WDR73* | Wdr73 | Alliance of Genome Resources | ||||
Galloway-Mowat syndrome 3 | OSGEP* | Osgep | Alliance of Genome Resources | ||||
Galloway-Mowat syndrome 4 | TP53RK* | Trp53rka, Trp53rkb | Alliance of Genome Resources | ||||
gamma-glutamyl transpeptidase deficiency | GGT1*, GGT2P, GGT3P, GGTLC1, GGTLC2, GGTLC3 | Ggt1 | Alliance of Genome Resources | ||||
GAPO syndrome | ANTXR1* | Antxr1 | Alliance of Genome Resources | ||||
Gaucher's disease type III | GBA1* | Gba1 | Alliance of Genome Resources | ||||
Gaucher's disease type IIIC | GBA1* | Gba1 | Alliance of Genome Resources | ||||
gelatinous drop-like corneal dystrophy | TACSTD2* | Tacstd2 | Alliance of Genome Resources | ||||
geleophysic dysplasia 2 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
geleophysic dysplasia 3 | LTBP3* | Ltbp3 | Alliance of Genome Resources | ||||
geroderma osteodysplasticum | GORAB* | Gorab | Alliance of Genome Resources | ||||
Ghosal hematodiaphyseal syndrome | TBXAS1* | Tbxas1 | Alliance of Genome Resources | ||||
giant axonal neuropathy 2 | DCAF8* | Dcaf8 | Alliance of Genome Resources | ||||
Gillespie syndrome | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
gingival fibromatosis 5 | REST* | Rest | Alliance of Genome Resources | ||||
Gitelman syndrome | CLCNKB*, CLCNKA | Clcnka, Clcnkb | Alliance of Genome Resources | ||||
glomangioma | GLMN* | Glmn | Alliance of Genome Resources | ||||
glucocorticoid deficiency 1 | MC2R* | Mc2r | Alliance of Genome Resources | ||||
glucose-galactose malabsorption | SLC5A1* | Slc5a1 | Alliance of Genome Resources | ||||
glucose transporter type 1 deficiency syndrome | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
glucose transporter type 1 deficiency syndrome 2 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
glutamate-cysteine ligase deficiency | GCLC* | Gclc | Alliance of Genome Resources | ||||
glutamate formiminotransferase deficiency | FTCD* | Ftcd | Alliance of Genome Resources | ||||
glutathione synthetase deficiency of erythrocytes | GSS* | Gss | Alliance of Genome Resources | ||||
glutatione synthetase deficiency with 5-oxoprolinuria | GSS* | Gss | Alliance of Genome Resources | ||||
glycine encephalopathy | AMT* | Amt | Alliance of Genome Resources | ||||
glycogen storage disease Ib | SLC37A4* | Slc37a4 | Alliance of Genome Resources | ||||
glycogen storage disease Ic | SLC37A4* | Slc37a4 | Alliance of Genome Resources | ||||
glycogen storage disease IXc | PHKG2* | Phkg2 | Alliance of Genome Resources | ||||
glycosylphosphatidylinositol biosynthesis defect 16 | PIGC* | Pigc | Alliance of Genome Resources | ||||
GM1 gangliosidosis type 1 | GLB1* | Glb1 | Alliance of Genome Resources | ||||
GM1 gangliosidosis type 2 | GLB1* | Glb1 | Alliance of Genome Resources | ||||
GM1 gangliosidosis type 3 | GLB1* | Glb1 | Alliance of Genome Resources | ||||
GM2 gangliosidosis | GM2A* | Gm2a | Alliance of Genome Resources | ||||
GNE myopathy | GNE* | Gne | Alliance of Genome Resources | ||||
Gordon Holmes syndrome | RNF216* | Rnf216 | Alliance of Genome Resources | ||||
granular corneal dystrophy 1 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
granular corneal dystrophy 2 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
gray platelet syndrome | GFI1B* | Gfi1b | Alliance of Genome Resources | ||||
Greenberg dysplasia | LBR* | Lbr | Alliance of Genome Resources | ||||
Griscelli syndrome type 2 | RAB27A* | Rab27a | 1 model | Alliance of Genome Resources | |||
Griscelli syndrome type 3 | MLPH* | Mlph | Alliance of Genome Resources | ||||
growth hormone insensitivity syndrome with immune dysregulation 1 | STAT5B* | Stat5b | Alliance of Genome Resources | ||||
growth hormone insensitivity syndrome with immune dysregulation 2 | STAT5B* | Stat5b | Alliance of Genome Resources | ||||
Guttmacher syndrome | HOXA13* | Hoxa13 | Alliance of Genome Resources | ||||
Hailey-Hailey disease | ATP2C1* | Atp2c1 | 1 "NOT" model | Alliance of Genome Resources | |||
Halperin-Birk syndrome | SEC31A* | Sec31a | Alliance of Genome Resources | ||||
Harel-Yoon syndrome | ATAD3A*, ATAD3B, ATAD3C | Atad3a | Alliance of Genome Resources | ||||
hawkinsinuria | HPD* | Hpd | Alliance of Genome Resources | ||||
Heimler syndrome 1 | PEX1* | Pex1 | Alliance of Genome Resources | ||||
Heimler syndrome 2 | PEX6* | Pex6 | Alliance of Genome Resources | ||||
Heinz body anemia | HBA1*, HBA2* | Hba-a1, Hba-a2 | Alliance of Genome Resources | ||||
Heinz body anemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
Helsmoortel-Van Der Aa Syndrome | ADNP* | Adnp | Alliance of Genome Resources | ||||
hemoglobin H disease | HBA1*, HBA2* | Hba-a1, Hba-a2 | Alliance of Genome Resources | ||||
Hengel-Maroofian-Schols syndrome | BCAS3* | Bcas3 | Alliance of Genome Resources | ||||
heparin cofactor II deficiency | SERPIND1* | Serpind1 | Alliance of Genome Resources | ||||
hepatic venoocclusive disease with immunodeficiency | SP110* | Sp110, Sp110-ps1, Sp110-ps2 | Alliance of Genome Resources | ||||
hereditary angioedema | KNG1* | Kng1, Kng2 | Alliance of Genome Resources | ||||
hereditary angioedema | MYOF* | Myof | Alliance of Genome Resources | ||||
hereditary angioedema | ANGPT1* | Angpt1 | Alliance of Genome Resources | ||||
hereditary angioedema | HS3ST6* | Hs3st6 | Alliance of Genome Resources | ||||
hereditary angioedema | F12* | F12 | Alliance of Genome Resources | ||||
hereditary angioedema | PLG* | Plg | Alliance of Genome Resources | ||||
hereditary angioedema | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
hereditary angioedema type I | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
hereditary angioedema type III | F12* | F12 | Alliance of Genome Resources | ||||
hereditary arterial and articular multiple calcification syndrome | NT5E* | Nt5e | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | PALB2* | Palb2 | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | BRCA1* | Brca1 | 3 models | Alliance of Genome Resources | |||
hereditary breast ovarian cancer syndrome | RAD51D* | Rad51d | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | RAD51C* | Rad51c | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
hereditary desmoid disease | APC* | Apc | Alliance of Genome Resources | ||||
hereditary diffuse gastric cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
hereditary folate malabsorption | SLC46A1* | Slc46a1 | Alliance of Genome Resources | ||||
hereditary hemorrhagic telangiectasia | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
hereditary hemorrhagic telangiectasia | GDF2* | Gdf2 | Alliance of Genome Resources | ||||
hereditary lymphedema IA | FLT4* | Flt4 | Alliance of Genome Resources | ||||
hereditary lymphedema IC | GJC2* | Gjc2 | Alliance of Genome Resources | ||||
hereditary lymphedema ID | VEGFC* | Vegfc | Alliance of Genome Resources | ||||
hereditary mixed polyposis syndrome 2 | BMPR1A* | Bmpr1a | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 2 | MLH1* | Mlh1 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 4 | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 5 | MSH6* | Msh6 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 6 | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 7 | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 8 | EPCAM* | Epcam | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1A | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1C | SPTLC2* | Sptlc2 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 2A | WNK1* | Wnk1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 2B | RETREG1* | Retreg1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 5 | NGF* | Ngf | 2 models | Alliance of Genome Resources | |||
hereditary sensory and autonomic neuropathy type 7 | SCN11A* | Scn11a | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 8 | PRDM12* | Prdm12 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1D | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1E | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1F | ATL3* | Atl3 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 2C | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 4 | NTRK1* | Ntrk1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 10 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 12 | RTN2* | Rtn2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 17 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 18 | ERLIN2* | Erlin2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 23 | DSTYK* | Dstyk | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 26 | B4GALNT1* | B4galnt1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 28 | DDHD1* | Ddhd1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 39 | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 3A | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 42 | SLC33A1* | Slc33a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 43 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 44 | GJC2* | Gjc2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 45 | NT5C2* | Nt5c2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 46 | GBA2* | Gba2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 47 | AP4B1* | Ap4b1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 49 | TECPR2* | Tecpr2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 50 | AP4M1* | Ap4m1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 51 | AP4E1* | Ap4e1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 52 | AP4S1* | Ap4s1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 53 | VPS37A* | Vps37a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 55 | MTRFR* | Mtrfr | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 56 | CYP2U1* | Cyp2u1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 57 | TFG* | Tfg | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 5A | CYP7B1* | Cyp7b1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 6 | NIPA1* | Nipa1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 61 | ARL6IP1* | Arl6ip1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 62 | ERLIN1* | Erlin1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 63 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 64 | ENTPD1* | Entpd1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 70 | MARS1* | Mars1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 72A | REEP2* | Reep2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 73 | CPT1C* | Cpt1c | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 74 | IBA57* | Iba57 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 75 | MAG* | Mag | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 76 | CAPN1* | Capn1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 77 | FARS2* | Fars2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 78 | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 79A | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 79B | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 8 | WASHC5* | Washc5 | 1 "NOT" model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 81 | SELENOI* | Selenoi | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 82 | PCYT2* | Pcyt2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 83 | HPDL* | Hpdl | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 84 | PI4KA* | Pi4ka | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 85 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 86 | ABHD16A* | Abhd16a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 87 | TMEM63C* | Tmem63c | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 88 | KPNA3* | Kpna3 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 89 | AMFR* | Amfr | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90A | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90B | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 9A | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 9B | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
hereditary spherocytosis type 2 | SPTB* | Sptb | Alliance of Genome Resources | ||||
hereditary spherocytosis type 5 | EPB42* | Epb42 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | HPS5* | Hps5 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | HPS6* | Hps6 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | AP3D1* | Ap3d1 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | HPS3* | Hps3 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | HPS4* | Hps4 | Alliance of Genome Resources | ||||
Hermansky-Pudlak syndrome | AP3B1* | Ap3b1 | Alliance of Genome Resources | ||||
high molecular weight kininogen deficiency | KNG1* | Kng1, Kng2 | Alliance of Genome Resources | ||||
histiocytosis-lymphadenopathy plus syndrome | SLC29A3* | Slc29a3 | Alliance of Genome Resources | ||||
holoprosencephaly 12 | CNOT1* | Cnot1 | Alliance of Genome Resources | ||||
holoprosencephaly 4 | TGIF1* | Tgif1 | 1 "NOT" model | Alliance of Genome Resources | |||
holoprosencephaly 7 | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
holoprosencephaly 9 | GLI2* | Gli2 | Alliance of Genome Resources | ||||
Holt-Oram syndrome | SALL4* | Sall4 | Alliance of Genome Resources | ||||
homocystinuria-megaloblastic anemia cblE type | MTRR* | Mtrr | Alliance of Genome Resources | ||||
hyaline fibromatosis syndrome | ANTXR2* | Antxr2 | Alliance of Genome Resources | ||||
hydrolethalus syndrome 1 | HYLS1* | Hyls1 | Alliance of Genome Resources | ||||
hydrolethalus syndrome 2 | KIF7* | Kif7 | Alliance of Genome Resources | ||||
hydroxykynureninuria | KYNU* | Kynu | Alliance of Genome Resources | ||||
hyperalphalipoproteinemia 1 | CETP* | ||||||
hyperekplexia 4 | ATAD1* | Atad1 | Alliance of Genome Resources | ||||
hyperferritinemia-cataract syndrome | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
hyper IgE recurrent infection syndrome 2 | DOCK8* | Dock8 | Alliance of Genome Resources | ||||
hyper IgE recurrent infection syndrome 3 | ZNF341* | Zfp341 | Alliance of Genome Resources | ||||
hyper IgE recurrent infection syndrome 4 | IL6ST* | Il6st | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 1 | PIGV* | Pigv | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 2 | PIGO* | Pigo | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 3 | PGAP2* | Pgap2 | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 4 | PGAP3* | Pgap3 | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 5 | PIGW* | Pigw | Alliance of Genome Resources | ||||
hyperphosphatasia with impaired intellectual development syndrome 6 | PIGY* | Pigyl | Alliance of Genome Resources | ||||
hyperprolinemia type 1 | PRODH* | Prodh | Alliance of Genome Resources | ||||
hyperprolinemia type 2 | ALDH4A1* | Aldh4a1 | Alliance of Genome Resources | ||||
hypertension and brachydactyly syndrome | PDE3A* | Pde3a | Alliance of Genome Resources | ||||
hypervalinemia and hyperleucine-isoleucinemia | BCAT2* | Bcat2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 10 with or without anosmia | TAC3* | Tac2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 14 with or without anosmia | WDR11* | Wdr11 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 15 with or without anosmia | HS6ST1* | Hs6st1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 16 with or without anosmia | SEMA3A* | Sema3a | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 17 with or without anosmia | SPRY4* | Spry4 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 18 with or without anosmia | IL17RD* | Il17rd | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 19 with or without anosmia | DUSP6* | Dusp6 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 20 with or without anosmia | FGF17* | Fgf17 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 21 with or without anosmia | FLRT3* | Flrt3 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 22 with or without anosmia | FEZF1* | Fezf1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 23 with or without anosmia | LHB*, CGB1, CGB2, CGB3, CGB5, CGB7, CGB8 | Lhb | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 24 without anosmia | FSHB* | Fshb | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 2 with or without anosmia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 3 with or without anosmia | PROKR2* | Prokr2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 4 with or without anosmia | PROK2* | Prok2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 5 with or without anosmia | CHD7* | Chd7 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 6 with or without anosmia | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 7 with or without anosmia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 7 with or without anosmia | NSMF* | Nsmf | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 9 with or without anosmia | NSMF* | Nsmf | Alliance of Genome Resources | ||||
hypoinsulinemic hypoglycemia with hemihypertrophy | AKT2* | Akt2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 10 | PYCR2* | Pycr2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 11 | POLR1C* | Polr1c | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 12 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 13 | HIKESHI* | Hikeshi | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 14 | UFM1* | Ufm1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 15 | EPRS1* | Eprs1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 16 | TMEM106B* | Tmem106b | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 17 | AIMP2* | Aimp2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 18 | DEGS1* | Degs1, Degs1l | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 19 | TMEM63A* | Tmem63a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 20 | CNP* | Cnp | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 21 | POLR3K* | Polr3k | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 22 | CLDN11* | Cldn11 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 23 | RNF220* | Rnf220 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 24 | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 25 | TMEM163* | Tmem163 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 26 | SLC35B2* | Slc35b2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 3 | AIMP1* | Aimp1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 4 | HSPD1* | Hspd1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 5 | HYCC1* | Hycc1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 7 | POLR3A* | Polr3a | 2 "NOT" models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 8 | POLR3B* | Polr3b | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 9 | RARS1* | Rars1 | Alliance of Genome Resources | ||||
hypoparathyroidism-retardation-dysmorphism syndrome | TBCE* | Tbce | Alliance of Genome Resources | ||||
hypophosphatasia | ALPL* | Alpl | Alliance of Genome Resources | ||||
hypophosphatemic nephrolithiasis/osteoporosis 1 | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
hypophosphatemic nephrolithiasis/osteoporosis 2 | NHERF1* | Nherf1 | Alliance of Genome Resources | ||||
hypoplastic or aplastic tibia with polydactyly | SHH* | Shh | Alliance of Genome Resources | ||||
hypotonia, ataxia, and delayed development syndrome | EBF3* | Ebf3 | Alliance of Genome Resources | ||||
hypotrichosis 1 | APCDD1* | Apcdd1 | Alliance of Genome Resources | ||||
hypotrichosis 1 | SNRPE* | Snrpe, Snrpert | Alliance of Genome Resources | ||||
hypotrichosis 11 | SNRPE* | Snrpe, Snrpert | Alliance of Genome Resources | ||||
hypotrichosis 12 | RPL21* | Rpl21 | Alliance of Genome Resources | ||||
hypotrichosis 15 | C3orf52* | BC016579 | Alliance of Genome Resources | ||||
hypotrichosis 2 | CDSN* | Cdsn | Alliance of Genome Resources | ||||
hypotrichosis 3 | KRT74* | Krt74 | Alliance of Genome Resources | ||||
hypotrichosis 4 | HRURF* | ||||||
hypotrichosis 5 | EPS8L3* | Eps8l3 | Alliance of Genome Resources | ||||
hypotrichosis 7 | LIPH* | Liph | Alliance of Genome Resources | ||||
hypotrichosis 8 | LPAR6* | Lpar6 | Alliance of Genome Resources | ||||
hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | SOX18* | Sox18 | Alliance of Genome Resources | ||||
hypotrichosis-lymphedema-telangiectasia syndrome | SOX18* | Sox18 | Alliance of Genome Resources | ||||
ichthyosis vulgaris | FLG* | ||||||
idiopathic pulmonary fibrosis | BRD4* | Brd4 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | CXCL5*, CXCL6 | Cxcl5 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | EHMT2* | Ehmt2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | TERT* | Tert | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SETD2* | Setd2 | Alliance of Genome Resources | ||||
immunodeficiency 10 | STIM1* | Stim1 | Alliance of Genome Resources | ||||
immunodeficiency 11A | CARD11* | Card11 | Alliance of Genome Resources | ||||
immunodeficiency 11B | CARD11* | Card11 | Alliance of Genome Resources | ||||
immunodeficiency 12 | MALT1* | Malt1 | Alliance of Genome Resources | ||||
immunodeficiency 13 | UNC119* | Unc119 | Alliance of Genome Resources | ||||
immunodeficiency 14 | PIK3CD* | Pik3cd | Alliance of Genome Resources | ||||
immunodeficiency 15B | IKBKB* | Ikbkb | Alliance of Genome Resources | ||||
immunodeficiency 16 | TNFRSF4* | Tnfrsf4 | Alliance of Genome Resources | ||||
immunodeficiency 17 | CD3G* | Cd3g | Alliance of Genome Resources | ||||
immunodeficiency 18 | CD3E* | Cd3e | Alliance of Genome Resources | ||||
immunodeficiency 19 | CD3D* | Cd3d | Alliance of Genome Resources | ||||
immunodeficiency 20 | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
immunodeficiency 21 | GATA2* | Gata2 | Alliance of Genome Resources | ||||
immunodeficiency 22 | LCK* | Lck | Alliance of Genome Resources | ||||
immunodeficiency 23 | PGM3* | Pgm3 | Alliance of Genome Resources | ||||
immunodeficiency 24 | CTPS1* | Ctps1 | 1 "NOT" model | Alliance of Genome Resources | |||
immunodeficiency 25 | CD247* | Cd247 | Alliance of Genome Resources | ||||
immunodeficiency 26 | PRKDC* | Prkdc | Alliance of Genome Resources | ||||
immunodeficiency 27A | IFNGR1* | Ifngr1 | Alliance of Genome Resources | ||||
immunodeficiency 27B | IFNGR1* | Ifngr1 | Alliance of Genome Resources | ||||
immunodeficiency 28 | IFNGR2* | Ifngr2 | Alliance of Genome Resources | ||||
immunodeficiency 29 | IL12B* | Il12b | Alliance of Genome Resources | ||||
immunodeficiency 30 | IL12RB1* | Il12rb1 | Alliance of Genome Resources | ||||
immunodeficiency 31A | STAT1* | Stat1 | Alliance of Genome Resources | ||||
immunodeficiency 31B | STAT1* | Stat1 | Alliance of Genome Resources | ||||
immunodeficiency 31C | STAT1* | Stat1 | Alliance of Genome Resources | ||||
immunodeficiency 32A | IRF8* | Irf8 | Alliance of Genome Resources | ||||
immunodeficiency 32B | IRF8* | Irf8 | Alliance of Genome Resources | ||||
immunodeficiency 35 | TYK2* | Tyk2 | Alliance of Genome Resources | ||||
immunodeficiency 36 | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
immunodeficiency 37 | BCL10* | Bcl10 | Alliance of Genome Resources | ||||
immunodeficiency 38 | ISG15* | Isg15 | Alliance of Genome Resources | ||||
immunodeficiency 39 | IRF7* | Irf7 | Alliance of Genome Resources | ||||
immunodeficiency 40 | DOCK2* | Dock2 | Alliance of Genome Resources | ||||
immunodeficiency 41 | IL2RA* | Il2ra | Alliance of Genome Resources | ||||
immunodeficiency 42 | RORC* | Rorc | Alliance of Genome Resources | ||||
immunodeficiency 43 | B2M* | B2m | Alliance of Genome Resources | ||||
immunodeficiency 44 | STAT2* | Stat2 | Alliance of Genome Resources | ||||
immunodeficiency 45 | IFNAR2* | Ifnar2 | Alliance of Genome Resources | ||||
immunodeficiency 46 | TFRC* | Tfrc | Alliance of Genome Resources | ||||
immunodeficiency 48 | ZAP70* | Zap70 | Alliance of Genome Resources | ||||
immunodeficiency 49 | BCL11B* | Bcl11b | Alliance of Genome Resources | ||||
immunodeficiency 51 | IL17RA* | Il17ra | Alliance of Genome Resources | ||||
immunodeficiency 52 | LAT* | Lat | Alliance of Genome Resources | ||||
immunodeficiency 53 | RELB* | Relb | Alliance of Genome Resources | ||||
immunodeficiency 54 | MCM4* | Mcm4 | Alliance of Genome Resources | ||||
immunodeficiency 55 | GINS1* | Gins1 | Alliance of Genome Resources | ||||
immunodeficiency 56 | IL21R* | Il21r | Alliance of Genome Resources | ||||
immunodeficiency 57 | RIPK1* | Ripk1 | Alliance of Genome Resources | ||||
immunodeficiency 58 | CARMIL2* | Carmil2 | Alliance of Genome Resources | ||||
immunodeficiency 59 | HYOU1* | Hyou1 | Alliance of Genome Resources | ||||
immunodeficiency 60 | BACH2* | Bach2 | Alliance of Genome Resources | ||||
immunodeficiency 61 | SH3KBP1* | Sh3kbp1 | Alliance of Genome Resources | ||||
immunodeficiency 62 | ARHGEF1* | Arhgef1 | Alliance of Genome Resources | ||||
immunodeficiency 63 | IL2RB* | Il2rb | Alliance of Genome Resources | ||||
immunodeficiency 64 | RASGRP1* | Rasgrp1 | Alliance of Genome Resources | ||||
immunodeficiency 65 | IRF9* | Irf9 | Alliance of Genome Resources | ||||
immunodeficiency 66 | MRTFA* | Mrtfa | Alliance of Genome Resources | ||||
immunodeficiency 69 | IFNG* | Ifng | Alliance of Genome Resources | ||||
immunodeficiency 7 | TRAC*, TRA | Trac | Alliance of Genome Resources | ||||
immunodeficiency 70 | IVNS1ABP* | Ivns1abp | Alliance of Genome Resources | ||||
immunodeficiency 71 | ARPC1B* | Arpc1b | Alliance of Genome Resources | ||||
immunodeficiency 72 | NCKAP1L* | Nckap1l | Alliance of Genome Resources | ||||
immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis | RAC2* | Rac2 | Alliance of Genome Resources | ||||
immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia | RAC2* | Rac2 | Alliance of Genome Resources | ||||
immunodeficiency 79 | CD4* | Cd4 | Alliance of Genome Resources | ||||
immunodeficiency 9 | ORAI1* | Orai1 | Alliance of Genome Resources | ||||
immunodeficiency-centromeric instability-facial anomalies syndrome 2 | ZBTB24* | Zbtb24 | Alliance of Genome Resources | ||||
immunodeficiency-centromeric instability-facial anomalies syndrome 3 | CDCA7* | Cdca7 | Alliance of Genome Resources | ||||
immunodeficiency-centromeric instability-facial anomalies syndrome 4 | HELLS* | Hells | Alliance of Genome Resources | ||||
immunodeficiency with hyper IgM type 3 | CD40* | Cd40 | Alliance of Genome Resources | ||||
immunodeficiency with hyper IgM type 5 | UNG* | Ung | Alliance of Genome Resources | ||||
immunoglobulin alpha deficiency | ICOS* | Icos | Alliance of Genome Resources | ||||
immunoglobulin alpha deficiency | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
immunoglobulin alpha deficiency | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
inclusion body myopathy and brain white matter abnormalities | ANXA11* | Anxa11 | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1 | VCP* | Vcp | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 2 | HNRNPA2B1* | Hnrnpa2b1 | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
infantile cerebellar-retinal degeneration | ACO2* | Aco2 | Alliance of Genome Resources | ||||
infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | MED17* | Med17 | Alliance of Genome Resources | ||||
infantile hypotonia with psychomotor retardation and characteristic facies-3 | TBCK* | Tbck | Alliance of Genome Resources | ||||
infantile liver failure syndrome 1 | LARS1* | Lars1 | Alliance of Genome Resources | ||||
infantile parkinsonism-dystonia 2 | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
inflammatory bowel disease 25 | IL10RB* | Il10rb | Alliance of Genome Resources | ||||
inflammatory bowel disease 28 | IL10RA* | Il10ra | Alliance of Genome Resources | ||||
inflammatory bowel disease 29 | INAVA* | Inava | Alliance of Genome Resources | ||||
inflammatory bowel disease 30 | CARD8* | ||||||
inflammatory poikiloderma with hair abnormalities and acral keratoses | LTV1* | Ltv1 | Alliance of Genome Resources | ||||
intellectual developmental disorder with abnormal behavior, microcephaly, and short stature | PUS7* | Pus7 | Alliance of Genome Resources | ||||
intellectual developmental disorder with autistic features and language delay, with or without seizures | TANC2* | Tanc2 | Alliance of Genome Resources | ||||
intellectual developmental disorder with cardiac arrhythmia | GNB5* | Gnb5 | Alliance of Genome Resources | ||||
intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | TNPO2* | Tnpo2 | Alliance of Genome Resources | ||||
intellectual developmental disorder with short stature and behavioral abnormalities | IQSEC1* | Iqsec1 | Alliance of Genome Resources | ||||
intellectual disability-severe speech delay-mild dysmorphism syndrome | FOXP1* | Foxp1 | Alliance of Genome Resources | ||||
intermediate spinal muscular atrophy | SMN1*, SMN2 | Smn1 | 1 model | Alliance of Genome Resources | |||
interstitial lung disease 1 | SFTPA1*, SFTPA2 | Sftpa1 | Alliance of Genome Resources | ||||
interstitial lung disease 2 | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
interstitial lung disease 2 | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
intrahepatic cholestasis of pregnancy 1 | ATP8B1* | Atp8b1 | Alliance of Genome Resources | ||||
intrahepatic cholestasis of pregnancy 3 | ABCB4* | Abcb4 | Alliance of Genome Resources | ||||
ischiocoxopodopatellar syndrome | TBX4* | Tbx4 | Alliance of Genome Resources | ||||
isolated elevated serum creatine phosphokinase levels | ANO5* | Ano5 | Alliance of Genome Resources | ||||
isolated elevated serum creatine phosphokinase levels | CAV3* | Cav3 | Alliance of Genome Resources | ||||
isolated hyperchlorhidrosis | CA12* | Car12 | Alliance of Genome Resources | ||||
isolated microphthalmia 2 | VSX2* | Vsx2 | Alliance of Genome Resources | ||||
isolated microphthalmia 3 | RAX* | Rax | Alliance of Genome Resources | ||||
isolated microphthalmia 5 | MFRP* | Mfrp | Alliance of Genome Resources | ||||
isolated microphthalmia 7 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
isolated microphthalmia 8 | ALDH1A3* | Aldh1a3 | Alliance of Genome Resources | ||||
isolated sulfite oxidase deficiency | SUOX* | Suox | Alliance of Genome Resources | ||||
ITM2B-related cerebral amyloid angiopathy 1 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
ITM2B-related cerebral amyloid angiopathy 2 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
IVIC syndrome | SALL4* | Sall4 | Alliance of Genome Resources | ||||
Jackson-Weiss syndrome | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
Jackson-Weiss syndrome | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
Jalili syndrome | CNNM4* | Cnnm4 | Alliance of Genome Resources | ||||
Jansen's metaphyseal chondrodysplasia | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
junctional epidermolysis bullosa with pyloric atresia | ITGA6* | Itga6 | Alliance of Genome Resources | ||||
juvenile amyotrophic lateral sclerosis type 27 | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
juvenile glaucoma | MYOC* | Myoc | Alliance of Genome Resources | ||||
juvenile polyposis-hereditary hemorrhagic telangiectasia syndrome | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
Kahrizi syndrome | SRD5A3* | Srd5a3 | Alliance of Genome Resources | ||||
Kanzaki disease | NAGA* | Naga | Alliance of Genome Resources | ||||
Kenny-Caffey syndrome type 1 | TBCE* | Tbce | Alliance of Genome Resources | ||||
Kenny-Caffey syndrome type 2 | FAM111A* | Fam111a | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 1 | DSG1* | Dsg1a, Dsg1b, Dsg1c | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 2 | DSP* | Dsp | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 3 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
keratosis pilaris atrophicans | LRP1* | Lrp1 | Alliance of Genome Resources | ||||
King Denborough syndrome | RYR1* | Ryr1 | Alliance of Genome Resources | ||||
Kleefstra syndrome 2 | KMT2C* | Kmt2c | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 1 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 2 | MEOX1* | Meox1 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 3 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 4 | MYO18B* | Myo18b | Alliance of Genome Resources | ||||
Kniest dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 1 | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 2 | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 3 | FGF10* | Fgf10 | Alliance of Genome Resources | ||||
Larsen-like syndrome B3GAT3 type | B3GAT3* | B3gat3 | Alliance of Genome Resources | ||||
Larsen syndrome | FLNB* | Flnb | Alliance of Genome Resources | ||||
lateral meningocele syndrome | NOTCH3* | Notch3 | Alliance of Genome Resources | ||||
Laurence-Moon syndrome | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
Laurin-Sandrow syndrome | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 11 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 13 | RDH12* | Rdh12 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 15 | TULP1* | Tulp1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 16 | KCNJ13* | Kcnj13 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 17 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
Leber congenital amaurosis with early-onset deafness | TUBB4B* | Tubb4b | Alliance of Genome Resources | ||||
Legius syndrome | SPRED1* | Spred1 | Alliance of Genome Resources | ||||
Lenz-Majewski hyperostotic dwarfism | PTDSS1* | Ptdss1 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | ZBTB42* | Zbtb42 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | CNTNAP1* | Cntnap1 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | ADGRG6* | Adgrg6 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | ADCY6* | Adcy6 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | GLDN* | Gldn | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome | NEK9* | Nek9 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome 1 | GLE1* | Gle1 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome 2 | ERBB3* | Erbb3 | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome 3 | PIP5K1C* | Pip5k1c | Alliance of Genome Resources | ||||
lethal congenital contracture syndrome 4 | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
leucine-sensitive hypoglycemia of infancy | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
leukocyte adhesion deficiency | ITGB2* | Itgb2, Itgb2l | Alliance of Genome Resources | ||||
leukocyte adhesion deficiency 1 | FERMT3* | Fermt3 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 1 | EIF2B1* | Eif2b1 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 2 | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 3 | EIF2B3* | Eif2b3 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 4 | EIF2B4* | Eif2b4 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 5 | EIF2B5* | Eif2b5 | Alliance of Genome Resources | ||||
Leydig cell hypoplasia | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
Li-Fraumeni syndrome 1 | TP53* | Trp53 | Alliance of Genome Resources | ||||
Li-Fraumeni syndrome 2 | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
lissencephaly 1 | PAFAH1B1* | Pafah1b1 | Alliance of Genome Resources | ||||
lissencephaly 10 | CEP85L* | Cep85l | Alliance of Genome Resources | ||||
lissencephaly 3 | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
lissencephaly 4 | NDE1* | Nde1 | Alliance of Genome Resources | ||||
lissencephaly 5 | LAMB1* | Lamb1 | Alliance of Genome Resources | ||||
lissencephaly 6 | KATNB1* | Katnb1 | Alliance of Genome Resources | ||||
lissencephaly 7 with cerebellar hypoplasia | CDK5* | Cdk5 | Alliance of Genome Resources | ||||
lissencephaly 8 | TMTC3* | Tmtc3 | Alliance of Genome Resources | ||||
lissencephaly 9 with complex brainstem malformation | MACF1* | Macf1 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 1 | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 2 | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 3 | SMAD3* | Smad3 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 4 | TGFB2* | Tgfb2 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 5 | TGFB3* | Tgfb3 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 6 | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
long QT syndrome 10 | SCN4B* | Scn4b | Alliance of Genome Resources | ||||
long QT syndrome 11 | AKAP9* | Akap9 | Alliance of Genome Resources | ||||
long QT syndrome 12 | SNTA1* | Snta1 | Alliance of Genome Resources | ||||
long QT syndrome 13 | KCNJ5* | Kcnj5 | Alliance of Genome Resources | ||||
long QT syndrome 14 | CALM1* | Calm1 | Alliance of Genome Resources | ||||
long QT syndrome 15 | CALM2* | Calm2 | Alliance of Genome Resources | ||||
long QT syndrome 16 | CALM3* | Calm3 | Alliance of Genome Resources | ||||
long QT syndrome 2 | KCNH2* | Kcnh2 | Alliance of Genome Resources | ||||
long QT syndrome 2 | ALG10B*, ALG10 | Alg10b | Alliance of Genome Resources | ||||
long QT syndrome 5 | KCNE1* | Kcne1 | Alliance of Genome Resources | ||||
long QT syndrome 6 | KCNE2* | Kcne2 | Alliance of Genome Resources | ||||
long QT syndrome 8 | CACNA1C* | Cacna1c | Alliance of Genome Resources | ||||
long QT syndrome 9 | CAV3* | Cav3 | Alliance of Genome Resources | ||||
Luo-Schoch-Yamamoto syndrome | RNF2* | Rnf2 | Alliance of Genome Resources | ||||
lymphedema-distichiasis syndrome | FOXC2* | Foxc2 | Alliance of Genome Resources | ||||
lymphoproliferative syndrome 1 | ITK* | Itk | Alliance of Genome Resources | ||||
lymphoproliferative syndrome 2 | CD27* | Cd27 | Alliance of Genome Resources | ||||
Lynch syndrome | E2F4* | E2f4 | Alliance of Genome Resources | ||||
Lynch syndrome | TAF1B* | Taf1b | Alliance of Genome Resources | ||||
Lynch syndrome | RNASEL* | Rnasel | Alliance of Genome Resources | ||||
Lynch syndrome | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
Lynch syndrome | SLC22A9*, SLC22A10, SLC22A24, SLC22A25 | Slc22a19, Slc22a26, Slc22a27, Slc22a28, Slc22a29, Slc22a30 | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD3* | Smad3 | Alliance of Genome Resources | ||||
Lynch syndrome | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
Lynch syndrome | ACVR2A* | Acvr2a | Alliance of Genome Resources | ||||
Lynch syndrome | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
Lynch syndrome | ASTE1* | Aste1 | Alliance of Genome Resources | ||||
Lynch syndrome | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
Lynch syndrome | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
Lynch syndrome | TCF4* | Tcf4 | Alliance of Genome Resources | ||||
Lynch syndrome | KRAS* | Kras | Alliance of Genome Resources | ||||
Lynch syndrome | MARCKS* | Marcks | Alliance of Genome Resources | ||||
Lynch syndrome | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
Lynch syndrome | MRE11* | Mre11a | Alliance of Genome Resources | ||||
Lynch syndrome | MSH6* | Msh6 | Alliance of Genome Resources | ||||
Lynch syndrome | PMS1* | Pms1 | Alliance of Genome Resources | ||||
Lynch syndrome | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
Lynch syndrome 1 | MSH2* | Msh2 | Alliance of Genome Resources | ||||
Machado-Joseph disease | ATXN3* | Atxn3 | 1 model | Alliance of Genome Resources | |||
Machado-Joseph disease | BECN1* | Becn1 | Alliance of Genome Resources | ||||
malignant hyperthermia | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
malignant hyperthermia | CACNG1* | Cacng1 | Alliance of Genome Resources | ||||
mandibuloacral dysplasia type B lipodystrophy | ZMPSTE24* | Zmpste24 | Alliance of Genome Resources | ||||
mandibulofacial dysostosis, Guion-Almeida type | EFTUD2* | Eftud2 | 2 "NOT" models | Alliance of Genome Resources | |||
Martsolf syndrome | RAB3GAP2* | Rab3gap2 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 10 | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 11 | BLK* | Blk | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 13 | KCNJ11* | Kcnj11 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 14 | APPL1* | Appl1 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 5 | HNF1B* | Hnf1b | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 6 | NEUROD1* | Neurod1 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 7 | KLF11* | Klf11 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 8 | CEL* | Cel | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 9 | PAX4* | Pax4 | Alliance of Genome Resources | ||||
McKusick-Kaufman syndrome | MKKS* | Mkks | Alliance of Genome Resources | ||||
Meckel syndrome 13 | TMEM107* | Tmem107 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 1 | KRT12* | Krt12 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 2 | KRT3* | ||||||
megalencephalic leukoencephalopathy with subcortical cysts 2A | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
megalencephalic leukoencephalopathy with subcortical cysts 2B | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 1 | ORC1* | Orc1 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 2 | ORC4* | Orc4 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 3 | ORC6* | Orc6 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 4 | CDT1* | Cdt1 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 5 | CDC6* | Cdc6 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 6 | GMNN* | Gmnn | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 7 | CDC45* | Cdc45 | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 8 | MCM5* | Mcm5 | Alliance of Genome Resources | ||||
melanoma and neural system tumor syndrome | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
metachondromatosis | PTPN11* | Ptpn11 | Alliance of Genome Resources | ||||
metaphyseal dysplasia-maxillary hypoplasia-brachydactyly syndrome | RUNX2* | Runx2 | Alliance of Genome Resources | ||||
metatropic dysplasia | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
methemoglobinemia and ambiguous genitalia | CYB5A* | Cyb5a | Alliance of Genome Resources | ||||
microcephalic osteodysplastic primordial dwarfism type I | RNU4ATAC* | ||||||
microcephaly and chorioretinopathy 1 | TUBGCP6* | Tubgcp6 | Alliance of Genome Resources | ||||
microcephaly and chorioretinopathy 2 | PLK4* | Plk4 | Alliance of Genome Resources | ||||
microcephaly and chorioretinopathy 3 | TUBGCP4* | Tubgcp4 | Alliance of Genome Resources | ||||
microcephaly, seizures, and developmental delay | PNKP* | Pnkp | Alliance of Genome Resources | ||||
microcephaly, short stature, and limb abnormalities | DONSON* | Donson | Alliance of Genome Resources | ||||
microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | KIF11* | Kif11 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | ASTE1* | Aste1 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | MLH1* | Mlh1 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | MSH2* | Msh2 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | MSH6* | Msh6 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | POLE* | Pole | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | SLC22A9*, SLC22A10, SLC22A24, SLC22A25 | Slc22a19, Slc22a26, Slc22a27, Slc22a28, Slc22a29, Slc22a30 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | TAF1B* | Taf1b | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | TFDP1*, TFDP3 | Tfdp1 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
mismatch repair cancer syndrome | TP53* | Trp53 | Alliance of Genome Resources | ||||
Mitchell syndrome | ACOX1* | Acox1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 1 | SURF1* | Surf1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 10 | COX14* | Cox14 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 11 | COX20* | Cox20 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 12 | PET100* | Pet100 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 13 | COA6* | Coa6 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 14 | COA3* | Coa3 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 15 | COX8A* | Cox8a | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 16 | COX4I1* | Cox4i1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 17 | COA8* | Coa8 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 18 | COX6A2* | Cox6a2 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 19 | PET117* | Pet117 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 2 | SCO2* | Sco2 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 20 | COX5A* | Cox5a | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 21 | NDUFA4* | Ndufa4 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 22 | COX16* | Cox16 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 23 | COX11* | Cox11 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 3 | COX10* | Cox10 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 4 | SCO1* | Sco1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 6 | COX15* | Cox15 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 7 | COX6B1* | Cox6b1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 8 | TACO1* | Taco1 | Alliance of Genome Resources | ||||
mitochondrial complex IV deficiency nuclear type 9 | COA5* | Coa5 | Alliance of Genome Resources | ||||
mitochondrial complex V (ATP synthase) deficiency nuclear type 4A | ATP5F1A* | Atp5f1a | Alliance of Genome Resources | ||||
mitochondrial complex V (ATP synthase) deficiency nuclear type 4B | ATP5F1A* | Atp5f1a | Alliance of Genome Resources | ||||
mitochondrial complex V (ATP synthase) deficiency nuclear type 5 | ATP5F1D* | Atp5f1d | Alliance of Genome Resources | ||||
mitochondrial complex V (ATP synthase) deficiency nuclear type 7 | ATP5PO* | Atp5po | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 1 | TYMP* | Tymp | 1 model | Alliance of Genome Resources | |||
mitochondrial DNA depletion syndrome 11 | MGME1* | Mgme1 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 12a | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 12b | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 13 | FBXL4* | Fbxl4 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 15 | TFAM* | Tfam | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 16 | POLG2* | Polg2 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 16B | POLG2* | Polg2 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 17 | MRM2* | Mrm2 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 18 | SLC25A21* | Slc25a21 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 19 | SLC25A10* | Slc25a10 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 20 | LIG3* | Lig3 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 3 | DGUOK* | Dguok | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 4b | POLG* | Polg | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 6 | MPV17* | Mpv17 | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 7 | TWNK* | Twnk | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 8a | RRM2B* | Rrm2b | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 8b | RRM2B* | Rrm2b | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 9 | SUCLG1* | Suclg1 | Alliance of Genome Resources | ||||
mitochondrial pyruvate carrier deficiency | MPC1* | Mpc1 | Alliance of Genome Resources | ||||
mitochondrial short-chain enoyl-CoA hydratase 1 deficiency | ECHS1* | Echs1 | Alliance of Genome Resources | ||||
mitochondrial trifunctional protein deficiency | HADHA* | Hadha | Alliance of Genome Resources | ||||
mitochondrial trifunctional protein deficiency | HADHB* | Hadhb | Alliance of Genome Resources | ||||
Miura type epiphyseal chondrodysplasia | NPR2* | Npr2 | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 1 | DYSF* | Dysf | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 3 | ANO5* | Ano5 | Alliance of Genome Resources | ||||
monilethrix | KRT81*, KRT83*, KRT86*, KRT87P | Krt81, Krt83, Krt86, Krt87 | Alliance of Genome Resources | ||||
mosaic variegated aneuploidy syndrome 2 | CEP57* | Cep57 | Alliance of Genome Resources | ||||
mosaic variegated aneuploidy syndrome 3 | TRIP13* | Trip13 | Alliance of Genome Resources | ||||
mosaic variegated aneuploidy syndrome 4 | CENATAC* | Cenatac | Alliance of Genome Resources | ||||
Muckle-Wells syndrome | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
Muckle-Wells syndrome | NLRP3* | Nlrp3 | Alliance of Genome Resources | ||||
mucolipidosis III alpha/beta | GNPTAB* | Gnptab | Alliance of Genome Resources | ||||
mucolipidosis III gamma | GNPTG* | Gnptg | Alliance of Genome Resources | ||||
mucopolysaccharidosis Ih | IDUA* | Idua | Alliance of Genome Resources | ||||
mucopolysaccharidosis Ih/s | IDUA* | Idua | Alliance of Genome Resources | ||||
mucopolysaccharidosis IVA | GALNS* | Galns | Alliance of Genome Resources | ||||
mucopolysaccharidosis type IIIA | SGSH* | Sgsh | Alliance of Genome Resources | ||||
mucopolysaccharidosis type IIIB | NAGLU* | Naglu | Alliance of Genome Resources | ||||
mucopolysaccharidosis type IIIC | HGSNAT* | Hgsnat | Alliance of Genome Resources | ||||
mucopolysaccharidosis type IIID | GNS* | Gns | Alliance of Genome Resources | ||||
mucopolysaccharidosis type IVB | GLB1* | Glb1 | Alliance of Genome Resources | ||||
Muir-Torre syndrome | MLH1* | Mlh1 | Alliance of Genome Resources | ||||
Muir-Torre syndrome | MSH2* | Msh2 | Alliance of Genome Resources | ||||
Mullerian aplasia and hyperandrogenism | WNT4* | Wnt4 | Alliance of Genome Resources | ||||
multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly | CEP55* | Cep55 | Alliance of Genome Resources | ||||
multiple congenital anomalies-hypotonia-seizures syndrome 1 | PIGN* | Pign | Alliance of Genome Resources | ||||
multiple congenital anomalies-hypotonia-seizures syndrome 3 | PIGT* | Pigt | Alliance of Genome Resources | ||||
multiple congenital anomalies-hypotonia-seizures syndrome 4 | PIGQ* | Pigq | Alliance of Genome Resources | ||||
multiple cutaneous and mucosal venous malformations | TEK* | Tek | Alliance of Genome Resources | ||||
multiple endocrine neoplasia type 2A | RET* | Ret | Alliance of Genome Resources | ||||
multiple endocrine neoplasia type 4 | CDKN1B* | Cdkn1b | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 1 | COMP* | Comp | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 2 | COL9A2* | Col9a2 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 3 | COL9A3* | Col9a3 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 4 | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 6 | COL9A1* | Col9a1 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 7 | CANT1* | Cant1 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia with myopia and deafness | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
multiple intestinal atresia | TTC7A* | Ttc7 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 1 | NFU1* | Nfu1 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 2 | BOLA3* | Bola3 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 3 | IBA57* | Iba57 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 4 | ISCA2* | Isca2 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 5 | ISCA1* | AK157302, Isca1 | Alliance of Genome Resources | ||||
multiple mitochondrial dysfunctions syndrome 6 | PMPCB* | Pmpcb | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | NOG* | Nog | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 3 | FGF9* | Fgf9 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 4 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
multiple types of congenital heart defects 6 | GDF1* | Gdf1 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B15 | DPM3* | Dpm3 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B4 | FKTN* | Fktn | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C12 | POMK* | Pomk | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | SLC6A1* | Slc6a1 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
myoclonic dystonia 26 | KCTD17* | Kctd17 | Alliance of Genome Resources | ||||
myoclonic dystonia 34 | KCNN2* | Kcnn2 | Alliance of Genome Resources | ||||
myofibrillar myopathy 10 | SVIL* | Svil | Alliance of Genome Resources | ||||
myofibrillar myopathy 3 | MYOT* | Myot | 1 "NOT" model | Alliance of Genome Resources | |||
myofibrillar myopathy 4 | LDB3* | Ldb3 | Alliance of Genome Resources | ||||
myofibrillar myopathy 6 | BAG3* | Bag3 | Alliance of Genome Resources | ||||
myofibrillar myopathy 7 | KY* | Ky | Alliance of Genome Resources | ||||
myofibrillar myopathy 8 | PYROXD1* | Pyroxd1 | Alliance of Genome Resources | ||||
myopathy with extrapyramidal signs | MICU1* | Micu1 | Alliance of Genome Resources | ||||
N-acetylglutamate synthase deficiency | NAGS* | Nags | Alliance of Genome Resources | ||||
Naegeli-Franceschetti-Jadassohn syndrome | KRT14* | Krt14 | Alliance of Genome Resources | ||||
Nagashima-type palmoplantar keratosis | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
Native American myopathy | STAC3* | Stac3 | Alliance of Genome Resources | ||||
nemaline myopathy 1 | TPM3* | Tpm3 | Alliance of Genome Resources | ||||
nemaline myopathy 4 | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
nemaline myopathy 5B | TNNT1* | Tnnt1 | Alliance of Genome Resources | ||||
nemaline myopathy 5C | TNNT1* | Tnnt1 | Alliance of Genome Resources | ||||
nemaline myopathy 7 | CFL2* | Cfl2 | Alliance of Genome Resources | ||||
nemaline myopathy 9 | KLHL41* | Klhl41 | Alliance of Genome Resources | ||||
neonatal lethal pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome | ATAD3A*, ATAD3B, ATAD3C | Atad3a | Alliance of Genome Resources | ||||
neonatal-onset type II citrullinemia | SLC25A13* | Slc25a13 | Alliance of Genome Resources | ||||
nephrogenic diabetes insipidus type 2 | AQP2* | Aqp2 | Alliance of Genome Resources | ||||
nephronophthisis | SLC41A1* | Slc41a1 | Alliance of Genome Resources | ||||
nephronophthisis | IQCB1* | Iqcb1 | Alliance of Genome Resources | ||||
nephronophthisis | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
nephronophthisis | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
nephronophthisis | NPHP3* | Nphp3 | Alliance of Genome Resources | ||||
nephronophthisis | NPHP4* | Nphp4 | Alliance of Genome Resources | ||||
nephronophthisis | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
nephronophthisis 11 | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
nephronophthisis 12 | TTC21B* | Ttc21b | Alliance of Genome Resources | ||||
nephronophthisis 13 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
nephronophthisis 14 | ZNF423* | Zfp423 | Alliance of Genome Resources | ||||
nephronophthisis 15 | CEP164* | Cep164 | Alliance of Genome Resources | ||||
nephronophthisis 16 | ANKS6* | Anks6 | Alliance of Genome Resources | ||||
nephronophthisis 18 | CEP83* | Cep83 | Alliance of Genome Resources | ||||
nephronophthisis 19 | DCDC2* | Dcdc2a | Alliance of Genome Resources | ||||
nephronophthisis 20 | MAPKBP1* | Mapkbp1 | Alliance of Genome Resources | ||||
nephronophthisis 9 | NEK8* | Nek8 | Alliance of Genome Resources | ||||
nephronophthisis-like nephropathy 1 | XPNPEP3* | Xpnpep3 | Alliance of Genome Resources | ||||
nephrotic syndrome type 1 | NPHS1* | Nphs1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 10 | EMP2* | Emp2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 11 | NUP107* | Nup107 | Alliance of Genome Resources | ||||
nephrotic syndrome type 12 | NUP93* | Nup93 | Alliance of Genome Resources | ||||
nephrotic syndrome type 13 | NUP205* | Nup205 | Alliance of Genome Resources | ||||
nephrotic syndrome type 14 | SGPL1* | Sgpl1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 15 | MAGI2* | Magi2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 16 | KANK2* | Kank2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 17 | NUP85* | Nup85 | Alliance of Genome Resources | ||||
nephrotic syndrome type 18 | NUP133* | Nup133 | Alliance of Genome Resources | ||||
nephrotic syndrome type 19 | NUP160* | Nup160 | Alliance of Genome Resources | ||||
nephrotic syndrome type 2 | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
nephrotic syndrome type 2 | PLCE1* | Plce1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 2 | NPHS2* | Nphs2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 2 | TRPC6* | Trpc6 | Alliance of Genome Resources | ||||
nephrotic syndrome type 21 | AVIL* | Avil | Alliance of Genome Resources | ||||
nephrotic syndrome type 22 | NOS1AP* | Nos1ap | Alliance of Genome Resources | ||||
nephrotic syndrome type 23 | KIRREL1* | Kirrel1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 3 | PLCE1* | Plce1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 4 | WT1* | Wt1 | Alliance of Genome Resources | ||||
nephrotic syndrome type 5 | LAMB2* | Lamb2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 6 | PTPRO* | Ptpro | Alliance of Genome Resources | ||||
nephrotic syndrome type 7 | DGKE* | Dgke | Alliance of Genome Resources | ||||
nephrotic syndrome type 8 | ARHGDIA* | Arhgdia | Alliance of Genome Resources | ||||
nephrotic syndrome type 9 | COQ8B* | Coq8b | Alliance of Genome Resources | ||||
NESCAV syndrome | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
Nestor-Guillermo progeria syndrome | BANF1* | Banf1 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 2b | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 3 | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 4 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies | ADAT3* | Adat3 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities | SHMT2* | Shmt2 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with cerebellar atrophy and motor dysfunction | GEMIN5* | Gemin5 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities | SRSF1* | Srsf1 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with dysmorphic facies and thin corpus callosum | SUPT16H* | Supt16 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with eye movement abnormalities and ataxia | FRMD5* | Frmd5 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with hypotonia and speech delay | EIF4A2* | Eif4a2 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | CACNA1C* | Cacna1c | Alliance of Genome Resources | ||||
neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | MEF2C* | Mef2c | Alliance of Genome Resources | ||||
neurodevelopmental disorder with language delay and seizures | TIAM1* | Tiam1 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities | GEMIN4* | Gemin4 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy | TRAPPC6B* | Trappc6b | Alliance of Genome Resources | ||||
neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities | INTS11* | Ints11 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with poor growth and behavioral abnormalities | ATP9A* | Atp9a | Alliance of Genome Resources | ||||
neurodevelopmental disorder with poor growth, spastic tetraplegia, and hearing loss | PSMC1* | Psmc1 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties | DPH5* | Dph5 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with spasticity and poor growth | UFC1* | Ufc1 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with spastic paraplegia and microcephaly | GPT2* | Gpt2 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with speech impairment and dysmorphic facies | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
neurofibromatosis-Noonan syndrome | NF1* | Nf1 | Alliance of Genome Resources | ||||
neurogenic scapuloperoneal syndrome Kaeser type | DES* | Des | Alliance of Genome Resources | ||||
neurogenic-type arthrogryposis multiplex congenita-2 | ERGIC1* | Ergic1 | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 11 | GRN* | Grn | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 13 | CTSF* | Ctsf | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 4 | DNAJC5* | Dnajc5 | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 6B | CLN6* | Cln6 | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 8 northern epilepsy variant | CLN8* | Cln8 | Alliance of Genome Resources | ||||
neuronal intranuclear inclusion disease | NOTCH2NLC* | ||||||
neurooculocardiogenitourinary syndrome | WDR37* | Wdr37 | Alliance of Genome Resources | ||||
nevoid basal cell carcinoma syndrome 1 | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
NFIA-related disorder | NFIA* | Nfia | Alliance of Genome Resources | ||||
Nicolaides-Baraitser syndrome | SMARCA2* | Smarca2 | Alliance of Genome Resources | ||||
nonautoimmune hyperthyroidism | TSHR* | Tshr | Alliance of Genome Resources | ||||
nonphotosensitive trichothiodystrophy 4 | MPLKIP* | Mplkip, Mplkipl1 | Alliance of Genome Resources | ||||
nonphotosensitive trichothiodystrophy 6 | GTF2E2* | Gtf2e2 | Alliance of Genome Resources | ||||
nonphotosensitive trichothiodystrophy 7 | TARS1* | Tars1 | Alliance of Genome Resources | ||||
nonprogressive cerebellar ataxia with mental retardation | CAMTA1* | Camta1 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 1 | FZD6* | Fzd6 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 3 | PLCD1* | Plcd1 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 4 | RSPO4* | Rspo4 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 8 | COL7A1* | Col7a1 | Alliance of Genome Resources | ||||
Noonan syndrome 11 | MRAS* | Mras | Alliance of Genome Resources | ||||
Noonan syndrome 12 | RRAS2* | Rras2 | Alliance of Genome Resources | ||||
Noonan syndrome 13 | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
Noonan syndrome 2 | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
Noonan syndrome 6 | NRAS* | Nras | Alliance of Genome Resources | ||||
Noonan syndrome 7 | BRAF* | Braf | Alliance of Genome Resources | ||||
Noonan syndrome 9 | SOS2* | Sos2 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 1 | PTPN11* | Ptpn11 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 2 | RAF1* | Raf1 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 3 | BRAF* | Braf | Alliance of Genome Resources | ||||
Norman-Roberts syndrome | RELN* | Reln | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 1 | NDUFS4* | Ndufs4 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 10 | NDUFAF2* | Ndufaf2 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 11 | NDUFAF1* | Ndufaf1 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 13 | NDUFA2* | Ndufa2 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 14 | NDUFA11* | Ndufa11, Ndufa11b | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 15 | NDUFAF4* | Ndufaf4 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 16 | NDUFAF5* | Ndufaf5 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 17 | NDUFAF6* | Ndufaf6 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 18 | NDUFAF3* | Ndufaf3 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 19 | FOXRED1* | Foxred1 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 2 | NDUFS8* | Ndufs8 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 21 | NUBPL* | Nubpl | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 22 | NDUFA10* | Ndufa10 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 23 | NDUFA12* | Ndufa12 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 24 | NDUFB9* | Ndufb9 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 25 | NDUFB3* | Ndufb3 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 26 | NDUFA9* | Ndufa9 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 27 | MTFMT* | Mtfmt | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 28 | NDUFA13* | Ndufa13 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 29 | TMEM126B* | Tmem126b | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 3 | NDUFS7* | Ndufs7 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 31 | TIMMDC1* | Timmdc1 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 32 | NDUFB8* | Ndufb8 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 33 | NDUFA6* | Ndufa6 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 34 | NDUFAF8* | Ndufaf8 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 35 | NDUFB10* | Ndufb10 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 4 | NDUFV1* | Ndufv1 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 5 | NDUFS1* | Ndufs1 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 6 | NDUFS2* | Ndufs2 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 7 | NDUFV2* | Ndufv2 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 8 | NDUFS3* | Ndufs3 | Alliance of Genome Resources | ||||
nuclear type mitochondrial complex I deficiency 9 | NDUFS6* | Ndufs6, Ndufs6b | Alliance of Genome Resources | ||||
oblique facial clefting 1 | SPECC1L* | Specc1l | Alliance of Genome Resources | ||||
oculocutaneous albinism | HPS1* | Hps1 | Alliance of Genome Resources | ||||
oculocutaneous albinism | TYRP1* | Tyrp1 | Alliance of Genome Resources | ||||
oculocutaneous albinism | DCT* | Dct | Alliance of Genome Resources | ||||
oculocutaneous albinism type IA | TYR* | Tyr | Alliance of Genome Resources | ||||
oculocutaneous albinism type IB | TYR* | Tyr | Alliance of Genome Resources | ||||
oculocutaneous albinism type II | OCA2* | Oca2 | Alliance of Genome Resources | ||||
oculocutaneous albinism type II | MC1R* | Mc1r | Alliance of Genome Resources | ||||
oculocutaneous albinism type III | TYRP1* | Tyrp1 | Alliance of Genome Resources | ||||
oculocutaneous albinism type IV | SLC45A2* | Slc45a2 | Alliance of Genome Resources | ||||
oculocutaneous albinism type VI | SLC24A5* | Slc24a5 | Alliance of Genome Resources | ||||
oculocutaneous albinism type VII | LRMDA* | Lrmda | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 1 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 2 | GIPC1* | Gipc1 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 3 | NOTCH2NLC* | ||||||
oculopharyngodistal myopathy 4 | RILPL1* | Rilpl1 | Alliance of Genome Resources | ||||
Oguchi disease-1 | SAG* | Sag | Alliance of Genome Resources | ||||
Oliver-McFarlane syndrome | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
omodysplasia 1 | GPC6* | Gpc6 | Alliance of Genome Resources | ||||
omodysplasia 2 | FZD2* | Fzd2 | Alliance of Genome Resources | ||||
optic atrophy 1 | OPA1* | Opa1 | Alliance of Genome Resources | ||||
optic atrophy 1 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
optic atrophy 10 | RTN4IP1* | Rtn4ip1 | Alliance of Genome Resources | ||||
optic atrophy 11 | YME1L1* | Yme1l1 | Alliance of Genome Resources | ||||
optic atrophy 12 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
optic atrophy 3 | OPA3* | Opa3 | Alliance of Genome Resources | ||||
optic atrophy 5 | DNM1L* | Dnm1l | Alliance of Genome Resources | ||||
optic atrophy 7 | TMEM126A* | Tmem126a | Alliance of Genome Resources | ||||
optic atrophy 9 | ACO2* | Aco2 | Alliance of Genome Resources | ||||
optic disc anomalies with retinal and/or macular dystrophy | SIX6* | Six6 | Alliance of Genome Resources | ||||
orofacial cleft 6 | IRF6* | Irf6 | Alliance of Genome Resources | ||||
orofaciodigital syndrome II | NEK1* | Nek1 | Alliance of Genome Resources | ||||
orofaciodigital syndrome IV | TCTN3* | Tctn3 | Alliance of Genome Resources | ||||
orofaciodigital syndrome V | DDX59* | Ddx59 | Alliance of Genome Resources | ||||
orofaciodigital syndrome XIV | C2CD3* | C2cd3 | Alliance of Genome Resources | ||||
orofaciodigital syndrome XIX | SCNM1* | Scnm1 | Alliance of Genome Resources | ||||
orofaciodigital syndrome XVI | TMEM107* | Tmem107 | Alliance of Genome Resources | ||||
orofaciodigital syndrome XVII | INTU* | Intu | Alliance of Genome Resources | ||||
orofaciodigital syndrome XVIII | IFT57* | Ift57 | Alliance of Genome Resources | ||||
orofaciodigital syndrome XX | RAB34* | Rab34 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 11 | FKBP10* | Fkbp10 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 12 | SP7* | Sp7 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 13 | BMP1* | Bmp1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 15 | WNT1* | Wnt1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 17 | SPARC* | Sparc | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 18 | TENT5A* | Tent5a | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 20 | MESD* | Mesd | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 21 | KDELR2* | Kdelr2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 4 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteoglophonic dysplasia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
osteosclerotic metaphyseal dysplasia | LRRK1* | Lrrk1 | Alliance of Genome Resources | ||||
otosclerosis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
otosclerosis | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
otosclerosis | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
otosclerosis | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
otosclerosis | AGT* | Agt | Alliance of Genome Resources | ||||
otosclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
otosclerosis 11 | FOXL1* | Foxl1 | Alliance of Genome Resources | ||||
otospondylomegaepiphyseal dysplasia, autosomal dominant | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
otulipenia | OTULIN* | Otulin | Alliance of Genome Resources | ||||
ovarian dysgenesis 1 | FSHR* | Fshr | Alliance of Genome Resources | ||||
ovarian dysgenesis 3 | PSMC3IP* | Psmc3ip | Alliance of Genome Resources | ||||
ovarian dysgenesis 4 | MCM9* | Mcm9 | Alliance of Genome Resources | ||||
ovarian dysgenesis 5 | SOHLH1* | Sohlh1 | Alliance of Genome Resources | ||||
ovarian dysgenesis 6 | NUP107* | Nup107 | Alliance of Genome Resources | ||||
ovarian dysgenesis 7 | MRPS22* | Mrps22 | Alliance of Genome Resources | ||||
ovarian dysgenesis 8 | ESR2* | Esr2 | Alliance of Genome Resources | ||||
overhydrated hereditary stomatocytosis | RHAG* | Rhag | Alliance of Genome Resources | ||||
oxoglutarate dehydrogenase deficiency | OGDH* | Ogdh | Alliance of Genome Resources | ||||
pachyonychia congenita | KRT6A*, KRT6B*, KRT6C | Gm5414, Gm5478, Krt6a, Krt6b | 1 model | Alliance of Genome Resources | |||
pachyonychia congenita | KRT17* | Krt17 | 1 model | Alliance of Genome Resources | |||
Paget's disease of bone 2 | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
Paget's disease of bone 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
Paget's disease of bone 5 | TNFRSF11B* | Tnfrsf11b | Alliance of Genome Resources | ||||
Paget's disease of bone 6 | ZNF687* | Zfp687 | Alliance of Genome Resources | ||||
palmoplantar keratoderma and woolly hair | KANK2* | Kank2 | Alliance of Genome Resources | ||||
palmoplantar keratoderma-deafness syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
pancreatic hypoplasia-diabetes-congenital heart disease syndrome | GATA6* | Gata6 | Alliance of Genome Resources | ||||
pantothenate kinase-associated neurodegeneration | PANK2* | Pank2 | 1 "NOT" model | Alliance of Genome Resources | |||
PAPA syndrome | PSTPIP1* | Pstpip1 | Alliance of Genome Resources | ||||
Papillon-Lefevre disease | CTSC* | Ctsc | Alliance of Genome Resources | ||||
paraganglioma | SDHB* | Sdhb | Alliance of Genome Resources | ||||
paraganglioma | SDHC* | Sdhc | 1 "NOT" model | Alliance of Genome Resources | |||
paraganglioma | SDHAF2* | Sdhaf2 | Alliance of Genome Resources | ||||
paraganglioma | SDHA* | Sdha | Alliance of Genome Resources | ||||
paraganglioma | SDHD* | Sdhd | 3 "NOT" models | Alliance of Genome Resources | |||
paraganglioma | SLC25A11* | Slc25a11 | Alliance of Genome Resources | ||||
paraganglioma | DLST* | Dlst | Alliance of Genome Resources | ||||
paramyotonia congenita of Von Eulenburg | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
parastremmatic dwarfism | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Parkinson's disease 15 | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
Parkinson's disease 19A | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
Parkinson's disease 20 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
Parkinson's disease 22 | CHCHD2*, CHCHD2P9 | Chchd2, Chchd2-ps | Alliance of Genome Resources | ||||
Parkinson's disease 23 | VPS13C* | Vps13c | Alliance of Genome Resources | ||||
Parkinson's disease 25 | PTPA* | Ptpa | Alliance of Genome Resources | ||||
paroxysmal extreme pain disorder | SCN9A* | Scn9a | Alliance of Genome Resources | ||||
paroxysmal nonkinesigenic dyskinesia 3 | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
peeling skin syndrome 1 | CDSN* | Cdsn | Alliance of Genome Resources | ||||
peeling skin syndrome 2 | TGM5* | Tgm5 | Alliance of Genome Resources | ||||
peeling skin syndrome 4 | CSTA* | Csta1, Csta2, Csta3, Cstdc3, Cstdc4, Cstdc5, Cstdc6, Stfa1, Stfa2, Stfa2l1, Stfa3 | Alliance of Genome Resources | ||||
peeling skin syndrome 5 | SERPINB8* | Serpinb8 | Alliance of Genome Resources | ||||
peeling skin syndrome 6 | FLG2* | Flg2 | Alliance of Genome Resources | ||||
pentosuria | DCXR* | Dcxr | Alliance of Genome Resources | ||||
permanent neonatal diabetes mellitus | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
permanent neonatal diabetes mellitus | GCK* | Gck | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 10A | PEX3* | Pex3 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 10B | PEX3* | Pex3 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 11A | PEX13* | Pex13 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 11B | PEX13* | Pex13 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 12A | PEX19* | Pex19 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 13A | PEX14* | Pex14 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 14B | PEX11B* | Pex11b | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 1A | PEX1* | Pex1 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 1B | PEX1* | Pex1 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 2A | PEX5* | Pex5 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 2B | PEX5* | Pex5 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 3A | PEX12* | Pex12 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 3B | PEX12* | Pex12 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 4A | PEX6* | Pex6 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 4B | PEX6* | Pex6 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 5A | PEX2* | Pex2 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 5B | PEX2* | Pex2 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 6A | PEX10* | Pex10 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 6B | PEX10* | Pex10 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 7A | PEX26* | Pex26 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 7B | PEX26* | Pex26 | Alliance of Genome Resources | ||||
peroxisome biogenesis disorder 8A | PEX16* | Pex16 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 8B | PEX16* | Pex16 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 9B | PEX7* | Pex7 | Alliance of Genome Resources | ||||
Perrault syndrome | TWNK* | Twnk | Alliance of Genome Resources | ||||
Perrault syndrome | HARS2* | Hars2 | Alliance of Genome Resources | ||||
Perrault syndrome | HSD17B4* | Hsd17b4 | Alliance of Genome Resources | ||||
Perrault syndrome | LARS2* | Lars2 | Alliance of Genome Resources | ||||
Perrault syndrome 6 | ERAL1* | Eral1 | Alliance of Genome Resources | ||||
Perry syndrome | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
photosensitive trichothiodystrophy 1 | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
photosensitive trichothiodystrophy 2 | ERCC3* | Ercc3 | Alliance of Genome Resources | ||||
photosensitive trichothiodystrophy 3 | GTF2H5* | Gtf2h5 | Alliance of Genome Resources | ||||
piebaldism | SNAI2* | Snai2 | Alliance of Genome Resources | ||||
pigmented paravenous chorioretinal atrophy | CRB1* | Crb1 | Alliance of Genome Resources | ||||
Pitt-Hopkins-like syndrome 2 | NRXN1* | Nrxn1 | Alliance of Genome Resources | ||||
Pitt-Hopkins syndrome | CNTNAP2* | Cntnap2 | Alliance of Genome Resources | ||||
PLACK syndrome | CAST* | Cast | Alliance of Genome Resources | ||||
plasminogen deficiency type I | PLG* | Plg | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 11 | GP6* | Gp6 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 15 | ACTN1* | Actn1 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 17 | GFI1B* | Gfi1b | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 18 | RASGRP2* | Rasgrp2 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 19 | PRKACG* | ||||||
platelet-type bleeding disorder 20 | SLFN14* | Slfn14 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 3 | GP1BA* | Gp1ba | Alliance of Genome Resources | ||||
poikiloderma with neutropenia | USB1* | Usb1 | Alliance of Genome Resources | ||||
polycystic kidney disease 3 | GANAB* | Ganab | Alliance of Genome Resources | ||||
polycystic kidney disease 5 | DZIP1L* | Dzip1l | Alliance of Genome Resources | ||||
polycystic kidney disease 6 | DNAJB11* | Dnajb11 | Alliance of Genome Resources | ||||
polycystic kidney disease 7 | ALG5* | Alg5 | Alliance of Genome Resources | ||||
polycystic liver disease | GANAB* | Ganab | Alliance of Genome Resources | ||||
polycystic liver disease 1 | PRKCSH* | Prkcsh | Alliance of Genome Resources | ||||
polycystic liver disease 1 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
polycystic liver disease 2 | SEC63* | Sec63 | Alliance of Genome Resources | ||||
polycystic liver disease 3 | ALG8* | Alg8 | Alliance of Genome Resources | ||||
polycystic liver disease 4 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
polyhydramnios, megalencephaly, and symptomatic epilepsy | STRADA* | Strada | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 11 | TBC1D23* | Tbc1d23 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 12 | COASY* | Coasy | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 13 | VPS51* | Vps51 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 15 | CDC40* | Cdc40 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 16 | MINPP1* | Minpp1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1A | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1B | EXOSC3* | Exosc3 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1C | EXOSC8* | Exosc8 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1D | EXOSC9* | Exosc9 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1E | SLC25A46* | Slc25a46 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1F | EXOSC1* | Exosc1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2A | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2B | TSEN2* | Tsen2 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2C | TSEN34* | Tsen34 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2D | SEPSECS* | Sepsecs | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2E | VPS53* | Vps53 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2F | TSEN15* | Tsen15 | Alliance of Genome Resources | ||||
poor metabolism of thiopurines | NUDT15* | Nudt15 | Alliance of Genome Resources | ||||
postaxial acrofacial dysostosis | DHODH* | Dhodh | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | OVOL2* | Ovol2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | VSX1* | Vsx1 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 2 | COL8A2* | Col8a2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 4 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
primary autosomal dominant microcephaly 18 | WDFY3* | Wdfy3 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | ASPM* | Aspm | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | WDR62* | Wdr62 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | TRAPPC14* | Trappc14 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | RRP7A*, RRP7BP | Rrp7a | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | PDCD6IP* | Pdcd6ip | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NUP37* | Nup37 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | BUB1* | Bub1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | CPAP* | Cpap | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPH* | Ncaph | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPD3* | Ncapd3 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | KIF14* | Kif14 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | KNL1* | Knl1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | LMNB1* | Lmnb1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPD2* | Ncapd2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 1 | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 10 | ZNF335* | Zfp335 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 11 | PHC1* | Phc1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 12 | CDK6* | Cdk6 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 13 | CENPE* | Cenpe | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 14 | SASS6* | Sass6 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 15 | MFSD2A* | Mfsd2a | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 16 | ANKLE2* | Ankle2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 17 | CIT* | Cit | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 19 | COPB2* | Copb2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 3 | CDK5RAP2* | Cdk5rap2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 4 | KNL1* | Knl1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 5 | ASPM* | Aspm | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 6 | CPAP* | Cpap | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 7 | STIL* | Stil | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 8 | CEP135* | Cep135 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 9 | CEP152* | Cep152 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 38 | CFAP300* | Cfap300 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 39 | LRRC56* | Lrrc56 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 40 | DNAH9* | Dnah9 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 41 | GAS2L2* | Gas2l2 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 42 | MCIDAS* | Mcidas | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 43 | FOXJ1* | Foxj1 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 44 | NEK10* | Nek10 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 45 | TTC12* | Ttc12 | Alliance of Genome Resources | ||||
primary coenzyme Q10 deficiency 9 | COQ5* | Coq5 | Alliance of Genome Resources | ||||
primary failure of tooth eruption | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
primary ovarian insufficiency 10 | MCM8* | Mcm8 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 11 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 14 | GDF9* | Gdf9 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 15 | FANCM* | Fancm | Alliance of Genome Resources | ||||
primary ovarian insufficiency 16 | BNC1* | Bnc1 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 18 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
primary ovarian insufficiency 3 | FOXL2* | Foxl2 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 5 | NOBOX* | Nobox | Alliance of Genome Resources | ||||
primary ovarian insufficiency 6 | FIGLA* | Figla | Alliance of Genome Resources | ||||
primary ovarian insufficiency 7 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 8 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 9 | HFM1* | Hfm1 | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 1 | PRKAR1A* | Prkar1a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 2 | PDE11A* | Pde11a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 4 | PRKACA* | Prkaca | Alliance of Genome Resources | ||||
progeria | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
progressive familial heart block type IB | TRPM4* | Trpm4 | Alliance of Genome Resources | ||||
progressive familial intrahepatic cholestasis 1 | ATP8B1* | Atp8b1 | Alliance of Genome Resources | ||||
progressive familial intrahepatic cholestasis 2 | ABCB11* | Abcb11 | Alliance of Genome Resources | ||||
progressive familial intrahepatic cholestasis 3 | ABCB4* | Abcb4 | Alliance of Genome Resources | ||||
progressive familial intrahepatic cholestasis 4 | TJP2* | Tjp2 | 1 model | Alliance of Genome Resources | |||
progressive familial intrahepatic cholestasis 5 | NR1H4* | Nr1h4 | Alliance of Genome Resources | ||||
progressive leukoencephalopathy with ovarian failure | AARS2* | Aars2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 10 | PRDM8* | Prdm8 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 1A | CSTB* | Cstb | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 3 | KCTD7* | Kctd7 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 4 | SCARB2* | Scarb2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 6 | GOSR2* | Gosr2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 7 | KCNC1* | Kcnc1 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 8 | CERS1* | Cers1 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 9 | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
progressive osseous heteroplasia | GNAS* | Gnas | Alliance of Genome Resources | ||||
prolidase deficiency | PEPD* | Pepd | Alliance of Genome Resources | ||||
proprotein convertase 1/3 deficiency | PCSK1* | Pcsk1 | Alliance of Genome Resources | ||||
proteasome-associated autoinflammatory syndrome 1 | PSMB8* | Psmb8 | Alliance of Genome Resources | ||||
proteasome-associated autoinflammatory syndrome 3 | PSMB4* | Psmb4 | Alliance of Genome Resources | ||||
protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
proteosome-associated autoinflammatory syndrome 2 | POMP* | Pomp | Alliance of Genome Resources | ||||
proteosome-associated autoinflammatory syndrome 4 | PSMG2* | Psmg2 | Alliance of Genome Resources | ||||
proteosome-associated autoinflammatory syndrome 5 | PSMB10* | Psmb10 | Alliance of Genome Resources | ||||
prothrombin deficiency | F2* | F2 | Alliance of Genome Resources | ||||
proximal symphalangism | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 1 | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
prune belly syndrome | CHRM3* | Chrm3 | Alliance of Genome Resources | ||||
pseudo-TORCH syndrome 1 | OCLN* | Ocln | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | CAT* | Cat | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | XYLT2* | Xylt2 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | ELN* | Eln | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | XYLT1* | Xylt1 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | SOD2* | Sod2 | Alliance of Genome Resources | ||||
pulmonary venoocclusive disease 1 | BMPR2* | Bmpr2 | Alliance of Genome Resources | ||||
pulmonary venoocclusive disease 2 | EIF2AK4* | Eif2ak4 | Alliance of Genome Resources | ||||
pycnodysostosis | CTSK* | Ctsk | Alliance of Genome Resources | ||||
Rafiq syndrome | MAN1B1* | Man1b1 | Alliance of Genome Resources | ||||
rapadilino syndrome | RECQL4* | Recql4 | Alliance of Genome Resources | ||||
Rapp-Hodgkin syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
renal hypomagnesemia 7, with or without dilated cardiomyopathy | RRAGD* | Rragd | Alliance of Genome Resources | ||||
restrictive dermopathy 1 | ZMPSTE24* | Zmpste24 | Alliance of Genome Resources | ||||
reticular dysgenesis | AK2* | Ak2 | Alliance of Genome Resources | ||||
retinal arterial tortuosity | COL4A1* | Col4a1 | Alliance of Genome Resources | ||||
retinal cone dystrophy 3B | KCNV2* | Kcnv2 | Alliance of Genome Resources | ||||
retinal dystrophy with leukodystrophy | ACBD5* | Acbd5 | Alliance of Genome Resources | ||||
retinal macular dystrophy 2 | PROM1* | Prom1 | Alliance of Genome Resources | ||||
retinal macular dystrophy 4 | CLEC3B* | Clec3b | Alliance of Genome Resources | ||||
retinal vasculopathy with cerebral leukodystrophy | TREX1* | Trex1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 10 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 25 | EYS* | ||||||
retinitis pigmentosa 27 | NRL* | Nrl | Alliance of Genome Resources | ||||
retinitis pigmentosa 33 | SNRNP200* | Snrnp200 | Alliance of Genome Resources | ||||
retinitis pigmentosa 35 | SEMA4A* | Sema4a | Alliance of Genome Resources | ||||
retinitis pigmentosa 37 | NR2E3* | Nr2e3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 38 | MERTK* | Mertk | Alliance of Genome Resources | ||||
retinitis pigmentosa 42 | KLHL7* | Klhl7 | Alliance of Genome Resources | ||||
retinitis pigmentosa 45 | CNGB1* | Cngb1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 50 | BEST1* | Best1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 57 | PDE6G* | Pde6g | Alliance of Genome Resources | ||||
retinitis pigmentosa 60 | PRPF6* | Prpf6 | Alliance of Genome Resources | ||||
retinitis pigmentosa 62 | MAK* | Mak | Alliance of Genome Resources | ||||
retinitis pigmentosa 68 | SLC7A14* | Slc7a14 | Alliance of Genome Resources | ||||
retinitis pigmentosa 69 | KIZ* | Kiz | Alliance of Genome Resources | ||||
retinitis pigmentosa 7 | ROM1* | Rom1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 70 | PRPF4* | Prpf4 | Alliance of Genome Resources | ||||
retinitis pigmentosa 71 | IFT172* | Ift172 | Alliance of Genome Resources | ||||
retinitis pigmentosa 72 | ZNF408* | Zfp408 | Alliance of Genome Resources | ||||
retinitis pigmentosa 73 | HGSNAT* | Hgsnat | Alliance of Genome Resources | ||||
retinitis pigmentosa 74 | BBS2* | Bbs2 | Alliance of Genome Resources | ||||
retinitis pigmentosa 75 | AGBL5* | Agbl5 | Alliance of Genome Resources | ||||
retinitis pigmentosa 81 | IFT43* | Ift43 | Alliance of Genome Resources | ||||
retinitis pigmentosa 83 | ARL3* | Arl3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 84 | DHX38* | Dhx38 | Alliance of Genome Resources | ||||
retinitis pigmentosa 85 | AHR* | Ahr | Alliance of Genome Resources | ||||
retinitis pigmentosa 86 | KIAA1549* | D630045J12Rik | Alliance of Genome Resources | ||||
retinitis pigmentosa 87 | RPE65* | Rpe65 | Alliance of Genome Resources | ||||
retinitis pigmentosa 88 | RP1L1* | Rp1l1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 89 | KIF3B* | Kif3b | Alliance of Genome Resources | ||||
retinitis pigmentosa 9 | RP9* | Rp9 | Alliance of Genome Resources | ||||
retinitis pigmentosa 90 | IDH3A* | Idh3a | Alliance of Genome Resources | ||||
Revesz syndrome | TINF2* | Tinf2 | Alliance of Genome Resources | ||||
rhizomelic chondrodysplasia punctata | AGPS* | Agps | Alliance of Genome Resources | ||||
rhizomelic chondrodysplasia punctata type 5 | PEX5* | Pex5 | Alliance of Genome Resources | ||||
rhizomelic chondrodysplasia punctate type 4 | FAR1* | Far1 | Alliance of Genome Resources | ||||
ring dermoid of cornea | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Ritscher-Schinzel syndrome 1 | WASHC5* | Washc5 | Alliance of Genome Resources | ||||
RNASET2-deficient cystic leukoencephalopathy | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
Roberts syndrome | ESCO2* | Esco2 | Alliance of Genome Resources | ||||
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
Rubinstein-Taybi syndrome | EP300* | Ep300 | Alliance of Genome Resources | ||||
Ruijs-Aalfs syndrome | SPRTN* | Sprtn | Alliance of Genome Resources | ||||
SADDAN | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
Saethre-Chotzen syndrome | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
salt and pepper syndrome | ST3GAL5* | St3gal5 | Alliance of Genome Resources | ||||
Sandestig-Stefanova syndrome | NUP188* | Nup188 | Alliance of Genome Resources | ||||
sarcosinemia | SARDH* | Sardh | Alliance of Genome Resources | ||||
Saul-Wilson syndrome | COG4* | Cog4 | Alliance of Genome Resources | ||||
scapuloperoneal spinal muscular atrophy | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Schindler disease type 1 | NAGA* | Naga | Alliance of Genome Resources | ||||
Schinzel Giedion syndrome | SETBP1* | Setbp1 | Alliance of Genome Resources | ||||
Schinzel type phocomelia | WNT7A* | Wnt7a | Alliance of Genome Resources | ||||
schizophrenia 15 | SHANK3* | Shank3 | Alliance of Genome Resources | ||||
schizophrenia 4 | PRODH* | Prodh | Alliance of Genome Resources | ||||
schizophrenia 6 | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
Schopf-Schulz-Passarge syndrome | WNT10A* | Wnt10a | Alliance of Genome Resources | ||||
Schuurs-Hoeijmakers Syndrome | PACS1* | Pacs1 | Alliance of Genome Resources | ||||
schwannomatosis | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
schwannomatosis | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
schwannomatosis 1 | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
schwannomatosis 2 | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
Seckel syndrome | CDK5RAP2* | Cdk5rap2 | Alliance of Genome Resources | ||||
Seckel syndrome 1 | ATR* | Atr | Alliance of Genome Resources | ||||
Seckel syndrome 10 | NSMCE2* | Nsmce2 | Alliance of Genome Resources | ||||
Seckel syndrome 2 | RBBP8* | Rbbp8 | Alliance of Genome Resources | ||||
Seckel syndrome 4 | CPAP* | Cpap | Alliance of Genome Resources | ||||
Seckel syndrome 5 | CEP152* | Cep152 | Alliance of Genome Resources | ||||
Seckel syndrome 6 | CEP63* | Cep63 | Alliance of Genome Resources | ||||
Seckel syndrome 7 | NIN* | Nin | Alliance of Genome Resources | ||||
Seckel syndrome 8 | DNA2* | Dna2 | Alliance of Genome Resources | ||||
Seckel syndrome 9 | TRAIP* | Traip | Alliance of Genome Resources | ||||
selective pituitary thyroid hormone resistance | THRB* | Thrb | Alliance of Genome Resources | ||||
Sengers syndrome | AGK* | Agk | Alliance of Genome Resources | ||||
Senior-Loken syndrome | CEP290* | Cep290 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | TRAF3IP1* | Traf3ip1 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | SDCCAG8* | Sdccag8 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | NPHP4* | Nphp4 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
Senior-Loken syndrome | IQCB1* | Iqcb1 | Alliance of Genome Resources | ||||
sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | POLG* | Polg | Alliance of Genome Resources | ||||
sepiapterin reductase deficiency | SPR* | Spr | Alliance of Genome Resources | ||||
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive | RAG1* | Rag1 | Alliance of Genome Resources | ||||
severe congenital neutropenia 1 | ELANE* | Elane | Alliance of Genome Resources | ||||
severe congenital neutropenia 2 | GFI1* | Gfi1 | Alliance of Genome Resources | ||||
severe congenital neutropenia 3 | HAX1* | Hax1 | Alliance of Genome Resources | ||||
severe congenital neutropenia 4 | G6PC3* | G6pc3 | Alliance of Genome Resources | ||||
severe congenital neutropenia 5 | VPS45* | Vps45 | Alliance of Genome Resources | ||||
severe congenital neutropenia 6 | JAGN1* | Jagn1 | Alliance of Genome Resources | ||||
severe congenital neutropenia 7 | CSF3R* | Csf3r | Alliance of Genome Resources | ||||
severe congenital neutropenia 8 | SRP54* | Srp54a, Srp54b, Srp54c | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 10 with or without polydactyly | IFT172* | Ift172 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 11 with or without polydactyly | DYNC2I2* | Dync2i2 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 13 with or without polydactyly | CEP120* | Cep120 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 14 with polydactyly | KIAA0586* | 2700049A03Rik | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 18 with polydactyly | IFT43* | Ift43 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 19 with or without polydactyly | IFT81* | Ift81 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 6 with or without polydactyly | NEK1* | Nek1 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 8 with or without polydactyly | DYNC2I1* | Dync2i1 | Alliance of Genome Resources | ||||
short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 | SCUBE3* | Scube3 | Alliance of Genome Resources | ||||
short stature, hearing loss, retinitis pigmentosa, and distinctive facies | EXOSC2* | Exosc2 | Alliance of Genome Resources | ||||
sickle cell anemia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
sickle cell anemia | ALAD* | Alad | Alliance of Genome Resources | ||||
sickle cell anemia | APOB* | Apob | Alliance of Genome Resources | ||||
sickle cell anemia | NOS3* | Nos3 | Alliance of Genome Resources | ||||
sickle cell anemia | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
sickle cell anemia | BCL11A* | Bcl11a | Alliance of Genome Resources | ||||
sickle cell anemia | HMBS* | Hmbs | Alliance of Genome Resources | ||||
sickle cell anemia | HBE1*, HBG2*, HBG1 | Hbb-bh0, Hbb-bh1, Hbb-y | Alliance of Genome Resources | ||||
sickle cell anemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | 7 models | Alliance of Genome Resources | |||
sickle cell anemia | C3* | C3 | Alliance of Genome Resources | ||||
sickle cell anemia | CFB* | Cfb | Alliance of Genome Resources | ||||
sickle cell anemia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
sickle cell anemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
sickle cell anemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
sickle cell anemia | CYP2C19*, CYP2C8, CYP2C9, CYP2C18 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c50, Cyp2c55, Cyp2c65, Cyp2c66 | Alliance of Genome Resources | ||||
sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay | TRNT1* | Trnt1 | Alliance of Genome Resources | ||||
Sifrim-Hitz-Weiss syndrome | CHD4* | Chd4 | Alliance of Genome Resources | ||||
sitosterolemia 1 | ABCG5* | Abcg5 | Alliance of Genome Resources | ||||
sitosterolemia 2 | ABCG5* | Abcg5 | Alliance of Genome Resources | ||||
Sjogren-Larsson syndrome | ALDH3A2* | Aldh3a2 | 1 model | Alliance of Genome Resources | |||
Smith-McCort dysplasia 1 | DYM* | Dym | Alliance of Genome Resources | ||||
snowflake vitreoretinal degeneration | KCNJ13* | Kcnj13 | Alliance of Genome Resources | ||||
solitary median maxillary central incisor | SHH* | Shh | Alliance of Genome Resources | ||||
Sotos syndrome | NSD1* | Nsd1 | 1 model | Alliance of Genome Resources | |||
Sotos syndrome 1 | NSD1* | Nsd1 | Alliance of Genome Resources | ||||
Sotos syndrome 3 | APC2* | Apc2 | Alliance of Genome Resources | ||||
spastic ataxia 1 | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
spastic ataxia 2 | KIF1C* | Kif1c | Alliance of Genome Resources | ||||
spastic ataxia 3 | MARS2* | Mars2 | Alliance of Genome Resources | ||||
spastic ataxia 4 | MTPAP* | Mtpap | Alliance of Genome Resources | ||||
spastic ataxia 5 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
spastic ataxia 8 | NKX6-2* | Nkx6-2 | Alliance of Genome Resources | ||||
spastic quadriplegic cerebral palsy 3 | ADD3* | Add3 | Alliance of Genome Resources | ||||
speech-language disorder-1 | FOXP2* | Foxp2 | Alliance of Genome Resources | ||||
spermatogenic failure 10 | SEPTIN12* | Septin12 | Alliance of Genome Resources | ||||
spermatogenic failure 11 | KLHL10* | Klhl10 | Alliance of Genome Resources | ||||
spermatogenic failure 12 | NANOS1* | Nanos1 | Alliance of Genome Resources | ||||
spermatogenic failure 13 | TAF4B* | Taf4b | Alliance of Genome Resources | ||||
spermatogenic failure 14 | ZMYND15* | Zmynd15 | Alliance of Genome Resources | ||||
spermatogenic failure 15 | SYCE1* | Syce1 | Alliance of Genome Resources | ||||
spermatogenic failure 16 | SUN5* | Sun5 | Alliance of Genome Resources | ||||
spermatogenic failure 17 | PLCZ1* | Plcz1 | Alliance of Genome Resources | ||||
spermatogenic failure 18 | DNAH1* | Dnah1 | Alliance of Genome Resources | ||||
spermatogenic failure 2 | MSH4* | Msh4 | Alliance of Genome Resources | ||||
spermatogenic failure 21 | BRDT* | Brdt | Alliance of Genome Resources | ||||
spermatogenic failure 22 | MEIOB* | Meiob | Alliance of Genome Resources | ||||
spermatogenic failure 23 | TEX14* | Tex14 | Alliance of Genome Resources | ||||
spermatogenic failure 25 | TEX15* | Tex15 | Alliance of Genome Resources | ||||
spermatogenic failure 26 | TSGA10* | Tsga10 | Alliance of Genome Resources | ||||
spermatogenic failure 27 | AK7* | Ak7 | Alliance of Genome Resources | ||||
spermatogenic failure 28 | FANCM* | Fancm | Alliance of Genome Resources | ||||
spermatogenic failure 29 | SPINK2* | Spink2 | Alliance of Genome Resources | ||||
spermatogenic failure 3 | SRSF6* | Srsf6 | Alliance of Genome Resources | ||||
spermatogenic failure 3 | SLC26A8* | Slc26a8 | Alliance of Genome Resources | ||||
spermatogenic failure 30 | TDRD9* | Tdrd9 | Alliance of Genome Resources | ||||
spermatogenic failure 32 | SOHLH1* | Sohlh1 | Alliance of Genome Resources | ||||
spermatogenic failure 33 | CFAP251* | Cfap251 | Alliance of Genome Resources | ||||
spermatogenic failure 34 | FSIP2* | Fsip2 | Alliance of Genome Resources | ||||
spermatogenic failure 35 | QRICH2* | Qrich2 | Alliance of Genome Resources | ||||
spermatogenic failure 36 | PPP2R3C* | Ppp2r3c | Alliance of Genome Resources | ||||
spermatogenic failure 37 | TTC21A* | Ttc21a | Alliance of Genome Resources | ||||
spermatogenic failure 38 | ARMC2* | Armc2 | Alliance of Genome Resources | ||||
spermatogenic failure 4 | SYCP3* | Gm773, Sycp3 | Alliance of Genome Resources | ||||
spermatogenic failure 41 | CFAP70* | Cfap70 | Alliance of Genome Resources | ||||
spermatogenic failure 42 | TTC29* | Ttc29 | Alliance of Genome Resources | ||||
spermatogenic failure 43 | SPEF2* | Spef2 | Alliance of Genome Resources | ||||
spermatogenic failure 44 | CEP112* | Cep112 | Alliance of Genome Resources | ||||
spermatogenic failure 45 | DNAH2* | Dnah2 | Alliance of Genome Resources | ||||
spermatogenic failure 48 | M1AP* | M1ap | Alliance of Genome Resources | ||||
spermatogenic failure 49 | CFAP58* | Cfap58 | Alliance of Genome Resources | ||||
spermatogenic failure 5 | AURKC* | Aurkc | Alliance of Genome Resources | ||||
spermatogenic failure 50 | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
spermatogenic failure 51 | CFAP91* | Cfap91 | Alliance of Genome Resources | ||||
spermatogenic failure 52 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
spermatogenic failure 53 | ACTL9* | Actl9 | Alliance of Genome Resources | ||||
spermatogenic failure 54 | CATIP* | Catip | Alliance of Genome Resources | ||||
spermatogenic failure 55 | SPAG17* | Spag17 | Alliance of Genome Resources | ||||
spermatogenic failure 56 | DNAH10* | Dnah10 | Alliance of Genome Resources | ||||
spermatogenic failure 57 | PNLDC1* | Pnldc1 | Alliance of Genome Resources | ||||
spermatogenic failure 58 | IFT74* | Ift74 | Alliance of Genome Resources | ||||
spermatogenic failure 59 | TERB2* | Terb2 | Alliance of Genome Resources | ||||
spermatogenic failure 6 | SPATA16* | Spata16 | Alliance of Genome Resources | ||||
spermatogenic failure 60 | TERB1* | Terb1 | Alliance of Genome Resources | ||||
spermatogenic failure 61 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
spermatogenic failure 62 | RNF212* | Rnf212 | Alliance of Genome Resources | ||||
spermatogenic failure 63 | RPL10L* | Rpl10l | Alliance of Genome Resources | ||||
spermatogenic failure 64 | FBXO43* | Fbxo43 | Alliance of Genome Resources | ||||
spermatogenic failure 65 | DNHD1* | Dnhd1 | Alliance of Genome Resources | ||||
spermatogenic failure 66 | ZPBP* | Zpbp | Alliance of Genome Resources | ||||
spermatogenic failure 67 | CCDC62* | Ccdc62 | Alliance of Genome Resources | ||||
spermatogenic failure 68 | C2CD6* | C2cd6 | Alliance of Genome Resources | ||||
spermatogenic failure 69 | GGN* | Ggn | Alliance of Genome Resources | ||||
spermatogenic failure 7 | CATSPER1* | Catsper1 | Alliance of Genome Resources | ||||
spermatogenic failure 70 | PDHA2* | Pdha2 | Alliance of Genome Resources | ||||
spermatogenic failure 71 | ZSWIM7* | Zswim7 | Alliance of Genome Resources | ||||
spermatogenic failure 72 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
spermatogenic failure 73 | MOV10L1* | Mov10l1 | Alliance of Genome Resources | ||||
spermatogenic failure 74 | MSH5* | Msh5 | Alliance of Genome Resources | ||||
spermatogenic failure 75 | SHOC1* | Shoc1 | Alliance of Genome Resources | ||||
spermatogenic failure 76 | CCDC34* | Ccdc34 | Alliance of Genome Resources | ||||
spermatogenic failure 77 | FKBP6* | Fkbp6 | Alliance of Genome Resources | ||||
spermatogenic failure 78 | IQCN* | Iqcn | Alliance of Genome Resources | ||||
spermatogenic failure 79 | KCNU1* | Kcnu1 | Alliance of Genome Resources | ||||
spermatogenic failure 8 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
spermatogenic failure 80 | DRC1* | Drc1 | Alliance of Genome Resources | ||||
spermatogenic failure 81 | TEKT3* | Tekt3 | Alliance of Genome Resources | ||||
spermatogenic failure 82 | AKAP3* | Akap3 | Alliance of Genome Resources | ||||
spermatogenic failure 83 | DNALI1* | Dnali1 | Alliance of Genome Resources | ||||
spermatogenic failure 84 | CFAP61* | Cfap61 | Alliance of Genome Resources | ||||
spermatogenic failure 85 | SPACA1* | Spaca1 | Alliance of Genome Resources | ||||
spermatogenic failure 86 | ACTL7A* | Actl7a | Alliance of Genome Resources | ||||
spermatogenic failure 87 | ACR* | Acr | Alliance of Genome Resources | ||||
spermatogenic failure 88 | KASH5* | Kash5 | Alliance of Genome Resources | ||||
spermatogenic failure 89 | AK9* | Ak9 | Alliance of Genome Resources | ||||
spermatogenic failure 9 | DPY19L2*, DPY19L2P1, DPY19L2P2 | Dpy19l2 | Alliance of Genome Resources | ||||
spermatogenic failure 90 | ARMC12* | Armc12 | Alliance of Genome Resources | ||||
spermatogenic failure 91 | CCIN* | Ccin | Alliance of Genome Resources | ||||
spermatogenic failure 92 | LRRC23* | Lrrc23 | Alliance of Genome Resources | ||||
spermatogenic failure 93 | STK33* | Stk33 | Alliance of Genome Resources | ||||
spermatogenic failure 94 | CCDC146* | Ccdc146 | Alliance of Genome Resources | ||||
spermatogenic failure 95 | CFAP57* | Cfap57 | Alliance of Genome Resources | ||||
spinal muscular atrophy, Jokela type | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 1 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2A | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | ND6* | mt-Nd6 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with progressive myoclonic epilepsy | ASAH1* | Asah1 | Alliance of Genome Resources | ||||
spinal neurofibromatosis | NF1* | Nf1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 44 | GRM1* | Grm1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 45 | FAT2* | Fat2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 46 | PLD3* | Pld3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 10 | ATXN10* | Atxn10 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 11 | TTBK2* | Ttbk2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 12 | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 13 | KCNC3* | Kcnc3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 15 | ITPR1* | Itpr1 | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 19/22 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 21 | TMEM240* | Tmem240 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 23 | PDYN* | Pdyn | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 25 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 26 | EEF2* | Eef2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 29 | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 31 | BEAN1* | Bean1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 34 | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 35 | TGM6* | Tgm6 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 36 | NOP56* | Nop56 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 37 | DAB1* | Dab1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 38 | ELOVL5* | Elovl5 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 4 | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 40 | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 8 | ATXN8* | ||||||
spinocerebellar ataxia type 8 | ATXN8OS* | ||||||
spinocerebellar ataxia with axonal neuropathy 2 | SETX* | Setx | Alliance of Genome Resources | ||||
spinocerebellar ataxia with axonal neuropathy type 3 | COA7* | Coa7 | Alliance of Genome Resources | ||||
split hand-foot malformation 1 with sensorineural hearing loss | DLX5* | Dlx5 | Alliance of Genome Resources | ||||
split hand-foot malformation 4 | TP63* | Trp63 | Alliance of Genome Resources | ||||
split hand-foot malformation 6 | WNT10B* | Wnt10b | Alliance of Genome Resources | ||||
SPOAN syndrome | KLC2* | Klc2 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 1 | DLL3* | Dll3 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 2 | MESP2* | Mesp2 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 3 | LFNG* | Lfng | Alliance of Genome Resources | ||||
spondylocostal dysostosis 4 | HES7* | Hes7 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 5 | TBX6* | Tbx6 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 6 | RIPPLY2* | Ripply2 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Genevieve-type | NANS* | Nans | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Missouri type | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Sponastrime type | TONSL* | Tonsl | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Strudwick type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 1 | B3GALT6* | B3galt6 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 2 | KIF22* | Kif22 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 3 | EXOC6B* | Exoc6b | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Kimberley type | ACAN* | Acan | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Kondo-Fu type | MBTPS1* | Mbtps1 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Maroteaux type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Nishimura type | MIR140* | Mir140 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis | NMNAT1* | Nmnat1 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Stanescu type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondylometaepiphyseal dysplasia, short limb-hand type | DDR2* | Ddr2 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia corner fracture type | FN1* | Fn1 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Kozlowski type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Megarbane-Dagher-Melike type | PAM16* | Pam16, Pam16l | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Sedaghatian type | GPX4* | Gpx4 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia with cone-rod dystrophy | PCYT1A* | Pcyt1a | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia with corneal dystrophy | PLCB3* | Plcb3 | Alliance of Genome Resources | ||||
spondyloperipheral dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
steatocystoma multiplex | KRT17* | Krt17 | Alliance of Genome Resources | ||||
Stickler syndrome 1 | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
Stickler syndrome 2 | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
stiff skin syndrome | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
stress-induced childhood-onset neurodegeneration with variable ataxia and seizures | ADPRS* | Adprs | Alliance of Genome Resources | ||||
Sweeney-Cox syndrome | TWIST1* | Twist1 | Alliance of Genome Resources | ||||
syndactyly-telecanthus-anogenital and renal malformations syndrome | CCNQ* | Ccnq | Alliance of Genome Resources | ||||
syndactyly type 1 | IHH* | Ihh | Alliance of Genome Resources | ||||
syndactyly type 3 | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
syndactyly type 4 | SHH* | Shh | Alliance of Genome Resources | ||||
syndactyly type 4 | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
syndactyly type 5 | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
syndromic microphthalmia 12 | RARB* | Rarb | Alliance of Genome Resources | ||||
syndromic microphthalmia 14 | MAB21L2* | Mab21l2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 3 | SOX2* | Sox2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 5 | OTX2* | Otx2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 6 | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
syndromic microphthalmia 9 | STRA6* | Stra6 | Alliance of Genome Resources | ||||
TANGO2-related metabolic encephalopathy and arrythmias | TANGO2* | Tango2 | Alliance of Genome Resources | ||||
tarsal-carpal coalition syndrome | NOG* | Nog | Alliance of Genome Resources | ||||
Tatton-Brown-Rahman syndrome | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
temtamy preaxial brachydactyly syndrome | CHSY1* | Chsy1 | Alliance of Genome Resources | ||||
Temtamy syndrome | C12orf57* | Grcc10 | Alliance of Genome Resources | ||||
terminal osseous dysplasia | FLNA* | Flna | Alliance of Genome Resources | ||||
tetraamelia syndrome 1 | WNT3* | Wnt3 | Alliance of Genome Resources | ||||
tetraamelia syndrome 2 | RSPO2* | Rspo2 | Alliance of Genome Resources | ||||
thalassemia | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
Thiel-Behnke corneal dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
Thomsen disease | CLCN1* | Clcn1 | Alliance of Genome Resources | ||||
thrombocytopenia-absent radius syndrome | RBM8A* | Rbm8a, Rbm8a2 | Alliance of Genome Resources | ||||
thrombophilia due to activated protein C resistance | F5* | F5 | Alliance of Genome Resources | ||||
thrombophilia due to activated protein C resistance | PROC* | Proc | Alliance of Genome Resources | ||||
thrombophilia due to HRG deficiency | HRG* | Hrg | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | HABP2* | Habp2 | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | F2* | F2 | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | F13A1* | F13a1 | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
thrombophilia due to thrombomodulin defect | THBD* | Thbd | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 1 | SLC5A5* | Slc5a5 | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 2A | TPO* | Tpo | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 3 | TG* | Tg | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 4 | IYD* | Iyd | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 5 | DUOXA2* | Duoxa2 | Alliance of Genome Resources | ||||
thyroid dyshormonogenesis 6 | DUOX2* | Duox2 | Alliance of Genome Resources | ||||
torsion dystonia 2 | HPCA* | Hpca | Alliance of Genome Resources | ||||
torsion dystonia 4 | TUBB4A* | Tubb4a | Alliance of Genome Resources | ||||
Townes-Brocks syndrome | DACT1* | Dact1 | Alliance of Genome Resources | ||||
transient bullous dermolysis of the newborn | COL7A1* | Col7a1 | Alliance of Genome Resources | ||||
transient infantile liver failure | TRMU* | Trmu | Alliance of Genome Resources | ||||
Treacher Collins syndrome 1 | TCOF1* | Tcof1 | Alliance of Genome Resources | ||||
Treacher Collins syndrome 2 | POLR1D* | Polr1d | Alliance of Genome Resources | ||||
Treacher Collins syndrome 3 | POLR1C* | Polr1c | Alliance of Genome Resources | ||||
Treacher Collins syndrome 4 | POLR1B* | Polr1b | Alliance of Genome Resources | ||||
trichodontoosseous syndrome | DLX3* | Dlx3 | Alliance of Genome Resources | ||||
trichohepatoenteric syndrome 1 | SKIC3* | Skic3 | Alliance of Genome Resources | ||||
trichohepatoenteric syndrome 2 | SKIC2* | Skic2 | Alliance of Genome Resources | ||||
trichorhinophalangeal syndrome type III | TRPS1* | Trps1 | Alliance of Genome Resources | ||||
trimethylaminuria | FMO3* | Fmo3 | Alliance of Genome Resources | ||||
triple-A syndrome | AAAS* | Aaas | 1 "NOT" model | Alliance of Genome Resources | |||
tuberous sclerosis 1 | TSC1* | Tsc1 | Alliance of Genome Resources | ||||
tuberous sclerosis 2 | IFNG* | Ifng | Alliance of Genome Resources | ||||
tuberous sclerosis 2 | TSC2* | Tsc2 | Alliance of Genome Resources | ||||
tubular aggregate myopathy 2 | ORAI1* | Orai1 | Alliance of Genome Resources | ||||
type 1 diabetes mellitus 2 | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1A | COL6A1* | Col6a1 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1B | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1C | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 2 | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
urocanase deficiency | UROC1* | Uroc1 | Alliance of Genome Resources | ||||
urofacial syndrome | LRIG2* | Lrig2 | Alliance of Genome Resources | ||||
Usher syndrome | ARSG* | Arsg | Alliance of Genome Resources | ||||
Usher syndrome | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
Usher syndrome | USH1C* | Ush1c | Alliance of Genome Resources | ||||
Usher syndrome | USH2A* | Ush2a | Alliance of Genome Resources | ||||
Usher syndrome type 1 | USH1C* | Ush1c | Alliance of Genome Resources | ||||
Usher syndrome type 1D | PCDH15* | Pcdh15 | Alliance of Genome Resources | ||||
Usher syndrome type 1J | CIB2* | Cib2 | 1 "NOT" model | Alliance of Genome Resources | |||
Usher syndrome type 2 | USH2A* | Ush2a | Alliance of Genome Resources | ||||
Usher syndrome type 2A | PDZD7* | Pdzd7 | Alliance of Genome Resources | ||||
Usher syndrome type 2C | PDZD7* | Pdzd7 | Alliance of Genome Resources | ||||
Usher syndrome type 3B | HARS1* | Hars1 | Alliance of Genome Resources | ||||
uveal coloboma-cleft lip and palate-intellectual disability | YAP1* | Yap1 | Alliance of Genome Resources | ||||
UV-sensitive syndrome | ERCC8* | Ercc8 | Alliance of Genome Resources | ||||
UV-sensitive syndrome | UVSSA* | Uvssa | Alliance of Genome Resources | ||||
UV-sensitive syndrome | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
Van den Ende-Gupta syndrome | SCARF2* | Scarf2 | Alliance of Genome Resources | ||||
Van Maldergem syndrome 1 | DCHS1* | Dchs1 | Alliance of Genome Resources | ||||
Van Maldergem syndrome 2 | FAT4* | Fat4 | Alliance of Genome Resources | ||||
ventriculomegaly - cystic kidney disease | CRB2* | Crb2 | Alliance of Genome Resources | ||||
vertebral anomalies and variable endocrine and T-cell dysfunction | TBX2* | Tbx2 | Alliance of Genome Resources | ||||
vertebral hypersegmentation and orofacial anomalies | GDF11* | Gdf11 | Alliance of Genome Resources | ||||
vestibular schwannomatosis | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
vestibular schwannomatosis | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
Vici syndrome | EPG5* | Epg5 | Alliance of Genome Resources | ||||
Vissers-Bodmer syndrome | CNOT1* | Cnot1 | Alliance of Genome Resources | ||||
visual impairment and progressive phthisis bulbi | MARK3* | Mark3 | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 1A | CYP27B1* | Cyp27b1 | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 1B | CYP2R1* | Cyp2r1 | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 2A | VDR* | Vdr | Alliance of Genome Resources | ||||
Vohwinkel syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
Vulto-van Silfout-de Vries syndrome | DEAF1* | Deaf1 | Alliance of Genome Resources | ||||
Waardenburg syndrome | EDN3* | Edn3 | Alliance of Genome Resources | ||||
Waardenburg syndrome | EDNRB* | Ednrb | Alliance of Genome Resources | ||||
Waardenburg syndrome | KITLG* | Kitl | Alliance of Genome Resources | ||||
Waardenburg syndrome | MITF* | Mitf | Alliance of Genome Resources | ||||
Waardenburg syndrome | PAX3* | Pax3 | Alliance of Genome Resources | ||||
Waardenburg syndrome type 2E | SOX10* | Sox10 | Alliance of Genome Resources | ||||
Waardenburg syndrome type 3 | PAX3* | Pax3 | 5 "NOT" models | Alliance of Genome Resources | |||
Walker-Warburg syndrome | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKTN* | Fktn | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKRP* | Fkrp | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
Warburg micro syndrome 1 | RAB3GAP1* | Rab3gap1 | Alliance of Genome Resources | ||||
Warburg micro syndrome 2 | RAB3GAP2* | Rab3gap2 | Alliance of Genome Resources | ||||
Warsaw breakage syndrome | DDX11*, DDX11L8, DDX12P | Ddx11 | Alliance of Genome Resources | ||||
Watson syndrome | NF1* | Nf1 | Alliance of Genome Resources | ||||
Weill-Marchesani syndrome | LTBP2* | Ltbp2 | Alliance of Genome Resources | ||||
Werner syndrome | LMNA* | Lmna | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC* | Evc | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC2* | Evc2 | Alliance of Genome Resources | ||||
WHIM syndrome 2 | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
white sponge nevus 1 | KRT4* | Krt4 | Alliance of Genome Resources | ||||
white sponge nevus 2 | KRT13* | Krt13 | Alliance of Genome Resources | ||||
White-Sutton syndrome | POGZ* | Pogz | Alliance of Genome Resources | ||||
Wiedemann-Rautenstrauch syndrome | POLR3A* | Polr3a | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | BUD23* | Bud23 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | DNAJC30* | Dnajc30 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | ELN* | Eln | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FKBP6* | Fkbp6 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FZD3* | Fzd3 | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | LAT2* | Lat2 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | NCF1*, NCF1B, NCF1C | Ncf1 | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | RCC1L* | Rcc1l | Alliance of Genome Resources | ||||
Wolfram syndrome 2 | CISD2* | Cisd2 | 1 model | Alliance of Genome Resources | |||
Woodhouse-Sakati syndrome | DCAF17* | Dcaf17 | Alliance of Genome Resources | ||||
Worth syndrome | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
wrinkly skin syndrome | ATP6V0A2* | Atp6v0a2 | Alliance of Genome Resources | ||||
xanthinuria type I | XDH* | Xdh | Alliance of Genome Resources | ||||
xeroderma pigmentosum | ERCC4* | Ercc4 | Alliance of Genome Resources | ||||
xeroderma pigmentosum | ERCC3* | Ercc3 | Alliance of Genome Resources | ||||
xeroderma pigmentosum | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
xeroderma pigmentosum | DDB2* | Ddb2 | Alliance of Genome Resources | ||||
xeroderma pigmentosum | XPC* | Xpc | Alliance of Genome Resources | ||||
xeroderma pigmentosum | XPA* | Xpa | Alliance of Genome Resources | ||||
XFE progeroid syndrome | ERCC4* | Ercc4 | Alliance of Genome Resources | ||||
X-linked keratosis follicularis spinulosa decalvans | MBTPS2* | Mbtps2 | Alliance of Genome Resources | ||||
Yoon-Bellen neurodevelopmental syndrome | OGDHL* | Ogdhl | Alliance of Genome Resources | ||||
Zellweger syndrome | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
Zellweger syndrome | ABCD3* | Abcd3 | Alliance of Genome Resources | ||||
Zellweger syndrome | PHYH* | Phyh | Alliance of Genome Resources | ||||
ZTTK syndrome | SON* | Son | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
abdominal obesity-metabolic syndrome | Tg(RP11-578M14)5Mkru | 1 model | |
abdominal obesity-metabolic syndrome 1 | Tg(Fabp4-Hsd11b1)7Jesf | 1 model | |
abdominal obesity-metabolic syndrome 1 | Tg(Fabp4-ENPP1)#Naba | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Lmnb1)1Yfu | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-LMNB1)1108Qsp | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-Lmnb1)#Yfu | 1 model | |
advanced sleep phase syndrome 1 | Tg(PER2*S662G)867Ljp | 1 model | |
advanced sleep phase syndrome 2 | Tg(CSNK1D*,-EGFP)827Yfu | 1 model | |
advanced sleep phase syndrome 2 | Tg(CSNK1D*,-EGFP)816Yfu | 1 model | |
age related macular degeneration 1 | Tg(APOB)1102Sgy | 1 model | |
Alexander disease | Tg(Gfap-GFAP*R239H)60TMIke | 1 model | |
Alexander disease | Tg(GFAP)10Mes | 3 models | |
Alexander disease | Tg(GFAP)7Mes | 1 model | |
alpha thalassemia | Hba | 8 models | |
Alzheimer's disease 3 | Tg(PSEN1dE9)S9Dbo | 4 models | |
Alzheimer's disease 3 | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 1 model | |
Alzheimer's disease 3 | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
Alzheimer's disease 3 | Tg(PSEN1H163R)G9Btla | 1 model | |
Alzheimer's disease 4 | Tg(APP695)3Dbo | 3 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)D-14Dbo | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)2Gur | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)dl1Gur | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G127X)716Mrkl | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)#Maw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)IAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)LAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)58Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)139Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)45Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)#Deng | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-DCTN1*G59S)M2Pcw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-Sncg)HvP36Putt | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-SOD1*G93A)T3Hgrd | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Sod1*G86R)M1Jwg | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)737Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)641Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)#Roos | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)148Dwc | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)74Dwc | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)106Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)42Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)29Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)9Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)1Dwc | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)DF7Yaw | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)1Gur | 6 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)125Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-Immt/SOD1*G93A)7Gmnf | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(NFH)120Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(NEFH)200Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Myl1-SOD1*G93A)#Amu | 1 model | |
arrhythmogenic right ventricular dysplasia 12 | Tg(Myh6-Jup*)1Ajm | 2 models | |
arrhythmogenic right ventricular dysplasia 12 | Tg(Myh6-JUP*)1Dpju | 1 model | |
arrhythmogenic right ventricular dysplasia 9 | Tg(Myh6-Pkp2*/mRuby)4Rbrug | 2 models | |
arrhythmogenic right ventricular dysplasia 9 | Tg(Myh6-Pkp2*/mRuby)5Rbrug | 2 models | |
atrichia with papular lesions | Tg(K6ODCtr)55Tgo | 1 model | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diap3)924Lesp | 1 model | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diaph3)771Lesp | 1 model | |
autosomal dominant hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
autosomal dominant keratitis-ichthyosis-deafness syndrome | Tg(tetO-GJB2*G45E,-EGFP)#Tww | 1 model | |
autosomal dominant limb-girdle muscular dystrophy type 1 | Tg(Ckm-DNAJB6_ib*F93L)#Ccwe | 1 model | |
autosomal dominant nocturnal frontal lobe epilepsy 3 | Tg(tetO-Chrnb2*V287L)H3Gica | 1 model | |
autosomal dominant polycystic kidney disease | Tg(HBB-Myc)#Cos | 1 model | |
autosomal recessive hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
autosomal recessive nonsyndromic deafness 1A | Del(14Gjb6-Cryl1)1Lmon | 1 model | |
autosomal recessive nonsyndromic deafness 38 | Phl1 | 2 models | |
autosomal recessive polycystic kidney disease | T(2;10)67Gso | 1 model | |
autosomal recessive polycystic kidney disease | Tg(Pkd1)26Mtru | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)AHjal | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)BHjal | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(KRT14-Hmgn2)#Baam | 1 model | |
beta thalassemia | Rr320 | 2 models | |
beta thalassemia | Hbb | 6 models | |
CADASIL 1 | Tg(Notch3*R169C)88Bbb | 1 model | |
Carney complex | Tg(tetO-Prkar1a*x2as)1Stra | 1 model | |
cataract 19 multiple types | Tg(Lim2*G15V)1Rlc | 2 models | |
cataract 2 multiple types | Tg(CRYBB1-CRYGC*)#Jfhe | 1 model | |
cataract 30 | Tg(Vim*R113C)1Tmm | 1 model | |
cataract 5 multiple types | Tg(Hsf4/EGFP)N7Spbh | 1 model | |
Charcot-Marie-Tooth disease axonal type 2F | Tg(Thy1-HSPB1*S135F)#Lvdb | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(tetO/CMV-Pmp22)JP18Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)247Ueli | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C3Fbas | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C22Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C61Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)My41Clh | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.2Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)31Mes | 2 models | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.1Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)30Mes | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.4Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1C | Tg(CMV-LITAF*W116G)#Lli | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L51Ugfm | 2 models | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L87Ugfm | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(tetO-NEFL)173.2Jpj | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(NEFL*E397K)#Milg | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)32Mes | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)33Mes | 1 model | |
Charcot-Marie-Tooth disease type 4J | Tg(ACTB-Fig4*I41T)705Mm | 1 model | |
congenital generalized lipodystrophy type 2 | Tg(aP2-SREBF1c)9884Reh | 1 model | |
congenital myasthenic syndrome 3A | Tg(Ckm-Chrnd*S262T)40Cgz | 1 model | |
congenital myasthenic syndrome 4A | Tg(Ckm-Chrne*L269F)5Cgz | 1 model | |
congenital stationary night blindness autosomal dominant 1 | Tg(Rho*G90D*A337V)202Sie | 1 model | |
cystic fibrosis | Tg(Scgb1a1-Scnn1b)6608Bouc | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)150Dbo | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)124Dbo | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)3Tx | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)14Tx | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(ATN1*)Q129Stsu | 1 model | |
DiGeorge syndrome | Del(16Es2el-Ufd1l)217Bld | 1 model | |
DiGeorge syndrome | Del(16Dgcr2-Hira)3Aam | 1 model | |
DiGeorge syndrome | Del(16Dgcr2-Hira)1Rak | 1 model | |
dilated cardiomyopathy 1A | Tg(Myh6-LMNA*E82K)35Lizh | 1 model | |
dilated cardiomyopathy 1C | Tg(Myh6-LDB3*S196L)93Mva | 1 model | |
dilated cardiomyopathy 1D | Tg(Myh6-TNNT2*R141W)#Ajm | 1 model | |
dilated cardiomyopathy 1D | Tg(Myh6-TNNT2*R141W)#Lian | 1 model | |
dilated cardiomyopathy 1E | Tg(Myh6*/tetO-SCN5A*F1759A)#Marx | 1 model | |
dilated cardiomyopathy 1R | Tg(Myh6-ACTC1*E361G)361.20Sbm | 1 model | |
dilated cardiomyopathy 1R | Tg(Myh6-Actc1*R312H)307Iko | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*D230N)HJcf | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*E54K)67Dfw | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*E54K)30Dfw | 1 model | |
familial cold autoinflammatory syndrome 4 | Tg(Cd74-Nlrc4*)1Kyas | 1 model | |
familial encephalopathy with neuroserpin inclusion bodies | Tg(Thy1-SERPINI1*G392E)333Icka | 2 models | |
familial temporal lobe epilepsy 1 | Tg(Lgi1*)#Mpan | 1 model | |
Feingold syndrome | Mirc1 | 1 model | |
fibrodysplasia ossificans progressiva | Tg(Eno2-Bmp4)3Jake | 1 model | |
fibrodysplasia ossificans progressiva | Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis | 1 model | |
Finnish type amyloidosis | Tg(Ckm-GSN*D187N)AJewe | 2 models | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*P111Q)F615Walz | 1 model | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*E896K)F75aWalz | 1 model | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6)F419Walz | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Camk2a-Tardbp)#Ckjs | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*A315T)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*G348C)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Thy1-TARDBP*)BOddo | 2 models | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)300Wha | 1 model | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)382Wha | 1 model | |
hyper IgE recurrent infection syndrome 1 | Tg(Stat3*)9199Alau | 1 model | |
idiopathic pulmonary fibrosis | Tg(SFTPC-Tnf)2Pva | 1 model | |
idiopathic pulmonary fibrosis | Tg(H2-K-Fosl2,-EGFP)13Wag | 1 model | |
juvenile polyposis syndrome | Tg(CAG-Bmpr1a*,-lacZ)1Nobs | 1 model | |
Lafora disease | Tg(CAG-EPM2A*C266S)1Bmin | 1 model | |
leukoencephalopathy with vanishing white matter | Tg(Plp1-Eif2ak3*)18Pop | 1 model | |
long QT syndrome 1 | Tg(Myh6-KCNQ1_i2)H05Desc | 1 model | |
long QT syndrome 1 | Tg(Myh6-KCNQ1_i2)H02Desc | 1 model | |
Machado-Joseph disease | Tg(CMV-ATXN3*94Q)94Pama | 2 models | |
Machado-Joseph disease | Tg(ATXN3*)67.2Cce | 2 models | |
Machado-Joseph disease | Tg(ATXN3*)84.2Cce | 3 models | |
Machado-Joseph disease | Tg(CMV-ATXN3*135Q)CPama | 1 model | |
Machado-Joseph disease | Tg(Htt-ATXN3*148Q)3746Thsc | 1 model | |
Machado-Joseph disease | Tg(Pcp2-ATXN3*69Q)bHirai | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*70Q)70.61Olri | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*79Q)#Hlw | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)148.19Olri | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)NLS.28Olri | 1 model | |
Marsili syndrome | Tg(Zfhx2*R1907K)#Jcox | 1 model | |
maturity-onset diabetes of the young type 3 | Tg(Ins2-TCF1*P291)2Kya | 1 model | |
maturity-onset diabetes of the young type 3 | Tg(Ins2-Hnf1a)#Cbw | 1 model | |
McCune Albright syndrome | Tg(EEF1A1-Gnas*R201C)184Pabi | 1 model | |
McCune Albright syndrome | Tg(PGK1-Gnas*R201C)60Pabi | 1 model | |
McCune Albright syndrome | Tg(tetO-HTR4*D100A)2Niss | 1 model | |
myofibrillar myopathy 1 | Tg(Myh6-Des*)641Rbns | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-CRYAB*R120G)7302Ijb | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-Cryab*R120G)708Rbns | 1 model | |
myofibrillar myopathy 3 | Tg(ACTA1-MYOT*T57I)71Mah | 1 model | |
myofibrillar myopathy 6 | Tg(Myh6-BAG3*P209L)#Mswi | 1 model | |
nemaline myopathy 1 | Tg(ACTA1-TPM3*M9R)4Hrd | 1 model | |
nemaline myopathy 3 | Tg(ACTA1*D286G)#Kjno | 2 models | |
nemaline myopathy 3 | Tg(ACTA1*D286G/EGFP)#Kjno | 1 model | |
Netherton syndrome | Tg(IVL-KLK5)#Hov | 1 model | |
neurodegeneration with brain iron accumulation 3 | Tg(PGK1-FTL*)#Sle | 1 model | |
neurodegeneration with brain iron accumulation 3 | Tg(Prnp-FTL*)4Ruvi | 1 model | |
Noonan syndrome 1 | Tg(Myh7-Ptpn11*Q79R)11Rbns | 1 model | |
Noonan syndrome 1 | Tg(CAG-cat,-Ptpn11*Q97R)1Rbns | 2 models | |
Noonan syndrome with multiple lentigines | Tg(Myh7-Ptpn11*Q510E)#Krnz | 1 model | |
Noonan syndrome with multiple lentigines | Tg(CAG-cat,-Ptpn11*Q510E)#Krnz | 1 model | |
osteogenesis imperfecta type 1 | Tg(COL1A1)73Prc | 1 model | |
osteogenesis imperfecta type 5 | Tg(Col1a1-Ifitm5*)1Brle | 1 model | |
Parkinson's disease 1 | Tg(THY1-SNCA*A53T)M53Sud | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*)#Ztzh | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*A30P)18Pjk | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*E57K)16Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA)4Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA*A53T)8Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA/EGFP)78Ema | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)25Mkle | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)83Vle | 2 models | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)AAub | 2 models | |
Parkinson's disease 1 | Tg(SNCA)ARyot | 1 model | |
Parkinson's disease 1 | Tg(SNCA*E46K)3Elan | 1 model | |
Parkinson's disease 1 | Tg(Snca-SNCA)#Galt | 1 model | |
Parkinson's disease 1 | Tg(Th-SNCA*)1702Yosh | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA)61Ema | 1 model | |
Parkinson's disease 2 | Tg(Slc6a3-PARK2*Q311X)AXwy | 1 model | |
Parkinson's disease 4 | Tg(Thy1-Snca)1S13Putt | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*R1441C)31Hlw | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*G2019S)32Hlw | 1 model | |
Parkinson's disease 8 | Tg(Lrrk2*G2019S)2Yue | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)704Ljp | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)671Ljp | 1 model | |
PCWH syndrome | Tg(Venus/SOX10*)55Kein | 2 models | |
Perry syndrome | Tg(Thy1-DCTN1*G71A)#Ytsu | 1 model | |
polycystic kidney disease 1 | Tg(Pkd1*)39Mtru | 2 models | |
polycystic kidney disease 2 | Tg(CAG-PKD2)#Hwl | 1 model | |
progeria | Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer | 1 model | |
progeria | Tg(LMNA*G608G)HClns | 1 model | |
pseudoachondroplasia | Tg(Col2a1-rtTA,tetO-COMP*)2Jath | 1 model | |
retinitis pigmentosa 4 | Tg(RHO*P347S)A1Tili | 3 models | |
retinitis pigmentosa 4 | Tg(RHO-P23H)DTpd | 1 model | |
retinitis pigmentosa 4 | Tg(Rho)1Wbae | 1 model | |
rippling muscle disease 2 | Tg(Ckmm-Cav3)1Ysu | 1 model | |
Sandhoff disease | Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa | 1 model | |
Sandhoff disease | Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa | 1 model | |
SOST-related sclerosing bone dysplasia | Rr20 | 1 model | |
SOST-related sclerosing bone dysplasia | Tg(RP11-209M4)AGglo | 2 models | |
Sotos syndrome | Del(13Simc1-B4galt7)2Dja | 1 model | |
spinocerebellar ataxia type 1 | Tg(Pcp2-ATXN1*82Q)5Horr | 1 model | |
spinocerebellar ataxia type 1 | Tg(tetO-ATXN1*82Q)#Horr | 1 model | |
spinocerebellar ataxia type 10 | Tg(Prnp-lacZ/ATXN10*)#Teas | 1 model | |
spinocerebellar ataxia type 14 | Tg(tetO-PRKCG*S361G,-GFP)3Jpka | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)105Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-27Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-16Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Pcp2-TBP*)69Hmhl | 1 model | |
spinocerebellar ataxia type 2 | Tg(Pcp2-ATXN2*127Q)#Plt | 1 model | |
spinocerebellar ataxia type 2 | Tg(ATXN2*72Q)#Plt | 1 model | |
spinocerebellar ataxia type 5 | Tg(tetO-SPTBN2*)#Lpwr | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)6076Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(RHO-SCA7)R7EJman | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)1963Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(Pcp2-SCA7)P7EJman | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2542Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2521Als | 1 model | |
split hand-foot malformation 1 | Del(6Dlx6-Dlx5)1Tlu | 1 model | |
spondyloepiphyseal dysplasia congenita | Tg(Col2a1*R789C)#Waho | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)1Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)2Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)3Kzh | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)2Nush | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)1Nush | 1 model | |
torsion dystonia 1 | Tg(Eno2-TOR1A*)13Shas | 1 model | |
transthyretin amyloidosis | Tg(TTR)#Jbux | 1 model | |
transthyretin amyloidosis | Tg(TTR-V30M)15Imeg | 3 models | |
tuberous sclerosis | Tg(CAG-Mtor*)#Atai | 1 model | |
tuberous sclerosis | Tg(CMV-Tsc2*)1Arbi | 1 model | |
type 1 diabetes mellitus 2 | Tg(Ins-Igf2)1Fbos | 3 models | |
Usher syndrome type 3 | Tg(Atoh1-Clrn1)#Kuna | 2 models | |
Werner syndrome | Tg(CAG-WRN*K577M)5025Wcl | 1 model | |
Williams-Beuren syndrome | Del(5Gtf2i-Fkbp6)1Vcam | 1 model | |
xeroderma pigmentosum | Tg(KRT5-Terf2)POBlas | 1 model | |
xeroderma pigmentosum | Tg(KRT5-Terf2)PMBlas | 1 model |